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Summary 
 
α3/4-Fucosyltransferases (α3/4-FUTs) are glycosyltransferases (GTs) 
that catalyze the transfer of fucose in an α3/4-linkage onto the                   
N-acetylglucosamine residue from acceptors containing the type II or type I 
(Galβ4/3GlcNAc, respectively) structures, thus synthesizing the fucosylated 
Lewis (Le) carbohydrate determinants. Fucosyltransferase IX (FUT9), the most 
recently identified member of the family, presents the higher divergence from the 
other FUTs and its sequence is the only highly conserved among species. FUT9 
synthesizes the Lewisx (Lex) epitope (Galβ4(Fucα3)GlcNAc). Recent evidence 
has suggested that it is the enzyme responsible for the synthesis of Lex in the 
mouse brain. Lex expression has been described in glycoproteins, proteoglycans 
and glycolipids from the central nervous system (CNS) of diverse species, 
including rodents and humans.  
The major goal of the work presented in this thesis has been to 
characterize human FUT9 and elucidate the functional role of Lex in 
differentiating neurons in vitro. In Chapter 2, FUT9 has been cloned from human 
NT2N neurons and overexpressed in HeLa cells (FUT9wt), where it presented in 
vivo activity with de novo synthesis of the Lex determinant. In vitro specificity 
studies towards small synthetic oligosaccharide acceptors linked to a 
hydrophobic moiety showed that FUT9wt synthesized preferentially Lex and Ley, 
whereas Lea was produced with low efficiency, and only in the presence of the 
activating manganese cation. The corresponding oligosaccharides substituted 
with α2,3-linked neuraminic acid were not acceptors of FUT9wt. FUT9wt has 
been found to efficiently fucosylate desialylated N-glycans from glycoproteins, 
such as human asialoerythropoietin, but not native sialylated erythropoietin. 
Detailed analysis of the modified glycan structures from asialoerythropoietin by 
HPAEC-PAD and MALDI/TOF-MS showed that FUT9wt predominantly 
transferred one fucose residue onto the outer antennae of di-, tri- and 
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tetrantennary structures, containing proximal fucose, with or without repeats, thus 
synthesizing the corresponding peripherally monofucosylated structures. 
Difucosylated glycans were also detected, although in minor amounts and only in 
tetrantennary structures with repeats. These results demonstrated the high 
specificity of FUT9 for the synthesis of the Lex determinant in N-linked glycans 
from glycoproteins. Furthermore, FUT9 is an adequate enzyme for in vitro 
synthesis of Lex-carrier glycoproteins. 
FUT9wt was localized in the trans-Golgi and trans-Golgi network (TGN) of 
HeLa cells, colocalizing with the trans-Golgi and TGN resident enzyme             
β4-galactosyltransferase and with the TGN marker TGN-46. Deletion of the 
cytoplasmic tail of FUT9, or just the Ser/Thr cluster contained in it, caused a shift 
to earlier Golgi sub-compartments, as indicated by higher colocalization with the 
cis-Golgi marker GM130 and redistribution into an endoplasmic reticulum-like 
pattern after incubation with brefeldin A. These results indicated that the 
information for intra-Golgi localization is contained in the cytosolic tail of FUT9.  
With the purpose of obtaining high amounts of recombinant FUT9, in 
Chapter 3, a soluble form of the enzyme, sFUT9, was overexpressed in the 
Spodoptera frugiperda Sf9 insect cell line. sFUT9 was efficiently secreted and it 
presented higher efficiency for fucosylating glycoproteins, both sialylated and 
non-sialylated, than full-length FUT9wt from HeLa cells. Thus, sFUT9 is suitable 
for synthetic purposes. Moreover, it can also be used for further functional and 
structural studies of FUT9, such as the determination of its three-dimensional 
structure. 
In Chapter 4, identification of FUT9 as the enzyme responsible for the 
synthesis of Lex in human NT2N neurons cultured in vitro was achieved through 
the detection of FUT9 transcripts by RT-PCR, detection of FUT9 protein by 
Western blot, and efficient synthesis of Lex and Ley using in vitro activity assays. 
Immunofluorescence confocal microscopy studies showed that the Lex 
determinant was present on the plasma membrane and in intracellular vesicles 
positive for the late endosomal/lysosomal marker lysosomal associated 
 xi 
membrane protein-1 (LAMP-1) and the v-SNARE tetanus neurotoxin-insensitive 
vesicle-associated membrane protein (TI-VAMP). Furthermore, Lex was found in 
the cell bodies and neurites of NT2N neurons. These results associated for the 
first time the Lex epitope with the TI-VAMP mediated exocytic pathway, known to 
be involved in neurite outgrowth. Moreover, antibody incubation assays with an 
anti-Lex monoclonal impaired adhesion of NT2N neurons to the surface matrix 
and inhibited neurite initiation of outgrowth.  
The levels of the Lex epitope during neuronal development in rat primary 
hippocampal cultures were also studied, as addressed in Chapter 5. Lex was 
detected in a subset of GABAergic interneurons, where it was also found to 
colocalize with the TI-VAMP marker similarly to that found in NT2N human 
neurons. On the plasma membrane of mature hippocampus GABAergic neurons, 
Lex was detected in spine-like protrusions or phillopodia, dendritic domains 
adjacent to synaptic regions. 
In conclusion, the work described in this thesis showed that FUT9 
synthesized the Lex epitope in human NT2N neurons, underlying neuronal 
adhesion and initiation of neurite outgrowth. Localization of Lex in the TI-VAMP 
exocytic pathway in both human and rat neurons suggested common functions 
for the carbohydrate determinant in the CNS of both organisms. Furthermore, the 
discovery of efficient synthesis of Lex on N-glycans from glycoproteins by FUT9 
indicated that the effectors of those biological functions could be Lex-glycoprotein 
carriers.  
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Sumário 
 
Os α3/4-fucosiltransferases (α3/4-FUTs) são glicosiltransferases (GTs) 
que catalizam a transferência de fucose, numa ligação α3/4, para resíduos de  
N-acetilglucosamina de aceitadores que contenham estruturas do tipo II ou do 
tipo I (Galβ4/3GlcNAc, respectivamente), sintetizando assim epítopos fucosilados 
designados determinantes Lewis (Le). O fucosiltransferase IX (FUT9) foi o último 
elemento da família a ser identificado, sendo o que apresenta maior divergência 
em relação aos outros FUTs e o único com elevada homologia entre espécies. O 
FUT9 sintetiza o epítopo Lewisx (Lex) (Galβ4(Fucα3)GlcNAc). Estudos recentes 
sugeriram que o FUT9 é responsável pela síntese do Lex no cérebro de 
murganho. A expressão do Lex foi descrita em glicoproteínas, proteoglicanos e 
glicolípidos do sistema nervoso central (SNC) de várias espécies, incluindo 
roedores e humanos. 
O objectivo principal do trabalho apresentado nesta tese foi a 
caracterização do FUT9 humano e a elucidação da função do Lex na 
diferenciação neuronal in vitro. No Capítulo 2, o FUT9 humano foi clonado de 
neurónios NT2N e sobrexpresso em células HeLa (FUT9wt), tendo apresentado 
actividade in vivo, com síntese de novo do determinante Lex. In vitro, estudos de 
especificidade usando aceitadores sintéticos, constituídos por pequenos 
oligossacáridos ligados a uma porção hidrófoba, revelaram que o FUT9wt 
sintetizou preferencialmente Lex e Ley, enquanto o Lea foi produzido com baixa 
eficiência e apenas na presença do catião manganês como activador. Os 
oligossacáridos correspondentes substituídos com ácido neuramínico, numa 
ligação α2,3, não foram aceitadores do FUT9wt. Foi observado que o FUT9wt 
fucosilou eficientemente N-glícidos não sialilados de glicoproteínas, como a 
asialoeritropoietina, mas não a eritropoietina nativa sialilada. A análise por 
HPAEC-PAD e MALDI/TOF-MS das estruturas glicídicas modificadas revelou 
que o FUT9wt transferiu predominantemente um resíduo de fucose para as 
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antenas exteriores de estruturas bi-, tri- e tetrarramificadas contendo fucose 
próxima, com ou sem repetições, sintetizando as estruturas correspondentes 
com monofucosilação periférica. Foram ainda detectados glícidos bifucosilados, 
embora em menores quantidades, e apenas em estruturas tetrarramificadas com 
repetições. Estes resultados demonstraram a elevada especificidade do FUT9 
para sintetizar o determinante Lex em N-glícidos de glicoproteínas. Indicaram 
ainda que o FUT9 é um enzima adequado para a síntese in vitro de 
glicoproteínas contendo Lex. 
O FUT9wt foi detectado no trans-Golgi e no trans-Golgi reticular (TGN) de 
células HeLa, colocalizando com o enzima β4-galactosiltransferase, residente no 
trans-Golgi e no TGN, e com o TGN-46, marcador do TGN. A remoção total da 
cauda citoplasmática do FUT9, ou apenas do cluster de Ser e Thr nela contido, 
provocou uma deslocalização do enzima para sub-compartimentos anteriores, 
revelada pela colocalização aumentada com a proteína GM130, marcadora do 
cis-Golgi, e pela redistribuição por compartimentos com uma marcação típica de 
retículo endoplasmático após incubação com brefeldina A. Estes resultados 
indicaram que a informação que determina a localização    intra-Golgi do FUT9 
está contida na cauda citoplasmática do enzima.  
Com o objectivo de obter quantidades elevadas de FUT9 recombinante, 
no Capítulo 3, foi sobrexpressa uma forma solúvel do enzima - sFUT9 - na linha 
celular de insecto Spodoptera frugiperda Sf9. O sFUT9 foi secretado 
eficientemente e apresentou uma eficácia superior na fucosilação de 
glicoproteínas, tanto sialiladas como não sialiladas, à apresentada pela forma 
total do enzima, FUT9wt, expressa em células HeLa. Assim, o sFUT9 é 
adequado para fins de síntese. Adicionalmente, poderá também ser utilizado em 
estudos funcionais e estruturais do FUT9, incluindo a determinação da estrutura 
tridimensional do enzima. 
No Capítulo 4, o FUT9 foi identificado como o enzima responsável pela 
síntese do Lex em neurónios humanos NT2N em cultura, com base na detecção 
de transcritos do FUT9 por RT-PCR, na detecção do enzima FUT9 por Western 
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blot e na síntese eficiente de Lex e Ley em ensaios de actividade in vitro. Estudos 
de microscopia confocal de imunofluorescência revelaram que o determinante 
Lex se encontrava na membrana plasmática e em vesículas intracelulares 
positivas para o marcador de endossomas secundários/lisossomas LAMP1 (do 
inglês lysosomal-associated membrane protein 1) e para a v-SNARE TI-VAMP 
(do inglês tetanus neurotoxin-insensitive vesicle-associated membrane protein). 
Foi ainda observado que o Lex se encontrava nos corpos celulares e nos 
prolongamentos neuronais dos neurónios NT2N. Estes resultados relacionaram 
pela primeira vez o epítopo Lex com a via de exocitose mediada pela TI-VAMP, 
que se sabe estar envolvida no crescimento dos prolongamentos neuronais. 
Para além disso, a incubação com um anticorpo monoclonal anti-Lex, reduziu a 
adesão dos neurónios NT2N à superfície da matriz e inibiu a iniciação do 
crescimento dos prolongamentos neuronais.  
Os níveis do epítopo Lex foram também estudados durante o 
desenvolvimento de culturas primárias do hipocampo de rato, como descrito no 
Capítulo 5. O Lex foi detectado num subgrupo de interneurónios GABAérgicos, 
tendo-se observado que colocalizava com o marcador TI-VAMP, à semelhança 
do verificado em neurónios humanos NT2N. Na membrana plasmática de 
neurónios GABAérgicos maturos, o Lex foi detectado em protuberâncias 
semelhantes a espículas ou filopodia, domínios dendríticos adjacentes a regiões 
sinápticas. 
Em conclusão, o trabalho descrito nesta tese mostrou que o FUT9 
sintetizou o epítopo Lex em neurónios humanos NT2N, estando na base dos 
processos de adesão neuronal e de iniciação do crescimento dos 
prolongamentos neuronais. A localização do Lex no compartimento exocítico 
definido pela TI-VAMP, tanto em neurónios humanos como de rato, sugeriu 
funções comuns para o determinante glicídico no SNC de ambos os organismos. 
Ademais, a descoberta de síntese eficiente de Lex em N-glícidos de 
glicoproteínas pelo FUT9 indicou que os efectores dessas funções biológicas 
poderão ser glicoproteínas decoradas com Lex.  
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Thesis Outline 
  
The work described herein concerns the study of fucosyltransferase IX in 
the central nervous system. Two lines of research were followed. One of them 
envisaged the characterization of human fucosyltransferase IX, while the other 
focused on the investigation of the biosynthetic product of the enzyme in 
neurons, the Lewisx determinant, and its biological role during neuronal 
differentiation.  
This dissertation starts with a general introduction to the 
endomembranous system of mammalian cells, where post-translational 
modifications, including glycosylation, occur. Particular relevance is given to the 
Golgi apparatus, as fucosyltransferase IX is a Golgi-resident protein. This is 
followed by an overview about protein glycosylation, including a summary of 
current knowledge of localization, structure and mechanism of 
glycosyltransferases. Fucosylation is focused in detail, specially the               
α3/4-fucosyltransferase family and the Lewisx determinant, one of its products. 
Finally, a brief characterization of the NTera 2 cell line as a model system for 
human neuronal differentiation is presented. 
Chapter 2 describes the cloning, overexpression and characterization of 
human fucosyltransferase IX. Studies concerning the substrate specificity of the 
enzyme, in particular towards glycoproteins, and its subcellular localization are 
presented. 
In Chapter 3, the production and characterization of a recombinant soluble 
form of human fucosyltransferase IX from Spodoptera frugiperda Sf9 cells is 
described. 
 Chapter 4 is concerned with the levels of Lewisx determinant during 
differentiation of human NT2N neurons and with the assignment of 
fucosyltransferase IX as the enzyme catalyzing its synthesis. The biological role 
of Lewisx in human neuritogenesis is addressed.  
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In Chapter 5, levels of Lewisx during the development of rat hippocampal 
neurons in culture are studied and the subpopulation of neurons that express the 
fucosylated determinant investigated.  
Chapter 6 consists of a general discussion, where future perspectives and 
main conclusions of the work are presented. 
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1. General introduction 
 
 
1.1. Membrane transport in mammalian cells 
 
A hallmark of eukaryotic cells is the presence of an elaborate 
endomembrane system that is responsible for the exchange of macromolecules 
between cells and their environment. The secretory pathway delivers newly 
synthesized proteins, carbohydrates and lipids to the plasma membrane and 
extracellular matrix, modifying them during the trafficking process (Figure 1, 
green arrows and membranes), whereas the endocytic pathway takes up 
macromolecules into the cell (Figure 1, blue arrows and membranes). Transport 
along these pathways occurs through anterograde or retrograde translocation of 
material between different membrane-enclosed organelles, via small vesicles and 
large transport containers. Despite this transfer, each organelle maintains its 
characteristic set of resident macromolecules via several mechanisms, of which 
retrieval (Figure 1, red arrows) plays a fundamental role (Bonifacino and 
Lippincott-Schwartz, 2003). 
 
 
1.1.1. The secretory pathway 
 
1.1.1.1. The endoplasmic reticulum 
 
The nascent proteins are targeted to the membrane of the endoplasmic 
reticulum (ER) and translocated into or across the ER via a cotranslational 
process. Once in the ER, proteins are processed for trafficking through the 
secretory pathway. One of the initial events in this process is the transfer of a 
precursor oligosaccharide to specific Asn residues in the polypeptide chain, the 
first step in N-glycosylation (See Section 1.2.1). Folding of the newly synthesized 
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polypeptides into their correct three-dimensional conformation is also started    
co-translationally in the ER. The quality control machinery in the lumen of the ER 
assures that only correctly folded proteins exit this compartment. Misfolded 
proteins are retained, triggering the unfolded protein response (UPR) pathway, 
which will regulate a battery of genes involved in ER-associated protein 
degradation (ERAD) but also in protein translocation, folding, glycosylation, and 
trafficking (reviewed by Ruddock and Molinari, 2006).  
Following ER processing, proteins are concentrated in ER export sites 
(ERES), specialized domains of the ER membrane, also known as transitional 
ER (tER), responsible for the export of secretory cargo. In mammalian cells, 
ERES are distributed throughout the cytoplasm but concentrated in the 
juxtanuclear region adjacent to the Golgi apparatus (GA) (reviewed by Watson 
and Stephens, 2005). These sites are characterized by the presence of the coat 
protein complex II (COPII) (Figure 1), formed by the assembly of a set of soluble 
proteins, which mediates the biogenesis of transport carriers. The COPII 
mediates the selection of cargo from within the ER lumen, either directly 
(transmembrane cargo molecules) or indirectly via specific cargo receptors 
(soluble cargo and some transmembrane cargo molecules) (reviewed by       
Tang et al., 2005). After detaching from the membrane of the ER, COPII carriers 
(vesicles and/or tubules) loose the COPII coat and undergo fusion to form 
pleiotropic membrane structures termed VTCs (vesicular-tubular clusters), that 
constitute the ER-to-Golgi-intermediate compartment (ERGIC, Figure 1). VTCs 
are then delivered to the cis-Golgi, fusing with the Golgi membrane and being 
absorbed into the stack (reviewed by Watson and Stephens, 2005).  
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Figure 1: Schematic representation of the secretory and endocytic pathways. In the 
secretory pathway (green arrows and membranes) newly synthesized proteins are 
exported from the ER via coat protein complex II (COPII) coated-carriers that fuse into 
the ER-to-Golgi intermediate compartment (ERGIC) and subsequently the cis-Golgi. 
Material is transported along the Golgi apparatus until the trans-Golgi network (TGN), 
where cargo targeted to endosomal compartments is packed in clathrin-coated vesicles 
and transported to the early endosome (EE) and to the late endosome (LE), while 
membrane components and secretory cargo are transported to the plasma membrane 
(PM). The endocytic pathway (blue arrows and membranes) can occur via clathrin-coated 
vesicles or caveolae. Molecules are internalized into EE, transported into the LE and 
subsequently packed into lysosomes (Lyso) for degradation. Lyso can also act as 
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secretory compartments, fusing with the PM. Multivesicular bodies (MVBs) derived from 
the LE can fuse with the PM, releasing the internal vesicles as exosomes. Retrieval is 
observed in the exocytic and endocytic pathways (red arrows): recycling of ER-resident 
proteins from the GA and intra-Golgi recycling are mediated by COPI-coated vesicles; 
internalized material can be recycled from the EE back to the PM directly or via recycling 
endosomes (RE). Adapted from Kartberg et al., 2005; Keller et al., 2006; van der Goot 
and Gruenberg, 2006; van Niel et al., 2006. 
 
 
1.1.1.2. The Golgi apparatus 
 
The GA comprises a stack of distinct compartments (cisternae) arranged 
from cis to trans. It acts as the central organelle of the secretory pathway, 
receiving newly synthesized proteins and lipids from the ER in the cis-side, 
covalently modifying them while they move through the stack to the trans-side, 
until the trans-Golgi network (TGN), where they are targeted to the final cellular 
destinations (anterograde transport) (Munro, 2005). Concomitantly, recycling of 
proteins and lipids to previous compartments (retrograde transport) occurs.  
A century after the GA discovery, fundamental molecular mechanisms 
underlying the maintenance of Golgi’s morphological and functional integrity, 
despite the constant flow of lipids and proteins along the exocytic pathway, 
remain unclear. These have been extensively addressed in the last decades, 
although they are still far from being fully understood.  
The observation of numerous, small sized (70-90 nm), peri-Golgi vesicles, 
which bud from the Golgi cisternae in a COPI coat dependent manner (Orci et al., 
1986; Malhotra et al., 1989), contributed to the proposal of several models. For 
many years, the predominant model defended vesicular transport and stable 
compartments, stating that newly synthesized cargo was transported in the 
anterograde direction by default. Transport would occur first via COPII vesicles 
leaving the ER and subsequently via COPI vesicles, budding and fusing 
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sequentially with Golgi cisternae. On the other hand, Golgi-resident proteins 
would be confined to the stable cisternae via retention signals excluding them 
from the trafficking vesicles (reviewed by Rothman and Wieland, 1996).  
However, the vesicular transport/stable compartments model could not 
explain the transport through the GA of molecules like 300 nm procollagen fibers 
(Bonfanti et al., 1998), far too large to fit in the vesicular transporters. 
Furthermore, it was observed that glycosyltransferases (GTs) localized in the  
cis-Golgi were processed by late-Golgi acting enzymes (Hoe et al., 1995; Harris 
and Waters, 1996) and that retrograde COPI vesicles recycled membrane-bound 
proteins containing the cytoplasmic ER recycling motif K(X)KXX (Cosson and 
Letourneur, 1994; Letourneur et al., 1994). 
Despite some divergent data (Orci et al., 2000; Cosson et al., 2002), in 
vitro and in situ studies showed that COPI vesicles were enriched in several 
Golgi-resident proteins, in a process dependent of GTP hydrolysis by the small 
GTPase ADP ribosylation factor 1 (ARF1) (Lanoix et al., 1999), and depleted of 
anterograde cargo that remained in the cisternae (Lanoix et al., 2001; Martinez-
Menarguez et al., 2001; Mironov et al., 2001; Malsam et al., 2005). In previous 
work we have observed that COPI vesicles, formed in vitro from Golgi 
membranes of Baby Hamster Kidney (BHK) cells, were enriched in the          
trans-Golgi and TGN resident enzyme fucosyltransferase III (FUT3), contrary to 
anterograde cargo, such as transferrin receptor (plasma membrane resident) or 
ApoE (soluble secretory protein), which were not detected in the same vesicles 
(Sousa et al., 2003). Lately, evidence suggested trafficking via transient tubular 
connections that may mediate several processes (reviewed by Mironov et al., 
2005), such as the recycling of GA resident enzymes (Kweon et al., 2004).  
All this data pointed to cisternal maturation/progression models, which 
stated that retrograde traffic via COPI transporters and/or tubular connections 
would be responsible for the constant maturation of Golgi cisternae into later 
compartments (reviewed by Kartberg et al., 2005).  
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Although this is still a theme subject to intense debate, the cisternal 
maturation model collects nowadays more substantial support from experimental 
evidence. Two very recent studies in yeast have shown that markers of the early 
Golgi were consistently replaced with late Golgi markers (but never vice versa) 
(Losev et al., 2006; Matsuura-Tokita et al., 2006), confirming by direct 
observation the cisternal maturation hypothesis. So, throughout this thesis 
localization in the GA will be discussed in the context of the cisternal maturation 
model. 
Assuming the cisternal maturation model, Golgi-resident proteins would 
be concentrated in retrograde COPI transporters and retrieved back to previous 
compartments. Therefore, Golgi localization would depend on sorting into COPI 
transporters and targeting to the acceptor membrane.  
 
1.1.1.2.1 COPI transporters 
COPI coat formation involves the interaction of the soluble coatomer 
protein complex to the membrane, via specific motifs present in the cytoplasmic 
domains of resident proteins (as, for example, the di-Lys K(X)KXX ER-retrieval 
motif) and via the small GTPase ARF1 in its GTP bound form. The several 
components polymerize in a lattice on the membrane, inducing sorting, budding 
and fission. Subsequent disassembly of the coat requires GTP hydrolysis on 
ARF1 by the membrane-associated GTPase activating protein for ARF1 
(ARFGAP) (reviewed by Lippincott-Schwartz and Liu, 2006). A role for ARFGAP 
in cargo sorting into COPI vesicles has also been suggested (reviewed by 
Kartberg et al., 2005) in a mechanism that would involve direct interactions with 
cytoplasmic domains of cargo proteins (Lanoix et al., 2001). 
Recently, new insights into the dynamics of COPI coat components, given 
by live-cell imaging techniques and photobleaching studies, suggested that all 
components and regulators involved in the process cycle on and off membranes, 
in a mechanism uncoupled from vesicle formation and independently of vesicle 
budding. The model hypothesizes that COPI coat has the ability to                  
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self-assemble, acting as a molecular machine that drives membrane sorting and 
trafficking processes (Lippincott-Schwartz and Liu, 2006).  
 
1.1.1.2.2. Membrane targeting 
After COPI vesicle formation, the processes of directioning, targeting, 
docking and finally fusion will depend on conserved proteins that act in a 
regulated cascade:  SNAREs (soluble N-ethylmaleimide-sensitive factor 
attachment protein receptors) on vesicle and target membranes, tethering factors 
and regulatory Rab small GTPases (Lupashin and Sztul, 2005).  
SNARES are a family of short coiled-coil membrane associated proteins 
that act in docking and fusion events, via the formation of a trans-SNARE 
complex (or SNAREpin) between one v-SNARE in the vesicle membrane and 
three t-SNAREs chains associated with the target compartment (reviewed by 
Hong, 2005). The combinatory use of different SNAREs gives rise to a wide 
variety of complexes. For example, the SNARE complexes consisting of 
GS15−Ykt6−GS-28−syntaxin-5 and membrin−Bet1−Sec22b−Syntaxin-5 are both 
involved in Golgi transport. After fusion, the trans-SNARE complex is converted 
into a cis-SNARE complex and then disassembles in a process driven by ATP 
hydrolysis (reviewed by Hong, 2005).  
Direct interactions between SNAREs and COPI coat have been observed 
(Rein et al., 2002). Formation of trans-SNARE complexes involved in intra-Golgi 
transport has been shown to require tethering factors, like the golgin p115 
(Shorter et al., 2002; Puthenveedu and Linstedt, 2004) and the multisubunit 
conserved oligomeric Golgi (COG) complex (Suvorova et al., 2002). Tethering 
factors, recruited by small GTPases, act as physical links, maintaining the 
vesicles and the acceptor membrane in close proximity (reviewed by Lupashin 
and Sztul, 2005). The number of known compartment-specific tethering factors 
(Allan et al., 2000; Shorter et al., 2002; Suvorova et al., 2002) is growing and 
cooperativity between different types of tethers was recently found (Sohda et al., 
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2007). This suggests a critical role for tethering factors in the fusion process, 
imposing membrane selectivity to vesicle-docking events.  
The identification of different subpopulations of COPI vesicles enriched in 
distinct cargo molecules, defined by different tethering factors and different 
SNAREs (Malsam et al., 2005), confirmed the importance of vesicle targeting 
events in the regulation of intra-Golgi transport. In summary, the concerted action 
of the large variety of SNAREs and tethering complexes, together with their 
effectors and regulators, impose membrane selectivity to vesicle-docking events 
and contributes to the spatial and temporal regulation of COPI transporters fusion 
with target Golgi membranes.  
 
 
1.1.1.3. The trans-Golgi network  
 
At the TGN, cargo is sorted into carriers moving to different destinations in 
the cell, including the endosomal compartments and the plasma membrane. In 
some cell types there is also regulated secretion from specific storage 
compartments. Evidence from live-imaging studies suggested that proteins 
travelling along the exocytic pathway leave the GA predominantly via tubular 
carriers emerging from specific cargo domains of the TGN (reviewed by Gleeson 
et al., 2004).  
Cargo targeted to the endosomal compartments is incorporated into 
clathrin-coated vesicles (Figure 1). The machinery needed for the formation of 
clathrin-coated vesicles is complex and involves the recruitment of clathrin 
adaptors which simultaneously bind to clathrin and to other machinery 
components including specific receptors (Owen et al., 2004). Clathrin adaptors, 
the heterotetrameric adaptor protein (AP) complexes AP-1, AP-2, AP-3, and   
AP-4 and the monomeric GGA1, GGA2, and GGA3 proteins, associate with the 
cytosolic domains of the transmembrane proteins via specific sorting signals. 
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 A classical example is the mannose 6-phosphate group (Man6P) present 
in lysosomal hydrolases. This glycan motif is recognized by the Man6P-receptor 
that recycles between the TGN and the endosomal compartment (reviewed by 
Gu et al., 2001). Other sorting signals that mediate endosomal and lysosomal 
targeting include the Tyr motifs, based on the amino acid sequence YXXØ 
(where X and Ø represents any amino acid residue and one with a bulky 
hydrophobic side chain, respectively), and the dileucine-based motifs 
(D/EXXXLL/I) (reviewed by Traub, 2005).  
Recent models propose that sorting continues at post-TGN locations. 
Evidence accumulated in the last years consolidates the hypothesis that 
endosomal intermediates are part of the secretory pathway (reviewed by 
Rodriguez-Boulan and Musch, 2005), as described below in Section 1.2.3. 
 
 
1.1.2. The endocytic pathway 
 
The endocytic pathway starts with the invagination of specific areas of the 
plasma membrane and internalization of the resulting vesicles (Figure 1). 
Endocytosis can occur via three main mechanisms: clathrin-coated vesicles, 
caveolae or non-caveolar non-clathrin entry pathways.  
With the exception of caveolae, whose destination can be regulated, all 
endocytic routes are thought to converge into endosomes. Endocytosed 
molecules first appearing in early endosomes (EE, Figure 1) where sorting takes 
place. Plasma membrane receptors are recycled directly or through recycling 
endosomes (RE, Figure 1), whereas other molecules are routed towards the 
TGN (Figure 1). Concomitantly, specific regions of the EE limiting membrane 
suffer local invaginations, which generate intraluminal vesicles. These contain 
cytoplasmic material and also membrane proteins with the extracellular domains 
exposed at the surface. EE regions enriched in intraluminal vesicles detach and 
fuse with the late endosomes (LE, Figure 1). Also, clathrin-coated vesicles 
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derived from the TGN fuse with the LE releasing digestive enzymes (Figure 1) 
(reviewed by van der Goot and Gruenberg, 2006; Perret et al., 2005).  
From the LE, some molecules are recycled to the TGN (Figure 1), like the 
Man6P-receptor, others integrated in intraluminal vesicles by reverse budding. 
These can be targeted to lysosomes (Lyso, Figure 1) for degradation or be 
integrated in multivesicular bodies (MVBs, Figure 1) that are targeted to the 
plasma membrane for exocytosis (Section 1.1.3) (reviewed by Keller et al., 2006; 
van Niel et al., 2006). 
Caveolae-mediated endocytosis (Figure 1) represents a low capacity but 
highly regulated pathway, restricted to certain cell types, contrary to the 
ubiquitous clathrin-mediated endocytosis. It occurs via caveolae, first described 
as smooth-surfaced flask-shaped pits covering the surface of many mammalian 
cell types (reviewed by Perret et al., 2005). The major protein constituent of 
calveolae is caveolin-1/caveolin-2 (or caveolin-3 in the muscle), associated with 
lipid raft domains (reviewed by Kirkham and Parton, 2005). Caveolar budding is 
induced by specific ligands such as viruses and toxins, like the simian virus 40 
and the cholera toxin. From caveolae, molecules can be sorted into EE or be 
transported to the ER or to the GA. In polarized cells, caveolae are also involved 
in basolateral-to-apical transcytosis (reviewed by Perret et al., 2005). 
Concerning the non-caveolar non-clathrin endocytosis, although its 
mechanisms and components are not well understood, it has been suggested to 
be a specialized high capacity pathway for lipids. Lipid-based sorting appears to 
be an important feature, as shown by sensitivity to cholesterol depleting agents 
and association of internalized components with lipid rafts (Kirkham and Parton, 
2005). 
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1.1.3. Non-conventional endosomal secretion  
 
Recently, novel findings suggested that endosomal compartments are key 
players not only in the endocytic pathway but also in the sorting of proteins in the 
biosynthetic routes, and that non-conventional secretion associated with 
endosomal compartments can also occur (reviewed by Rodriguez-Boulan and 
Musch, 2005).  
A mechanism of endosomal secretion occurs via MVBs, which can fuse 
with the plasma membrane and release their cargo into the extracellular space 
(Figure 1). The released intraluminal vesicles are called exosomes and many cell 
types secrete them via this mechanism, including haematopoietic cells, B- and  
T-lymphocytes, dendritic cells, mast cells, platelets, intestinal epithelial cells, 
astrocytes, tumor cells and neurons (reviewed by Keller et al., 2006;                
van Niel et al., 2006). 
Additionally, lysosomes also function as secretory organelles undergoing 
Ca2+-triggered exocytosis in non-specialized secretory cells. This pathway is 
involved in the membrane repair mechanism in several cell types, such as 
fibroblasts (Rodriguez et al., 1997; Reddy et al., 2001), and is subverted by the 
trypanosome parasite to invade the host cell (reviewed by Andrews, 2002). 
Melanosomes are also a form of secretory lysosome in melanocytes that store 
and release melanin (reviewed by Stinchcombe et al., 2004).  
Although the set of proteins required for effective lysosomal secretion 
varies in each cell type, lysosomal exocytosis involved in membrane repair has 
been shown to be regulated by the lysosomal Ca2+-sensor synaptotagmin VII 
(SYT7) (Martinez et al., 2000; Reddy et al., 2001). Membrane fusion is facilitated 
by the interaction of SYT7 with the plasma membrane t-SNARE, composed of 
synaptosomal associated protein of 23 kDa (SNAP-23) and syntaxin 4, which 
form a trans-SNARE complex with the lysosomal tetanus neurotoxin–insensitive 
vesicle associated membrane protein (TI-VAMP) (Rao et al., 2004). 
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 Secretory lysosomes seem to share many of the intricate molecular 
machinery required for neurite outgrowth: expression of TI-VAMP mutants 
(Martinez-Arca et al., 2000; Martinez-Arca et al., 2001) and TI-VAMP silencing in 
neuronal cells (Alberts et al., 2003) impaired neurite outgrowth; TI-VAMP forms 
trans-SNARE complexes with the plasma membrane syntaxin 4 and SNAP-25, 
the neuronal homologue of SNAP-23 (reviewed by Proux-Gillardeaux et al., 
2005). Furthermore, the involvement of SYT7 in neurite outgrowth was recently 
demonstrated (Arantes and Andrews, 2006), suggesting that Ca2+-regulated 
exocytosis from TI-VAMP-containing lysosomal compartments are the membrane 
source for neurite outgrowth. 
The non-conventional secretion events associated with endosomal 
compartments suggest the existence of cross talk between the secretory and 
endocytic pathways. A new perception of the endomembrane system and 
intracellular traffic emerges where the classical boundaries separating secretory 
and endocytic compartments become blurred. 
 
 
1.2. Protein glycosylation 
 
Glycosylation is the major post-translational modification of lipids and 
proteins that occurs along the secretory pathway of eukaryotic systems. Most 
secreted and membrane-bound proteins are glycosylated, from immunoglobulins 
to proteins of the extracellular matrix such as fibronectin and laminin (reviewed by 
Jones et al., 2005). The oligosaccharide components of glycoproteins and 
glycolipids were often thought of as elaborate sugar ornaments, but their 
importance in cell-cell communication, cell adhesion, cell protection and quality 
control has begun to be appreciated. 
The two most common types of glycosylation are N- and O-linked 
glycosylation. The N-glycosidic bond occurs via the nitrogen atom of the amide 
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group of an Asn residue and the O-glycosidic bond via the oxygen of any residue 
containing an hydroxyl group, like Ser or Thr (reviewed by Spiro, 2002).   
 
 
1.2.1. N-linked oligosaccharides   
 
In N-linked glycosylation, a preformed oligosaccharyl moiety 
(Glc3Man9GlcNAc2) is transferred from a dolichol-linked pyrophosphate donor to 
an Asn residue from a nascent polypeptide within the consensus sequence    
Asn-X-Ser/Thr, where X can be any amino acid residue except Pro. This initial 
step in the N-glycosylation pathway is catalyzed by the oligosaccharyltransferase 
(reviewed by Yan and Lennarz, 2005) and is the most ubiquitous co-translational 
protein modification occurring in the lumen of the ER. Initial processing of the 
oligosaccharide occurs in the ER, including removal of the three glucose (Glc) 
and one mannose (Man) units by glucosidases I and II, and α-mannosidase, 
respectively. Correct folding of the nascent glycoprotein is accompanied by the 
removal of the third Glc residue by glucosidase II, and subsequent trimming of a 
Man residue by α2-mannosidase marks the exit from the ER (reviewed by 
Herscovics, 1999). 
Processing continues in the GA with further trimming and addition of 
monosaccharides at the non-reducing end of the oligosaccharide by several GTs. 
Three different categories of N-linked oligosaccharides may be formed (Figure 2): 
high-mannose type, when the oligosaccharides remain unaltered after the initial 
trimming reactions, maintaining five to nine Man residues; complex-type, when 
there is further processing in the GA and the final structure presents a core of 
Man3GlcNAc2 and branches defined by N-acetylglucosamine (GlcNAc) residues 
and elongated by galactose (Gal), fucose (Fuc) and N-acetylneuraminic acid 
(NeuAc) residues; and the hybrid type when mannosidases of the GA do not act 
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after the addition of the first GlcNAc residue, resulting in complex structures on 
one arm and Man residues on the other (reviewed by Dennis et al., 2001). 
  
 
 
Figure 2: Schematic representation of N-linked oligosaccharide biosynthetic 
pathways in the Golgi apparatus. The high-mannose Man8GlcNAc2 core structure exits 
the ER to the Golgi apparatus (GA) where hybrid and complex N-glycans are formed by 
the sequential action of glycosidases and glycosyltransferases: mannosidase I (ManI);  
N-acetylglucosaminyltransferase I (GlcNAcTI); mannosidase II (ManII);                           
N-acetylglucosaminyltransferase II (GlcNAcTII); α6-fucosyltransferase (α6-FucT);         
β4-galactosyltransferase I (GalTI), α2,3-sialyltransferase (SialylT) and                        
α3/4-fucosyltransferase (FucT). Arrowheads indicate locations of possible elongation and 
branch formation. Adapted from Varki, 1999; Czlapinski and Bertozzi, 2006.   
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N-glycosylation presents enormous variation: macroheterogeneity arises 
from the fact that it does not occur at every potential glycosylation site, even 
among different molecules of the same protein, and microheterogeneity is caused 
by the different structures presented by the oligosaccharide moiety occupying 
each glycosylation site (reviewed by Jones et al., 2005). The glycosylation profile 
depends upon the sequential action of Golgi-resident glycosidases and especially 
of GTs. Factors such as differential tissue-specific expression of the enzymes, 
order of distribution of the enzymes along the secretory pathway, enzyme 
specificity and site accessibility of the substrate, donor availability, among others, 
affect the final structure of the oligosaccharide (reviewed by Czlapinski and 
Bertozzi, 2006). 
 
 
1.2.2. O-linked oligosaccharides   
 
In O-linked glycosylation, monosaccharide residues are sequentially 
added directly onto the protein, in contrast to the pre-assembled oligosaccharyl 
precursor that initiates N-linked glycosylation. There is not a consensus 
sequence and there are several possible O-glycosidic linkages, the mucin-type 
(GalNAc-α-Ser/Thr) being the best characterized. Mucin-type glycosylation is 
based on a set of 8 core O-linked oligosaccharide structures, which are further 
elongated by the addition of Gal, Fuc and NeuAc residues, with core 1 to        
core 4-types being the most common (Figure 3). Core 1-type structures are 
formed by the addition of a β3 linked Gal residue to N-acetylgalactosamine 
(GalNAc) and further substitution of GalNAc with a GlcNAc residue in a β6 
linkage gives core 2-type structures. Core 3-type structures are formed by the 
addition of a β3 linked GlcNAc residue to the initial GalNAc, and core 4-type 
structures present an additional substitution with β6 linked GlcNAc. The core 
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structures can be further elongated with GlcNAc, Gal, Fuc and NeuAc as 
exemplified in Figure 4 (reviewed by Peter-Katalinic, 2005).  
 
 
Figure 3: Schematic representation of core 1, core 2, core 3 and core 4 O-linked 
oligosaccharide subtype biosynthetic pathways. Core 1 and core 2 O-glycans 
subtype formation is regulated by β3-galactosyltransferase (Core 1 GalT) and               
β6-N-acetylglucosaminyltransferase (Core 2 GlcNAcT) activities, whereas core 3 and 
core 4 subtypes are controlled by β3-GlcNAcT (Core 3 GlcNAcT) and β6-GlcNAcT   
(Core 4 GlcNAcT). Branching by sequential action of several glycosyltransferases is 
represented by (n). Arrowhead indicates location of possible additional linkage. Symbols 
as in Figure 2 and  for N-acetylgalactosamine. Adapted from Varki, 1999. 
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Although less investigated, O-GlcNAc-type glycosylation, O-fucosylation, 
O-mannosylation, and O-glucosylation are also observed (reviewed by Spiro, 
2002). O-linked attachment of GlcNAc to Ser and Thr residues of nuclear and 
cytoplasmic proteins is not elongated nor further modified. It has gained 
considerable attention in the last years, not only because of its unusual cellular 
localization but also because it is rapidly reversible. Cycling of O-GlcNAc is 
controlled by soluble N-acetylglucosaminyltransferase (GlcNAcT) and                
N-acetylglucosaminidase in response to various cellular stimuli. This is a highly 
dynamic post-translational modification that plays a key role in signal transduction 
pathways, acting as a nutrient and stress sensor (reviewed by Hart et al., 2007). 
Numerous proteins have been identified as targets of O-GlcNAc, and modulation 
of O-GlcNAc levels has been shown to modify DNA binding, enzyme activity, 
protein–protein interactions, protein half-life and subcellular localization (reviewed 
by Zachara and Hart, 2004). Deregulation of the O-GlcNAc glycosylation cycle 
has been associated with several pathologies, including diabetes, 
cardiomyopathy and neurological disorders (reviewed by Hart et al., 2007). 
 
 
1.2.3. Glycosaminoglycans  
 
Historically, proteoglycans (PG) have been considered a distinct class of 
glycoproteins due to their unique structural characteristics. They are composed of 
a protein core that has one or more long linear glycosaminoglycan (GAG) chains, 
made up of repeating disaccharide units. Depending upon the composition of the 
GAG chains, PGs can be classified as heparin, chondroitin sulfate, dermatan 
sulfate, heparan sulfate or keratan sulfate PGs. GAGs are characterized by their 
high number of negatively charged functional groups, like carboxylate and sulfate 
(reviewed by Cattaruzza and Perris, 2006).  
Usually PGs are heavily O-glycosylated, via an O-glycosaminoglycan 
linkage in which GAG chains are attached to Ser or Thr via a β-linked xylose 
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(reviewed by Peter-Katalinic, 2005). The sequential addition of two β-Gal 
residues and a β3-linked glucoronic acid (GlcA) form the common 
tetrasaccharide from which the polymerization reactions occur. In the case of 
keratan sulfates, the GAG chains can be N- or O-linked to the protein core 
(Bulow and Hobert, 2006). 
 PGs are components of the extracellular matrix (ECM) of several tissues, 
contributing to configuration and integrity, especially in structural tissues like 
cartilage, blood vessels and brain (reviewed by Cattaruzza and Perris, 2006). 
 
 
1.2.4. Glycosyltransferases 
 
Glycosyltransferases are a large family of enzymes, involved in the 
biosynthesis of glycoconjugates that catalyze the transfer of a monosaccharide 
residue from an activated nucleotide sugar donor to the acceptor glycoconjugate, 
forming a glycosidic bond. GTs are characterized by its exclusivity for a 
nucleotide-sugar donor, being named according to it, and by a very precise 
specificity for the acceptor substrates. The monosaccharide residues are 
transferred individually to the acceptor, allowing the stepwise building of the 
oligosaccharide chain by the sequential action of different GTs. These are 
distributed along the exocytic pathway, mainly in the GA. Golgi-resident GTs are 
type II membrane proteins with a short N-terminal cytosolic tail, a single 
transmembrane domain (TM), a flexible region adjacent to the TM called stem 
and a large C-terminal globular catalytic domain facing the lumen of the GA 
(Paulson and Colley, 1989). 
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1.2.4.1. Glycosyltransferase localization 
 
Much of the GTs that catalyze the glycosylation of proteins and lipids in 
mammalian cells are localized in the GA. As referred in Section 1.2.1, relative 
localization of GTs is a factor of extreme importance in the determination of the 
oligosaccharide structures. Early-acting enzymes are concentrated in cis 
cisternae while late acting enzymes are enriched in the medial- and trans-Golgi, 
in an organization that has often been compared to an assembly line. 
Nevertheless, GTs are not strictly confined to particular cisternae but distributed 
in gradients along the Golgi stack, with consequent overlap of several enzymes 
(Nilsson et al., 1993). In Figure 4, this is exemplified for GTs from the N-linked 
oligosaccharide biosynthetic pathway.  
 
 
 
Figure 4: Schematic representation of the distribution of glycosyltransferases in 
the Golgi apparatus. Golgi-resident GTs are constantly recycled within the stack by 
retrograde transport via COPI carriers (red arrows) maintaining their distribution 
gradients. N-acetylglucosaminyltransferase I and II (GlcNAcTI and GlcNAcTII, 
respectively); α6-fucosyltransferase (α6-FucT); β4-galactosyltransferase (GalT);        
α2,3-sialyltransferase (SialylT); α3/4-fucosyltransferase (α3-FucT). Anterograde cargo is 
transported along the GA until the trans-Golgi network (TGN) (green arrowheads), where 
it is packed in clathrin-coated vesicles and delivered to the final destinations (green 
arrows). Adapted from Kornfeld and Kornfeld, 1985; Weiss and Nilsson, 2000. 
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Newly synthesized GTs are themselves cargo molecules of the exocytic 
pathway, transported from the ER to their specific destination in the GA. Thus, 
the mechanisms involved in their localization will be dependent on the 
mechanism of transport through the GA and also on the mechanisms underlying 
the maintenance of steady-state composition of the organelle referred in Section 
1.1.1.2.  
Common sorting motifs have never been found on the peptide sequences 
of the cytosolic tails of GTs. Studies with deletion mutants of resident GTs or 
fusion proteins with non-Golgi proteins have been carried out and revealed that 
the TM was essential for Golgi localization. Its presence was sufficient to target 
proteins from other subcellular compartments to the GA, as shown for              
β4-galactosyltransferase (GalT) (Teasdale et al., 1992; Teasdale et al., 1994), 
although the cytosolic tail of this trans-Golgi enzyme has also been shown to be 
involved in its localization (Nilsson et al., 1991). It was observed for other GTs 
that TM flanking regions were important for Golgi localization, for example,   
α2,6-sialyltransferase (SialylT) cytosolic tail and stem spaced by a TM of the 
same length as that of SialylT were sufficient for Golgi retention (Munro, 1991). In 
the last years, special attention has been given to the cytosolic tail proposed to 
play an accessory role to TM regions, conferring the specific sub-Golgi 
localization. Actually, for α2-FUT and α3-GalT the cytosolic tails have been 
shown to be sufficient for Golgi localization (Milland et al., 2001; Milland et al., 
2002). Furthermore, removal of the cytosolic tail of FUT3, a trans-Golgi/TGN 
resident enzyme, caused a localization shift to previous Golgi cisternae (Sousa  
et al., 2004). For the glycolipid SialylTII and N-acetylgalactosaminyltransferase 
(GalNAcT), proximal and distal Golgi enzymes respectively, swapping of the 
cytosolic domains did not affect Golgi localization but was sufficient to invert sub-
Golgi location of chimeric proteins (Uliana et al., 2006a). These data 
substantiates the role of the cytosolic tail of Golgi-resident GTs on the fine 
regulation of intra-Golgi localization. 
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Several Golgi-resident enzymes, such as mannosidase II (Lanoix et al., 
1999; Lanoix et al., 2001), GlcNAcTII, β4-GalT (Love et al., 1998) and FUT3 
(Sousa et al., 2003), have been shown to concentrate into COPI vesicles (Figure 
4). Although the direct binding of COPI coat components to the cytosolic domains 
of Golgi-resident proteins constitutes a direct way of ensuring the incorporation 
into vesicles (reviewed by Duden, 2003), this is not the case for Golgi GTs. Their 
cytosolic tails do not possess sorting motifs, contrary to the above-mentioned   di-
Lys motif present in ER-resident membrane proteins, and are probably too short 
to be able to interact directly with coat components. Thus, the mechanisms 
responsible for the correct localization of GTs in the GA are far from being 
understood. 
 
 
1.2.4.2. Glycosyltransferase structure and mechanism  
 
GTs have been classified into families on the basis of sequence 
similarities, identity of donor sugar and relative donor/product stereochemistry 
(Coutinho et al., 2003). The CAZY (Carbohydrate-Active enzymes) database 
comprises almost one hundred GT families (named GT1, GT2, etc.) and is 
constantly being updated (http://www.cazy.org/CAZY/). 
Despite the large number of families identified and the lack of significant 
primary structure homology among most families, the determination of the crystal 
structures of several GTs in recent years led to the proposal of just two major 
structural superfamilies: GT-A and GT-B. The classification was based on the 
observation of common topologies, similar or very close to the classical structural 
α/β/α sandwich motif called Rossmann-type fold, in the catalytic domains of the 
GTs for which the X-ray structure has been solved. In addition, the analysis of the 
uncharacterized families predicted that the majority adopt one of these two folds 
(Unligil and Rini, 2000; Bourne and Henrissat, 2001; Mulichak et al., 2001). This 
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may indicate that all transferases have evolved from a small number of progenitor 
sequences.  
All enzymes from the GT-A family share as common feature the DxD 
motif, shown to be involved in the interaction with the nucleotide sugar donor, via 
co-ordination of a divalent cation, typically Mn2+, in an octahedral geometry. The 
cation coordinates six oxygen atoms from one or both Asp residues and the        
α and β phosphate groups of the donor, together with two water molecules. GTs 
from this family require a divalent cation as cofactor and present two conserved 
regions – an N-terminal nucleotide binding domain with a topology that resembles 
a Rossmann fold and terminates with the DxD motif and a more variable            
C-terminal domain involved in recognition of the acceptor (reviewed by Breton et 
al., 2006). 
On the other hand, GT-B fold is characterized by two separate domains 
with Rossmann topology, connected by a linker region that comprises the 
catalytic site. The C-terminal domain, responsible for the nucleotide binding, is 
highly conserved. Greater variations are observed in the N-terminal domain, in 
the region involved in acceptor binding. In the GT-B family no conserved residue 
has been observed and, although divalent cations may act as activators, they are 
not essential for enzymatic activity (reviewed by Breton et al., 2006). 
Catalytically, GTs can be classified as inverting or retaining, depending if 
the anomeric configuration of the added monosaccharide residue in the product 
is inverted or retained with respect to the starting material. The mechanism of 
catalysis by inverting GTs has been proposed to be analogous to the one 
presented by inverting glycosidases: the carboxylate anion of an acidic amino 
acid residue present in the catalytic site (usually an Asp) deprotonates the 
acceptor sugar, facilitating the nucleophilic attack at C1 of the monosaccharide 
donor. This favours direct SN2 displacement of the nucleoside diphosphate with 
inversion of configuration (reviewed by Lairson and Withers, 2004). A metal ion 
(usually Mn2+) plays the role of electrophilic catalyst in GT-A family GTs, as 
referred above. The mechanism of retaining glycosidases has not yet been 
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elucidated. It was proposed to be a double-displacement mechanism, involving 
formation of a glycosyl-enzyme intermediate but the existence of this 
intermediate has never been demonstrated. More recently, an alternative 
mechanism called SNi-like was suggested, proposing a direct attack by the 
acceptor and departure of the leaving group of the donor on the same face 
(reviewed by Lairson and Withers, 2004). 
 
 
1.3. Fucosylation  
 
Fucose is a common component of N-, O- and lipid-linked 
oligosaccharides produced by mammalian cells. Usually fucosylation is a terminal 
modification of the glycan structure, with Fuc linked in an α2 glycosidic bond to 
Gal and α3, α4 or α6 to GlcNAc, although in the case of O-linked Fuc elongation 
with β-linked GlcNAc or β-linked Glc may occur (Moloney et al., 1997; Moloney 
and Haltiwanger, 1999). This variety of possible linkages originates a multiplicity 
of fucosylated structures (Figure 5). A wide range of roles has been assigned to 
terminal Fuc-containing oligosaccharides, whose expression is often regulated 
during cell differentiation and development, as well as in several pathological 
processes. Some of these functions will be covered in the following sections but, 
given the diversity of Fuc containing structures, it is probable that many remain 
unknown. 
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Figure 5: Structures of common fucosylated epitopes. (A) ABO blood group antigens; 
(B) Lewis-related antigens. R indicates N-, O- or lipid-linked precursors. Symbols as in 
Figure 2 and  represents N-acetylgalactosamine. Adapted from Becker and Lowe, 
2003.  
 
The study of fucosyltransferases (FUTs), the GTs that catalyze the 
transfer of Fuc residues from the GDP-Fuc donor to the acceptor molecules, has 
been of great importance in unraveling the functions of fucosylated epitopes. 
General introduction 
27 
FUTs have been classified into four families - α2-FUT, α3/4-FUT, α6-FUT 
and O-FUT - according to the site of Fuc addition. So far, thirteen genes coding 
for FUTs were identified in the human genome. α2, α3/4 and α6 known FUTs are 
typical Golgi-resident type II membrane proteins (reviewed by Ma et al., 2006) 
whereas O-FUTs are ER resident soluble enzymes (Luo and Haltiwanger, 2005). 
Golgi-resident FUTs will be addressed in the following sections. 
Concerning O-FUTs, two human enzymes are known - FUT12 (POFUT1) and 
FUT13 (POFUT2) - which transfer Fuc directly to the hydroxyl groups of Ser and 
Thr residues of glycoproteins that contain the epidermal growth factor (EGF) or 
thrombospondin type repeat sequences, respectively (reviewed by Ma et al., 
2006).  
 
 
1.3.1. The α2- and α6-fucosyltransferases 
 
FUT1 and FUT2 are α2-FUTs that transfer Fuc to terminal Gal residues 
from glycoproteins and glycolipids, synthesizing the H blood group antigen 
(Figure 5A). FUT1, also known as H transferase is expressed in erythroid 
precursors while FUT2, or secretor  transferase, is expressed in epithelial tissues 
and salivary glands and determines the secretory status. The H antigen can be 
further modified to A or B antigen, in individuals expressing the required GTs, 
encoded by the ABO locus. The expression of A transferase, B transferase, both 
or none of the enzymes are the basis of the classic ABO system of blood typing. 
Although the functional significance of the expression of the ABO blood group 
epitopes on erythrocytes is not clear, its high immunogenicity is a key issue in 
compatibility of blood transfusions (reviewed by Becker and Lowe, 2003). 
FUT8 catalyzes the addition of Fuc in an α6 linkage to the innermost 
GlcNAc moiety of the core of N-linked glycans. Core fucosylation is frequently 
observed in N-glycans of several human glycoconjugates, including EGF, TGF-β 
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receptors (Wang et al., 2005; Taniguchi et al., 2006; Wang et al., 2006) and 
human IgG1 (Shields et al., 2002). The importance of α6-fucosylation was 
confirmed by the phenotype presented by the FUT8 knockout mouse: growth 
retardation, lung emphysema and death during postnatal development        
(Wang et al., 2005). Recently, the X-ray structure of human FUT8 was solved 
(Ihara et al., 2007), constituting the first known three-dimensional structure for a 
FUT. The enzyme appears to have a catalytic region similar to GT-B GTs rather 
than GT-A and, in addition, it contains an SH3 domain at the C-terminus, which is 
quite similar to the SH3 domains found in other proteins but unique in GTs   
(Ihara et al., 2007). Further studies will be required to elucidate the function of 
this domain. 
 
 
1.3.2. The α3/4-fucosyltransferase family 
 
 FUT3 to FUT7 and FUT9 constitute the α3/4-FUT family, which catalyzes 
the transfer of Fuc to the GlcNAc moiety of type I (Galβ3GlcNAc) or type II 
(Galβ4GlcNAc) N-acetylactosamine (LacNAc) structures, determining the 
synthesis of Lewis-related epitopes (Figure 5B). Sequence analysis of the     
α3/4-FUT family members revealed that the N-terminal regions of FUTs (variable 
segment) contain the highest sequence heterogeneity while the C-terminal 
portions (constant segment) present higher homology (Figure 6) (reviewed by   
de Vries et al., 2001), and allowed the identification of several conserved peptide 
motifs in the catalytic domains.  
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Figure 6: Schematic representation of human α3/4-fucosyltransferases. The 
cytosolic (cyt) tail, the transmembrane domain (TM), the stem region and the catalytic 
domain are represented. The conserved peptide motifs of the α3/4 family are indicated: 
the α3-motifs I and II; the motif III that marks the beginning of the catalytic domain and 
the acceptor binding motif (abm). Adapted from Dupuy et al., 2004. 
 
Motifs I and II, present in the constant segment (Figure 6), characterize 
the α3/4-FUTs (Oriol et al., 1999). Recently, using the “Ala screening 
mutagenesis” approach in motif II of FUT3 and FUT6, it was determined that 
while some amino acid residues within this motif were essential for enzyme 
activity, others affected the affinity for donor and acceptor substrates (Jost et al., 
2005). Motif III, in the variable segment, contains the first amino acid residues 
required for correct folding and catalytic activity (Dupuy et al., 2002). The 
acceptor-binding motif (abm), also in the variable segment, is involved in enzyme 
specificity (Dupuy et al., 1999).  
The specificity patterns presented by the six members of the family are 
different. All possess α3-activity, although FUT3, the Lewis type enzyme, has 
only residual α3-FUT activity and shows predominant α4-FUT activity forming the 
Lewisa (Lea), sialyl-Lewisa (sLea) and Lewisb (Leb) determinants (Costa et al., 
1997). FUT3 together with FUT5 (de Vries et al., 1995) are the only enzymes that 
present α4-FUT activity. It has been shown by domain-swapping experiments 
that the region responsible for the differences in type I / type II specificity was the 
aforementioned abm (Xu et al., 1996). A single aromatic residue within this motif 
was required for the ability to bind type I acceptors (Dupuy et al., 1999; Dupuy   
et al., 2004). FUT3, FUT5 and FUT6 genes share very high sequence identity 
and are organized in a cluster, constituting the Lewis FUT gene subfamily. FUT6, 
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the plasma type FUT (Mollicone et al., 1994), and FUT5 synthesize Lewisx (Lex) 
and sialyl-Lewisx (sLex) determinants (Weston et al., 1992b; Weston et al., 
1992a; de Vries et al., 1995). FUT7, the leukocyte type, can only transfer Fuc to 
sialylated type II structures, with synthesis of sLex (Natsuka et al., 1994). FUT4, 
the myeloid type enzyme, synthesizes mostly the Lex epitope (Lowe et al., 1991; 
Sherwood et al., 2002). FUT9 (Kaneko et al., 1999b), that also synthesizes 
preferentially the Lex epitope (Toivonen et al., 2002), will be discussed in further 
detail in Section 1.3.2.1. FUT10 and FUT11 have been identified as α3-FUTs due 
to their homology with other FUTs (Roos et al., 2002), however, their activity has 
not been validated yet (Baboval et al., 2000). 
Lewis-related epitopes have been implicated in several cellular processes. 
The sLex determinant is of particular importance in inflammation, as it is the 
functional ligand of E-, P- and L-selectins, which mediate lymphocyte homing and 
leukocyte-endothelial cell adhesion events. FUT7 and FUT4 are the only          
α3-FUTs expressed in leukocytes (reviewed by Lowe, 2003). Abrogation of 
FUT7, FUT4 or both in the mouse model revealed that although FUT7 plays a 
major role in selectin-dependent adhesive activities, FUT4 also contributes to the 
synthesis of sLex (reviewed by Lowe, 2003). Another example of the important 
function of fucosylated glycans is their altered expression in cancer. Upregulation 
of sLea and of sLex has been shown for several cancers, associated with disease 
progression and bad prognosis. The epitopes are believed to promote metastasis 
via interaction with E- and P-selectins (reviewed by Becker and Lowe, 2003). 
Furthermore, in the host-microbe interaction between the gastric pathogen 
Helicobacter pylori and the gastric epithelium, a role for Lewis-related epitopes 
has been suggested. As the gastric surface epithelia express predominantly Lea 
and Leb and the gastric deep glands Lex and Ley, it was proposed that H. pylori, 
which expresses the same determinants, would use molecular mimicry to evade 
the immune system of the host and maintain a long-term infection (reviewed by 
Ma et al., 2006). Lex epitopes present on H. pylori have been shown to bind to 
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DC-SIGN (dendritic cell –specific ICAM-3 grabbing nonintegrin), a C-type lectin 
present on dendritic cells (Appelmelk et al., 2003) that binds several pathogens 
and is thought to play an important role in the modulation of the immune 
response (Cambi et al., 2005). The role envisioned for the Lex epitope in the CNS 
and development will be discussed in Section 1.3.3. 
 
 
1.3.2.1. Fucosyltransferase IX 
 
FUT9 is the most recently cloned member of the α3/4-FUT family (Kaneko 
et al., 1999b). Its sequence presents the lowest homology with the other FUTs 
and is the only one highly conserved among species (Kudo et al., 1998; Kaneko 
et al., 1999b; Baboval et al., 2000; Patnaik et al., 2000). Thus, FUT9 must have 
been under strong selective pressure during evolution, suggesting that it is 
responsible for an essential biological activity. FUT9 is able to synthesize 
efficiently the Lex and Ley epitopes but presents low reactivity towards 
NeuAcα2,3Galβ4GlcNAc and type I-based acceptors, with poor synthesis of sLex, 
Lea, sLea and Leb (Cailleau-Thomas et al., 2000; Toivonen et al., 2002). FUT9 
exhibits a unique site-specificity, generating terminal Lex motifs more efficiently 
than all the other α3-FUTs (Nishihara et al., 1999). 
 
 
Figure 7: Schematic representation of the reaction catalized by human                  
α3-fucosyltransferase IX (FUT9). FUT9 catalyzes the synthesis of the Lewisx (Lex) 
epitope using as substrate type II-based acceptors (Galβ4GlcNAc). R represents N-,     
O- and lipid-linked glycans. Symbols as in Figure 2. Adapted from de Vries et al., 2001. 
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A detailed analysis of FUT9 specificity towards type II polylactosamine 
acceptors revealed that the enzyme preferentially fucosylates terminal LacNAc 
units of neutral chains. However, when the polylactosamine is substituted with 
α2,3-linked NeuAc, the site-specificity of FUT9 is shifted to the two innermost 
LacNAc units (Toivonen et al., 2002). 
The differences in the acceptor profiles together with the differences in 
tissue distribution of the several α3-FUTs could underlie distinct biological roles. 
The human FUT9 gene is localized in chromosome 6q16 (Kaneko et al., 1999a), 
comprises a single exon, and is transcribed in two transcripts of different sizes 
that present tissue specific distribution (Cailleau-Thomas et al., 2000), implying 
that regulatory sequences may be present. The expression of the 2 kb transcript 
is ubiquitous in embryonic tissues and decreases in adult tissues. The 12 kb 
transcript presents a tissue-specific distribution, being strongly expressed in the 
embryonic brain and decreasing in adult brain. In adult tissues it is also detected 
in kidney, pancreas and placenta (Cailleau-Thomas et al., 2000). FUT9 is also 
expressed in human granulocytes and peripheral leukocytes (Nakayama et al., 
2001), where it synthesizes the Lex determinant present on a class of adhesion 
molecules of the immunoglobulin superfamily that binds to the DC-SIGN lectin on 
dendritic cells (Bogoevska et al., 2006; Bogoevska et al., 2007).  
FUT9 is mainly expressed in the CNS, in both developing and mature 
brain of human, rat and mouse (Kaneko et al., 1999b; Baboval et al., 2000; 
Cailleau-Thomas et al., 2000). It has also been shown to be increasingly 
expressed during neuronal retinoic acid-induced differentiation of PC19 murine 
embryonic carcinoma (EC) cells (Osanai et al., 2001). FUT9 has been shown to 
be the α3-FUT responsible for the synthesis of Lex in the mouse brain (Nishihara 
et al., 2003; Kudo et al., 2007), where it is controlled by Pax6, a transcription 
factor involved in brain patterning and neurogenesis (Shimoda et al., 2002). 
Recently, the importance of FUT9 for the synthesis and role of Lex in mouse brain 
was unequivocally shown with the study of FUT9-/- mouse (Kudo et al., 2007). 
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This animal showed disappearance of Lex in the brain, concomitant to increased 
anxiety-like behaviours. FUT9 appears to play a role in the functional regulation 
of interneurons from basolateral amygdala, as detected by a decreased number 
of calbindin-positive neurons in this region of the brain (Kudo et al., 2007). 
Taken together, the evidence presented points towards a spatial and 
temporal regulation of FUT9 expression and a specific role for this enzyme in 
embryonic and post-natal brain development.  
 
 
1.3.3. Lewisx in the central nervous system and development 
 
The fucosylated carbohydrate Lex determinant is expressed early during 
murine embryogenesis. Lex, also known as stage specific embryonic antigen 
(SSEA)-1 (Gooi et al., 1981), has been shown to be expressed at the cell surface 
at the morula stage and decline rapidly after compactation (Solter and Knowles, 
1978). Calcium-mediated Lex - Lex homotypic interactions were thought to be the 
basis for cell recognition during this compactation stage (Bird and Kimber, 1984; 
Fenderson et al., 1984; Eggens et al., 1989; Kojima et al., 1994). This interaction 
has recently been confirmed using Lex bearing lipids inserted in bilayers that 
mimic cell membranes (Gourier et al., 2004; Gourier et al., 2005). Nevertheless, 
the analysis of the FUT9-/- mouse revealed that the animal was fertile and 
developed normally, although the expression of the Lex, detected as SSEA-1 was 
absent in early embryos (Kudo et al., 2004). 
Lex from glycolipids or glycoproteins is expressed in several human 
tissues, including the brain. Complex-type N-glycans with terminal Lex on one 
arm are among the most abundant neutral carbohydrates detected in human 
brain (Albach et al., 2001). In the developing CNS of diverse species, including 
human, rat, mouse, chicken and Xenopus, expression of Lex is known to be 
temporally and spatially regulated (Dasgupta et al., 1996; Gotz et al., 1996; Mai 
et al., 1999; Yoshida-Noro et al., 1999). At the cellular level, it has been detected 
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in mouse neurons in the surfaces of cell bodies, processes and growth cones, as 
well as in cerebral primary cultures and in cerebellum sections (Nishihara et al., 
2003). Detection in neurons of developing Xenopus brain has also been reported 
(Yoshida-Noro et al., 1999).  
The hypothesis that Lex acts as a cell-cell recognition molecule in the 
CNS with an important role in neurogenesis has been largely discussed in the 
literature but has not been clearly demonstrated. For example, selective adhesion 
of cells from different telencephalic regions of rat and chicken during 
development correlates with Lex epitope localization and is developmentally 
regulated (Gotz et al., 1996). Also, Lex appears to have a role in neurite 
outgrowth or adhesion in Xenopus embryos since anti-Lex antibodies inhibit 
neurite outgrowth in explant brain cultures (Yoshida-Noro et al., 1999). A specific 
association between Lex and mouse brain cells was also suggested by its role as 
a neural stem cell marker (Capela and Temple, 2002).  
Until present, there has not been a clear assignment of the functional 
carriers of the Lex epitope in human neurons nor of its exact biological role. 
 
 
1.4. NTera2 cell line as model system for human neuronal differentiation 
 
NTera2/cl.D1 (NT2) is a teratocarcinoma cell line derived                      
from a human germ cell tumor, characterized by rapidly proliferating; 
undifferentiated, neuronally committed progenitor cells (Andrews, 1984).              
It preferentially differentiates into neuroectoderm, although its                            
ability to give rise to cells belonging to all three germ layers in vitro                   
has been recently reported (Pal and Ravindran, 2006). The NT2 progenitor        
cells can differentiate into all three neural lineages, depending on the 
experimental strategy (Pleasure et al., 1992;  Marchal-Victorion et al., 2003; 
Sandhu et al., 2003).  
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Exposure to all-trans retinoic acid (RA) generates an almost pure 
population of postmitotic neurons (NT2N) (Pleasure et al., 1992) or a mixed 
population of NT2N neurons and astrocytes (NT2A) (Sandhu et al., 2003), 
depending on the cell differentiation protocol. RA is a naturally occurring 
derivative of vitamin A known to be synthesized in the brain (Wagner et al., 1990) 
and to affect neuronal differentiation within the CNS (Wuarin and Sidell, 1991). 
During RA-induced differentiation, NT2 cells substitute their immature 
neuroepithelial markers, like nestin (Pleasure et al., 1992), for distinctive markers 
of mature CNS neurons, like neurofilaments (Lee and Andrews, 1986), tau 
protein, synaptophysin, and microtubule associated proteins (MAP) type 1 and 2 
(Pleasure et al., 1992). Under specific culture conditions these neurons form 
functional synapses (Hartley et al., 1999) and express a variety of 
neurotransmitter phenotypes, including GABAergic, catecholaminergic, 
cholinergic and serotonergic (Yoshioka et al., 1997; Guillemain et al., 2000). 
Moreover, NT2N neurons express functional NMDA and non-NMDA glutamate 
receptors (Younkin et al., 1993; Hardy et al., 1994) and the amyloid precursor 
protein (Wertkin et al., 1993). This cell type has also been used in several 
transplantation studies, which have demonstrated successful engraftment in 
animal models of stroke (Borlongan et al., 1998), Huntington’s (Hartley et al., 
1999; Muir et al., 1999), Parkinson’s disease (Baker et al., 2000) and 
Amyotrophic Lateral Sclerosis (Garbuzova-Davis et al., 2002). NT2N cells 
transplanted in patients with basal ganglia stroke improved motor and cognitive 
deficits (Kondziolka et al., 2000). Furthermore, the NT2 cells transfected or 
infected with genes of interest can deliver exogenous genetic products to the host 
brain following transplantation (Baselga et al., 1993; Hong et al., 1999; Watson et 
al., 2003). Therefore, this cell line can be used in transplantation not only as a 
substitute for foetal tissue but also as a vehicle for gene delivery. 
NT2 cells differentiation seems to model the in vivo system, as high 
concentrations of RA, RA-binding proteins and receptors are present in the 
developing nervous system (Zetterstrom et al., 1999). Furthermore, NT2 cells are 
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human EC cells, the stem cells of teratocarcinomas that resemble the pluripotent 
human embryo-derived embryonic stem (ES) cells. Differentiation of NT2N 
neurons induced by RA follows a gene expression pattern similar to that of the 
neuronal precursors during neurogenesis (Przyborski et al., 2000). Thus, the 
unique properties of NT2 cells make them a model system for studying the 
complex events accompanying the process of human neuronal differentiation - 
from the commitment of human pluripotent ES cells to the neuronal lineage, and 
their subsequent development into a terminally differentiated neuronal 
phenotype. They have been used as models of neuronal differentiation in several 
cDNA screening methods, like RNA fingerprinting by arbitrarily primed PCR 
(RAP-PCR) (Cheung et al., 1997), suppression subtraction hybridization (SSH) 
(Leypoldt et al., 2001), cDNA array (Satoh and Kuroda, 2000; Bani-Yaghoub      
et al., 2001) and microarray technology (Farlow et al., 2000; Freemantle et al., 
2002). 
Over the years, the characterization of EC and subsequently ES cells 
relied on the expression of a panel of cell surface antigen markers, mostly 
involving carbohydrate epitopes, whose exact function is still unknown. 
Nevertheless, the expression of these molecules is subject to tight regulation 
during differentiation. A switch in glycolipid synthesis from globoseries to 
lactoseries and ganglioseries structures (Fenderson et al., 1987) marks NT2 cells 
differentiation induced by RA. SSEA-1, a lactoseries carbohydrate structure 
corresponding to the Lex epitope, is induced early in differentiation and then 
declines (Fenderson et al., 1987; Fenderson et al., 1993; Andrews et al., 1996), 
being present on both glycolipids and glycoproteins (Fenderson et al., 1993).  
Evidence points out the comparable expression of stage specific 
embryonic antigens of human EC, ES cells and the inner cell mass of the human 
blastocyst, in contrast to mouse ES and EC cells (Henderson et al., 2002). 
Recently, cross-species transcriptional profiles of ES cells also suggested 
species-specific regulation mechanisms (Sun et al. 2007b). In this context, the 
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characteristics of the NT2 cell line make it a valuable model system to study the 
role of fucosylated epitopes, namely Lex, in human neuronal differentiation. 
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1.5 Aims of this thesis work 
 
Human FUT9 was the last member of the α3-FUT family to be identified. 
Its low homology with the other α3-FUTs and its high conservation between 
species envisioned an important biological role for this GT. At the beginning of 
this thesis work, there was evidence pointing to the importance of FUT9 in the 
rodent brain and a few studies concerning enzyme specificity suggested that the 
Lex epitope was its main biosynthetic product. Nevertheless, information about 
human FUT9 specificity and its biological role was scarce. The ultimate goal of 
the work described in this thesis was to contribute to the understanding of the 
biological role of FUT9 and its biosynthetic products in human neurons. 
The first objective of this thesis work consisted of the characterization     
of human FUT9 activity. Cloning and efficient expression of human FUT9       
were needed to determine the in vitro specificity of FUT9 towards         
biologically relevant acceptors, such as GPs. As FUT9 is a Golgi-resident        
GT, localization can constitute an important regulation mechanism of in vivo     
activity. Therefore, human FUT9 localization was studied, focusing on the 
properties of the cytoplasmic domain and how it can affect the localization of the 
enzyme.  
Obtaining high amounts of human FUT9 would be extremely useful for the 
establishment of the three-dimensional structure of the enzyme, as well as for 
synthesis purposes. In this context, the second objective of the work was to 
produce a recombinant soluble secreted form of human FUT9 that exhibited the 
ability of the native enzyme to synthesize the Lex epitope.  
The third objective consisted of the study of FUT9 and Lex during 
neuronal differentiation, having in view the elucidation of the localization and 
biological role of the carbohydrate adhesion determinant in neuronal cells. NT2N 
neurons were used as cell model of CNS human neurons. 
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The fourth objective was to characterize the Lex epitope in neurons from 
differentiating rat hippocampal neuronal cultures. 
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Chapter 2 
 
 
Human fucosyltransferase IX efficiently fucosylates           
N-linked asialoglycoproteins with the synthesis of the 
adhesion Lewisx determinant 
 
Work presented in this chapter corresponds to the following manuscript:  
 
Brito, C.; Kandzia, S.; Graça T.; Conradt, H.; Costa, J. (2007) “Human 
fucosyltransferase IX efficiently fucosylates N-linked asialoglycoproteins with the 
synthesis of the adhesion Lewisx determinant” (submitted). 
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2. Human fucosyltransferase IX efficiently fucosylates N-linked 
asialoglycoproteins with the synthesis of the adhesion Lewisx 
determinant 
 
 
2.1. Summary 
 
The α3-fucosyltransferase IX (FUT9) catalyzes the transfer of fucose in 
an α3 linkage onto terminal type II (Galβ4GlcNAc) acceptors, the final step in the 
biosynthesis of the Lewisx (Lex) epitope, in neurons.  
In the present work, FUT9 from NT2N neurons was cloned and 
overexpressed in HeLa cells (FUT9wt), where it was active. In vitro, FUT9wt was 
activated by Mn2+ and efficiently synthesized Lex and Ley, whereas Lea was 
produced with a low efficiency, and the corresponding sialylated determinants 
were not fucosylated, using small synthetic oligosaccharide acceptors linked to a 
hydrophobic moiety as substrates. FUT9wt was found to efficiently fucosylate the 
desialylated N-linked glycoproteins secreted human asialoerythropoietin 
(asialoEPO) from CHO cells and bovine asialofetuin. However, sialylated EPO 
was not an acceptor of FUT9wt. Analysis by HPAEC-PAD and MALDI/TOF-MS 
revealed predominantly mono-fucosylation by FUT9wt of type II di-, tri- and 
tetrantennary N-glycans with and without N-acetylactosamine repeats from 
recombinant asialoEPO. Minor amounts of difucosylated structures were also 
found. 
In vivo, HeLa cells transfected with FUT9wt expressed de novo Lex, as 
detected by immunofluorescence microscopy. FUT9 was found to be a         
trans-Golgi and trans-Golgi network (TGN) glycosyltransferase from confocal 
immunofluorescence colocalization studies with markers of the secretory pathway 
β4-galactosyltransferase (trans-Golgi and TGN) and TGN-46 (TGN), further 
supported by localization around the microtubule organization center after 
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incubation with brefeldin A. Analysis of mutants generated suggest that the 
information for intra-Golgi localization is contained in the cytosolic tail of FUT9. 
The results suggested that FUT9 could fucosylate glycoproteins with the 
synthesis of the cell adhesion Lewisx determinant in neurons. 
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2.2. Introduction 
 
Glycosyltransferases (GTs) mediate the transfer of monosaccharide 
residues from nucleotide sugar donors to glycoconjugates along their transport in 
the secretory pathway. α3-Fucosyltransferases (α3-FUTs) catalyze the transfer 
of fucose (Fuc) in an α3 linkage, onto terminal Galβ4GlcNAc motifs in the 
oligosaccharide chains, the final step in the biosynthesis of the Lewisx (Lex) 
epitope. FUT3, FUT4, FUT5, FUT6, FUT7 and FUT9 constitute the human    
α3/4-FUT family (reviewed by Becker and Lowe, 2003), presenting the type II 
membrane topology characteristics of Golgi resident GTs: a short N-terminal 
cytosolic tail, a single transmembrane domain (TM), a flexible region adjacent to 
the TM called stem and a large C-terminal globular catalytic domain, facing the 
lumen of the Golgi (Paulson and Colley, 1989).  
The α3/4-FUT family members share several conserved peptide motifs in 
their catalytic domains (reviewed by de Vries et al., 2001). FUT9 is the most 
recently cloned member of the α3/4-FUT family (Kaneko et al., 1999b). Its 
sequence presents the lowest homology with the other FUTs and is the only one 
highly conserved among species (Kudo et al., 1998; Kaneko et al., 1999b; 
Baboval et al., 2000) which indicates that it has been under strong selective 
pressure during evolution, suggesting that it is responsible for an essential 
biological activity. FUT9 exhibits a unique site-specificity, generating Lex 
determinants more efficiently than all the other α3-FUTs (Nishihara et al., 1999). 
It is also able to synthesize the Lewisy (Ley) epitope but not sialyl-Lewisx (sLex) 
and type I-based acceptors are poor substrates (Cailleau-Thomas et al., 2000; 
Toivonen et al., 2002).  
FUT9 is mainly expressed in the central nervous system (CNS), in both 
developing and mature brain of human, rat and mouse (Kaneko et al., 1999b; 
Baboval et al., 2000; Cailleau-Thomas et al., 2000). The FUT9-/- mouse showed 
disappearance of Lex in the brain, concomitantly to increased anxiety-like 
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behaviors (Kudo et al., 2007). In human neurons in culture FUT9 is the α3-FUT 
responsible for the synthesis of Lex (Brito et al., 2007). Thus, it is probable that 
FUT9 also synthesize Lex in human CNS similarly to that found in the mouse. 
Furthermore, the abundant neutral complex-type N-glycans with terminal Lex on 
one arm detected in human brain (Albach et al., 2001) may be products of FUT9 
action.  
The structure of the oligosaccharides present on glycoconjugates 
depends on the sequential action of Golgi resident glycosidases and GTs. The 
ordered, although overlapping, localization of GTs in the Golgi apparatus (GA) 
(Nilsson et al., 1993) is a key factor in the in vivo regulation of the glycosylation 
profile of the nascent glycoconjugate. Several studies have implicated the TM 
and flanking regions of GTs in GA localization (Grabenhorst and Conradt, 1999; 
Fenteany and Colley, 2005; Czlapinski and Bertozzi, 2006). The TM of GTs, e.g., 
β4-galactosyltransferase (β4-GalT) (Teasdale et al., 1992; Teasdale et al., 1994) 
or FUT3 (Sousa et al., 2003), has been shown to be required for localization in 
the Golgi apparatus. On the other hand, the cytosolic domain has been shown to 
be sufficient for GA localization for α2-FUT and α3-GalT (Milland et al., 2001; 
Milland et al., 2002), or to play a role in GT finer localization inside the GA (Sousa 
et al., 2004).  
In the present work, FUT9 cloned from NT2N neurons was efficiently 
expressed in HeLa cells, presenting in vivo activity with synthesis of Lex. In vitro, 
recombinant FUT9wt was found to efficiently fucosylate di-, tri- and tetrantennary 
N-glycans with and without N-acetylactosamine (LacNAc) repeats from an asialo 
form of human recombinant erythropoietin (EPO), as revealed by HPAEC-PAD 
and MALDI/TOF-MS analysis. Furthermore, FUT9wt localized in the Golgi/TGN 
of HeLa cells and the cytosolic tail played an important role in the regulation of 
sub-Golgi localization of the enzyme.  
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2.3. Materials and methods 
 
2.3.1. Cell culture 
 
NTERA-2/cl.D1 cells were cultured and differentiated into NT2N neurons 
essentially as described previously (Pleasure et al., 1992). Briefly, 
undifferentiated NT2- cells were grown in Opti-MEM I (Gibco) with 5% fetal 
bovine serum (FBS) (HyClone), 100 U/ml penicillin (P) and 100 μg/ml 
streptomycin (S) (Gibco). For differentiation, cells were cultured in Dulbecco's 
modified Eagle's medium (DMEM)-High Glucose (HG) (Gibco) with 10% FBS, P, 
S, and 10 μM retinoic acid (Sigma, St. Louis, MO) for 5 weeks. For neuron 
enrichment cell culture was in DMEM-HG with 5% FBS, P, S, supplemented with 
the mitosis inhibitors 1 μM cytosine arabinoside (Sigma), 10 μM 
fluorodeoxyuridine (Sigma), and 10 μM uridine (Sigma) for further 10 days. NT2N 
neurons were recovered after selective hydrolysis with trypsin (Gibco) and 
cultured on surfaces coated with 10 μg/ml poly-D-lysine (Sigma) and 0.26 mg/ml 
Matrigel (BD Biosciences). HeLa cells (ECCAC) were grown in DMEM-HG with 
10% FBS (Gibco) and P/S. All cells were grown in a 5% CO2 incubator, at 37°C.  
 
 
2.3.2. Cloning of human FUT9 from NT2N neurons  
 
Total RNA was extracted from 5x106 NT2N neurons using the RNeasy 
extraction kit (Qiagen), according to the manufacturer’s protocol. Two μg of total 
RNA were used in reverse transcription with the primer                   
5’-TTAATTCCAAAACCATTTCTCTA-3’ (FUT9-rev): after 5 minutes at 65°C, the 
reaction was performed at 37°C, for 50 minutes, using 1 unit of moloney murine 
leukemia virus reverse transcriptase (Invitrogen), and terminated by heating at 
70°C, for 15 minutes. The resulting cDNA was used to amplify two fragments of 
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human FUT9 by polymerase chain reaction (PCR). The 25 μl reaction mixtures 
contained 1 μl of cDNA, 1.5 mM MgCl2, 0.2 mM dNTPs, 0.4 μM primers and    2.5 
U of Taq DNA Polymerase (Invitrogen). As primer pairs                            
5’-ATGACATCAACATCCAAAGGAATTC-3’ (FUT9-fwd) with                            
5’-GCTTTTCCGTGATGTAATCCTTGTG-3’ (FUT9α3-rev) and                           
5’-GATTCAGATATCCAAGTGCCTTATG-3’ (FUT9α3-fwd) with FUT9-rev were 
used. PCR reactions were carried out in the following conditions: initial 
denaturation at 94°C for 5 minutes; 25 cycles of denaturation at 94°C for            
45 seconds, annealing at 55°C for 30 seconds and elongation at 68°C for            
1 minute; final elongation at 68°C for 7 minutes. The PCR products were cloned 
into the mammalian expression vector pcDNA3.1/V5-HisTOPO (Invitrogen). A 
mixture of the two plasmids was used as template in a second PCR reaction 
where the complete human FUT9 coding sequence was amplified. The primers 
used were FUT9-fwd and FUT9-rev with a mixture of Taq DNA polymerase 
(Invitrogen) and Pfu Turbo DNA polymerase (Stratagene) as described above. 
The amplified fragment (FUT9wt) was cloned in the pcDNA3.1/V5-HisTOPO 
vector (Invitrogen) and in the PCRScriptCam vector (Stratagene). Automatic DNA 
sequencing confirmed FUT9 sequence (Kaneko et al., 1999b). 
 
 
2.3.3. Plasmid construction 
 
The mutants FUT9dcyt, FUT9d6, FUT9S/A and FUT9wt with a V5 and 
His-tag were produced by PCR-based site directed mutagenesis using the 
PCRScriptCam-FUT9 vector as template. The V5 epitope was added at the         
C-terminus of FUT9 for detection purposes. 
  All V5-tagged mutants were constructed using the reverse primer 
FUT9V5-rev (5’-ATTCCAAAACCATTTCTCTA-3’). The forward primers were 
FUT9dcyt-fwd (5’-ATGCGCCCATTTTT-3’), FUT9d6-fwd                           
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(5’-ATGAAAGGAATTCTT-3’) and FUT9S/A-fwd                   
(5’-ATGACAgcaACAgccAAAGGAA-3’).  
PCR was carried out under the following conditions: 94°C  for 5 minutes; 
25 cycles of 94°C for 45 seconds, 55°C for 30 seconds and 68°C for 1 minute; 
68°C for 7 minutes. The 25 μl reaction mixtures contained 0.2 mM 
deoxynucleotides, 0.3 μM primers, 1 μg/ml of template DNA and a mixture of Taq 
DNA polymerase (Invitrogen) and Pfu Turbo DNA polymerase (Stratagene). All 
amplified fragments were cloned into the pcDNA3.1/V5-HisTOPO vector 
(Invitrogen). All sequences were confirmed by DNA sequencing. Clone analysis 
and maintenance were performed by standard techniques. 
 
 
2.3.4. Western blot analysis of FUT9wt and mutants overexpressed in HeLa cells 
 
HeLa cells, at approximately 70% confluency, were transiently transfected 
with FUT9 constructs using the Lipofectamine Plus (Invitrogen) reagent, 
according to the manufacturer’s protocol.  
Cells (2.5x105) were solubilized with 50 mM Tris-HCl pH 7.4 containing     
5 mM EDTA, 1% Triton X-100 (TX-100) and protease inhibitors (Complete 
Cocktail; Roche), at 4°C, for 1 hour and cleared by centrifugation at 10000x g, for 
5 minutes. Protein from cell extracts and corresponding supernatants were 
precipitated in 80% ethanol, and further deglycosylated with 100 U 
Endoglycosidase H (Endo H) or 1000 U of polypeptide N-glycosidase F (PNGase 
F) (New England BioLabs) under denaturing conditions, following the supplier's 
protocol.  
Total protein was separated by SDS-PAGE and transferred to 
polyvinyledene difluoride membranes. Membranes were blocked in 5% nonfat dry 
milk (Nestle) in PBS with 0.1% Tween-20. Primary antibodies were mouse 
monoclonal anti-V5 antibody (Invitrogen) (1:5000) and rabbit polyclonal          
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anti-calnexin antibody (Chen et al., 1995) (1:15000). HRP-conjugated polyclonal 
secondary antibodies anti-mouse IgG and anti-rabbit IgG (GE Healthcare) were 
used. All dilutions were in blocking solution. Chemiluminescent detection was by 
the ECL Plus system (GE Healthcare). 
 
 
2.3.5. Fucosyltransferase activity assays  
 
HeLa cells transiently transfected with vector pcDNA3.1/V5-HisTOPO 
coding for FUT9wt were assayed for fucosyltransferase activity. Twenty hours 
after transfection cells were solubilized with 100 mM MOPS/NaOH buffer pH 7.0, 
containing 1% TX-100, at 4°C, for 1 hour (Costa et al., 1997; Sousa et al., 2001). 
Activity was determined by the incorporation of radioactive Fuc from the GDP-
[14C]-Fuc donor onto several acceptors at 37°C. The assay mixtures (25 μl) 
contained: 100 mM MOPS/NaOH buffer, pH 7.0, 100 mM NaCl, 50 mM MnCl2, 
0.1475 mM GDP-Fuc, 0.0025 mM GDP-[14C]-Fuc (1:60 molar ratio) and the 
acceptor. The synthetic acceptors, used at 0.35 mM concentration, were the  type 
I - Galβ3GlcNAc-R, NeuAcα2,3Galβ3GlcNAc-R and Fucα2Galβ3GlcNAc-R (H 
type I); and the type II - Galβ4GlcNAc-R (LacNAc),              
NeuAcα2,3Galβ4GlcNAc-R (sLacNAc) and Fucα2Galβ4GlcNAc-R (H type II) 
(Lectinity Holding); R = O-(CH2)3NHCO(CH2)5NH-biotin.  
The glycoprotein acceptors used were: 2 mg/ml of bovine asialofetuin 
(AF) (52μM, considering the molecular mass 38.4 kDa corresponding to the 
polypeptide chain), 0.5 mg/ml of recombinant human EPO and an asialo form of 
EPO (asialoEPO) (17μM, considering the molecular mass 30 kDa determined by 
SDS-PAGE). For detailed characterization of the fucosylated N-glycans from 
EPO, the reaction mixtures were upscaled to 500 μl and extracts of HeLa cells 
mock transfected with human nicastrin (Morais et al., 2006) were used as 
negative control.  
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One unit of enzyme activity was defined as the amount of enzyme 
catalyzing the transfer of 1 μmol Fuc/min to the acceptor. Linearity of product 
formation was observed up to 180 minutes with the LacNAc-R acceptor. 
 
 
2.3.6. Native and desialylated (asialoEPO) EPO 
 
The EPO used in this study was expressed from a CHO cell line and was 
purified from cell culture supernatants by ion-exchange chromatography, gel 
filtration and RP-HPLC. Thorough N-glycosylation analysis after desialylation 
demonstrated the presence of di- tri- and tetrantennary oligosaccharides with and 
without LacNAc repeats as follows: diantennary 5.2 %, triantennary 7.0 %         
(2, 4 branched 20%, 2,6 branched 80%), tetrantennary 21.7%, triantennary with 
one two and three repeats 9.1%, 5.8% and 1.0% respectively and tetrantennary 
chains with one, two or three repeats, 26.9, 16.8 and 5.0 respectively. All 
structures were fully α6-fucosylated at the proximal N-acetylglucosamine as 
revealed by MALDI/TOF-MS analysis. In the native form >95% of the galactose 
residues were masked with α2,3-linked N-acetylneuraminic acid. Ten percent of 
the sialic acids were O-acetylated. The asialoEPO was prepared from native 
EPO by chemical desialylation by incubating of the intact glycoprotein in the 
presence of 0.22% (v/v) trifluoroacetic acid (TFA) for 1 h at 82 °C. The asialoEPO 
was recovered by gel filtration. 
 
 
2.3.7. Immunoaffinity isolation of desialylated EPO from FUT9 incubations for   N-
glycan analysis 
 
Desialylated EPO from incubations with FUT9 cell extracts was isolated 
by immunoaffinity chromatography using a column (1 ml of resin) with a 
monoclonal antibody raised against the human EPO polypeptide. Each sample 
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was applied to the affinity column equilibrated with PBS containing 0.02% (w/v) of 
sodium azide. After sample application, the column was washed with PBS buffer 
containing 0.02% sodium azide until the baseline was stable. EPO protein was 
eluted with 0.1 M glycine pH 2.5. Detection of protein was carried out at A=280 
nm. The EPO containing fractions were neutralized with a 12.5% solution of 
NH4OH. 
The flow-through of each immunoaffinity run from each sample was       
re-applied, washed and eluted a second time as described above. 
 
 
2.3.8. Release of N-glycans from EPO protein, purification and desalting  
 
After immunoaffinity purification, EPO samples, after cell extract 
incubations in the presence of GDP-Fuc, were incubated with 25 milliunits of 
recombinant PNGase F overnight at 37°C. Complete de-N-glycosylation was 
monitored by the specific mobility shift of the EPO protein in SDS-PAGE. The 
released N-glycans were separated from the polypeptide by addition of three 
volumes of cold 100 % ethanol and incubation at –20°C for at least 2 hours. The 
precipitated protein was removed by centrifugation at 13000 rpm for 10 minutes 
at 4ºC. The pellet was then subjected to two additional washes with 500 µl ice-
cold 75% ethanol. The oligosaccharides in the pooled supernatants were dried in 
a vacuum centrifuge (SpeedVac concentrator, Savant Instruments Inc., USA). 
The glycan samples were desalted using Hypercarb cartridges (100 mg) as 
follows: prior to use: the columns were washed three times with 500 µl 80% (v/v) 
acetonitrile in 0.1% (v/v) TFA followed by three washes with  500 µl water. The 
samples were diluted with water to a final volume of 300 μl before loading onto 
the cartridges. The loaded cartridges were rigorously washed with water. 
Oligosaccharides were eluted with 1.2 ml 25% acetonitrile containing 0.1% (v/v) 
TFA. The eluted oligosaccharides were neutralized with 2 M NH4OH and were 
dried in a SpeedVac concentrator. 
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2.3.9. Analysis of neutral oligosaccharides via HPAEC-PAD 
 
The analysis of the neutral EPO oligosaccharides via HPAEC-PAD was 
performed using an ICS-3000 ion chromatography system of Dionex Corporation, 
consisting of an AS autosampler, a DC detector/chromatography module and a 
DP dual pump. Twenty µl samples were injected into an equilibrated CarboPac 
PA200 guard column (3 x 50 mm, Dionex) connected to a CarboPac PA200 
column (3 x 250 mm, Dionex). The neutral oligosaccharides were eluted by using 
a concentration gradient of 0.15 M sodium hydroxide (solvent A) and 0.15 M 
sodium hydroxide/ 0.6 M sodium acetate flow rate of 0.4 ml/min (5 minutes 
isocratic at 100% solvent A, 30 minutes to 85% solvent A and 10 minutes to 70% 
A). The column temperature was maintained at 30°C. The electrochemical 
detection of the oligosaccharides was performed by application of the detection 
potentials and durations as recommended by the manufacturer. 
For subsequent MALDI/TOF-MS analysis of individual fractions from the 
HPAEC-PAD analysis, the corresponding fractions were desalted on-line by 
using a carbohydrate membrane desalter device (CMD-I; Dionex) and fractions 
were collected and dried in a SpeedVac concentrator. 
 
 
2.3.10. Analysis of N-glycans by Matrix-Assisted Laser Desorption Ionization/ 
Time-of-Flight Mass Spectrometry (MALDI/TOF-MS) 
 
Glycans were analyzed with a Bruker ULTRAFLEX time-of-flight 
(TOF/TOF) instrument in the linear positive ion mode. Native desialylated 
oligosaccharides were analyzed using 2,5-dihydroxybenzoic acid as                
UV-absorbing material. Samples of 1 µl at an approximate concentration of 1-10 
pmol/µl were mixed with equal amounts of the respective matrix. This mixture 
was spotted onto a stainless steel target and dried at room temperature before 
analysis. 
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2.3.11. Immunofluorescence microscopy and image quantification 
 
HeLa cells grown on glass coverslips to 70% confluency were transiently 
transfected with vector pcDNA3.1/V5-HisTOPO coding for FUT9wt and mutants. 
Twenty hours after transfection cells were incubated with 25 μg/ml cycloheximide 
for 3 hours, at 37°C and, when stated, with 5 μg/ml brefeldin A (BFA) for 45 
minutes, at 37°C. Cells were washed with PBS containing 0.5 mM MgCl2, fixed 
with 4 % paraformaldehyde in PBS for 20 minutes and permeabilized with 0.1 % 
TX-100 in PBS for 15 minutes. Blocking was done with 1 % bovine serum 
albumin (BSA) in PBS for 1 hour and primary and secondary antibodies were 
incubated in blocking solution, at room temperature, for 2 and 1 hours 
respectively. Washings were performed with PBS. Coverslips were mounted in 
Airvol. Primary antibodies were mouse IgG anti-Lex SH1 (Singhal et al., 1990) 
(10-fold concentrate with 1% BSA), rabbit anti-V5 (1:500) (Fortna et al., 2004) 
mouse IgG anti-ERGIC-53 (Alexis Biochemicals) (1:500); mouse IgG anti-GM130 
(BD Biosiences) (1:200); sheep IgG anti-GRASP55 (1:500) (Shorter et al., 1999); 
mouse IgG anti-GalT (1:25); sheep IgG anti-TGN-46 (Serotec) (1:200); mouse 
IgG anti–adaptor protein 1 (AP-1) (Sigma) (1:150); mouse IgG anti-γ-tubulin 
GTU88 (Sigma) (1:500). Secondary antibodies were goat anti-rabbit IgG 
AlexaFluor594, donkey anti-rabbit IgG AlexaFluor594, goat anti-mouse IgG 
AlexaFluor488 and donkey anti-sheep IgG AlexaFluor488. All AlexaFluor 
conjugates (Invitrogen) were used 1:500.  
Confocal images were acquired in a confocal microscope SP2+AOBS 
(Leica) equipped with a 63 x objective using zoom 2. Each fluorophore was 
excited and detected separately to avoid channel bleed-through.  For each cell, 
laser intensities and amplifier gains were adjusted in order to give maximum pixel 
intensity (225) and to avoid saturation. This was done using the GLOW LUT on 
the Leica Confocal Software. Each picture consisted of a z-series of 20 images of 
1024 x 1024 pixel resolution with a pinhole of 1.0 Airy unit and typically, 0.6 μm 
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focus intervals. Quantification of immunofluorescence images was performed 
using the open source Image J software version 1.30 (http://rsb.info.nih.gov/ij/). 
Eight to twelve cells have been analyzed per condition. Quantification of FUT9 
constructs colocalizing with other markers was done using the Image J macro 
described previously (Sousa et al., 2004). Statistical analysis was performed 
using the GraphPad Prism 4 software. 
 
 
2.4. Results  
 
2.4.1. Overexpression of human FUT9wt in HeLa cells and Lex biosynthesis  
 
Human FUT9 has been cloned from NT2N neurons. The cloned sequence 
was registered in GenBankTM with the accession number AY800264. It 
corresponded to the coding sequence of human FUT9 (Kaneko et al., 1999b), a 
359 amino acid protein predicted to have a type II membrane topology: a 
cytosolic tail of 11 amino acid residues; a TM of 21 amino acid residues and a 
luminal catalytic domain with three potential N-glycosylation sites (Asn-62,     
Ans-101 and Asn-153) (Figure 8A). To overexpress FUT9 in heterologous cells, 
this sequence was cloned in the pcDNA3.1/V5-HisTOPO vector, which codes for 
the V5 tag at the C-terminus for detection purposes.  
FUT9wt was transiently expressed in HeLa cells and monitored by 
Western Blot analysis with a monoclonal anti-V5 antibody (Figure 8B). A major 
band was detected at approximately 54 kDa (Figure 8B, arrow), which probably 
corresponded to the mature form of FUT9wt. Digestion with PNGaseF caused a 
shift to approximately 47 kDa (Figure 8B, closed arrowhead), the predicted 
molecular mass of the peptide sequence of FUT9wt with the tags. After Endo H 
treatment two bands were detected at approximately 50 and 47 kDa (Figure 8B, 
open and closed arrowheads, respectively). These results together showed that 
the three potential N-glycosylation sites of FUT9 were occupied.  
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Figure 8: Overexpression of FUT9wt and mutants in HeLa cells. (A) Schematic 
representation of FUT9 constructs: FUT9wt is composed of a short cytosolic tail (cyt), a 
single transmembrane domain (TM) and a C-terminal catalytic domain (cat). The three 
potential N-glycosylation sites are indicated (Y). FUT9wt and the mutant forms were 
constructed with a V5 tag and His6 tail in the C-terminal region. (B) Western blot analysis 
of FUT9wt and mutants deglycosylated with EndoH and PNGaseF. Primary antibody: 
anti-V5 monoclonal antibody (1:500 dilution). Chemiluminescent detection was performed 
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by the ECL Plus system. Mature (arrow), EndoH resistant (open arrowhead) and 
deglycosylated (closed arrowhead) forms of FUT9wt and mutant are indicated. A 
degradation product is indicated with an asterisk. (C) Immunofluorescence confocal 
microscopy of FUT9wt and Lewisx. Cells were treated with 25 μg/ml cycloheximide for 3 
hours, at 37°C, fixed with 4% paraformaldehyde and permeabilized with 0.1%           
Triton X-100. Primary antibodies: anti-V5 polyclonal (green) and monoclonal anti-Lex SH-
1 (red) antibodies. Secondary antibodies: goat anti-rabbit AlexaFluor488-conjugated and 
goat anti-mouse AlexaFluor594-conjugated, respectively. Scale bar: 10 μm. Experiments 
were performed at least three independent times. 
 
Probably two of the sites were occupied with high-mannose or hybrid 
oligosaccharides which were released with Endo H with a downward shift of 4kDa 
(considering the mass of a typical high mannose glycan Man9GlcNAc2 as 1.8 
kDa, and the mass of a hybrid oligosaccharide substituted with proximal and 
peripheral Fuc and terminal neuraminic acid as 2.3 kDa). The other glycosylation 
site probably contained complex-type oligosaccharides that were released with 
PNGaseF only with a further downward shift of 3 kDa (considering that the 
molecular mass of a complex-type glycan can go from 2.3 kDa for a biantennary 
N-glycan with proximal Fuc and terminal neuraminic acid, up to 5.0 kDa for a 
tetrantennary oligosaccharide with 3 repeats, proximal Fuc, peripheral neuraminic 
acid in all antenna and 3 peripheral Fuc residues).  
Overexpression caused de novo synthesis of the Lex determinant in HeLa 
cells expressing FUT9wt, as detected by immunofluorescence microscopy, using 
the monoclonal SH1 antibody (Figure 8C). Transfected cells were also probed 
with monoclonal antibodies for the other Lewis determinants but no significant 
immunolabeling was observed (results not shown). Thus, Lex is the major 
biosynthetic product of human FUT9 in vivo, corroborating previous in vitro data 
that described Lex as the major product of human FUT9 (Nishihara et al., 1999). 
Together, these results indicated that FUT9wt was efficiently expressed in 
HeLa cells, correctly exported from the ER and transported to the Golgi where it 
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acquired complex N-glycans and was active in vivo synthesizing the Lex 
determinant.  
 
 
2.4.2. FUT9wt preferentially synthesizes Lex and Ley in vitro 
 
The specificity of FUT9 towards small oligosaccharide acceptors was 
tested using cellular extracts of HeLa cells overexpressing FUT9wt without the 
V5 tag. For that purpose, a stop codon was introduced at the 3' end of the 
enzyme before cloning into the pcDNA3.1/V5-HisTOPO vector. 
To establish the assay conditions for efficient Fuc transfer three issues 
were optimized using LacNAc-R as the substrate: Mn2+ concentration, pH and 
reaction time. The results from the literature concerning the effect of Mn2+ on 
FUT9 are contradictory, with inhibition observed for FUT9 from Namalwa cells 
(Kaneko et al., 1999b), or activation for FUT9 from human brain homogenates 
(Mollicone et al., 1992) or human neuroblastoma cells (Foster et al., 1991). In this 
work, an activation effect of Mn2+ was observed, with an approximate 1.9-fold 
increase in activity at Mn2+ concentrations between 2.5 and 10 mM (Figure 9A). 
However, for higher concentrations (40 mM) there was a decrease in activity to 
values similar to those obtained in the absence of the cation (Figure 9A). 
Subsequent enzyme assays were performed in the presence of 5 mM Mn2+ at the 
optimum pH of 7.0 as determined in Figure 9B. The inhibitory effect at higher 
concentrations of Mn2+ was probably caused by the hydrolysis of the GDP-Fuc 
substrate by Mn2+ (Murray et al., 1996). 
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Figure 9: Effect of Mn2+ (A) and pH (B) on FUT9wt activity. Galβ4GlcNAc-R, where    
R = O-(CH2)3NHCO(CH2)5-NH-biotin, was used as acceptor substrate. 
 
The activity towards the LacNAc-R acceptor was 7.9 ± 0.4 μU/106 cell 
leading to the production of the Lex determinant (Table 1). Substitution of 
galactose with α2-linked Fuc (H type II-R) yielded a 1.5-fold increase in activity, 
with the production of the Ley determinant. On the other hand, when galactose 
was substituted with α2,3-linked neuraminic acid (sLacNAc-R), radioactivity 
incorporation was undetectable. These results are in good agreement with the 
substrate specificity of human FUT9 toward low molecular mass acceptors in the 
absence of Mn2+ (Cailleau-Thomas et al., 2000; Toivonen et al., 2002).  
Only a low FUT9 activity was observed with Galβ3GlcNAc-R                   
(R = O-(CH2)3NHCO(CH2)5NH-biotin) as a substrate, corresponding to 
approximately 4 % of the obtained with the type II acceptor (see Table 1). Thus, 
we were able to demonstrate the synthesis of the Lea determinant due to the 
presence of the activator Mn2+, since in the absence of the cation no radioactivity 
incorporation was observed (data not shown). 
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Table 1: Substrate specificity of recombinant FUT9wt from HeLa cells.  
Substrate Activity 
(μU/106cell) 
Relative Activity 
Type II acceptors    
     Galβ4GlcNAc-R 7.9 ± 0.4 1.00 
     NeuAcα2,3Galβ4GlcNAc-R N.D.  N.D. 
     Fucα2Galβ4GlcNAc-R 11.8 ±0.6 1.50 
Type I acceptors    
     Galβ3GlcNAc-R 0.3 ± 0.0 0.04 
     NeuAcα2,3Galβ3GlcNAc-R N.D.  N.D. 
     Fucα2Galβ3GlcNAc-R N.D.  N.D. 
R= O-(CH2)3NHCO(CH2)5-NH-biotin. N.D. not detectable (when the activity value was 
below 0.1 μU/million cell). Assays were performed in triplicate, at least twice. Values 
correspond to a representative experiment. 
 
Therefore, FUT9 exhibited a clear preference for non-sialylated type II 
synthetic acceptors in vitro, with the synthesis of Lex and Ley.  
 
 
2.4.3. FUT9wt efficiently fucosylates asialoglycoproteins 
 
The absence of the Lex-carrier proteins and lipids in the FUT9-/- mouse 
brain confirmed the hypothesis that FUT9 synthesizes the Lex epitope in the 
mouse brain, and most probably also in the rat brain (Baboval et al., 2000) as 
well as in human neurons (Brito et al., 2007). Furthermore, human FUT9 has 
been shown to be responsible for the synthesis of Lex on carcinoembryonic 
antigen-related cell adhesion molecule (CEACAM1) from human granulocytes 
(Bogoevska et al., 2006). FUT9 has been found to fucosylate small 
oligosaccharides (Cailleau-Thomas et al., 2000; Toivonen et al., 2002) and 
FUT9 synthesize Lex in asialoglycoproteins 
61 
glycolipids (Baboval et al., 2000; Nishihara et al., 2003), resulting in the synthesis 
of the Lex epitope. However, the specificity of FUT9 towards glycoproteins         
N-glycans has not yet been established.  
To address this issue, we used the same FUT9wt extracts and conditions 
as above, with recombinant human EPO from CHO cells, the corresponding 
desialylated form (asialoEPO) and bovine asialofetuin (AF) as substrates.  
Transfer of Fuc was detected to asialoEPO (14.1±0.1 μU/million cell) and 
AF (10.0±1.4 μU/million cell) but not to native sialylated EPO. Considering the 
high activity of FUT9wt towards type II acceptors (Table 1) it is probable that 
FUT9wt catalyzed the transfer of Fuc to the outermost type II structures present 
in all the N-glycans from EPO (Figure 11; Grabenhorst et al., 1998) and from AF 
(Costa et al., 1997). The failure of detection of radioactivity with native sialylated 
EPO (in which 98% of galactose residues are masked with α2,3 linked sialic acid) 
is in agreement with our findings that sialylated small oligosaccharide acceptors 
are not a substrate for FUT9. 
To elucidate if Fuc was transferred to the N-glycans from EPO, native and 
asialoEPO were incubated with FUT9wt from HeLa cells in the presence of 
radiolabeled Fuc, and further analyzed by SDS-PAGE and autoradiography 
(Figure 10). Radiolabeled Fuc was incorporated into asialoEPO (Figure 10, lane 
2), but not in EPO (Figure 10, lane 5). After de-N-glycosylation using PNGaseF 
the radioactive band was no longer detected in the autoradiography (Figure 10, 
lane 3). These observations unequivocally showed that FUT9 catalyzes the 
transfer of Fuc to the N-glycans of asialoEPO.  
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Figure 10: Analysis of asialoerythropoietin and erythropoietin after incubation with 
FUT9wt. Asialoerythropoietin (asialoEPO) and erythropoietin (EPO) (2.5 μg) (lanes 1  
and 4) were incubated with FUT9wt in the presence of radiolabeled GDP-Fuc (lanes 2 
and 5). Affinity purified radioactive asialoEPO analyzed in lane 2 was subsequently 
hydrolyzed with PNGaseF (lane 3). AsialoEPO (arrow), deglycosylated EPO (arrowhead) 
and PNGaseF (asterisk) are indicated. 
 
 
2.4.4. FUT9wt efficiently fucosylates di-, tri- and tetrantennary N-glycans from 
asialoEPO 
 
For a more detailed characterization of the EPO N-glycan fucosylation, 
250 μg of asialoEPO were incubated with extracts from HeLa cells 
overexpressing FUT9wt or mock transfected cells in the presence of 75 nmol of 
GDP-Fuc, for 0, 90, 180 and 360 min, at 37°C. AsialoEPO was then purified by 
affinity chromatography. The N-glycans from the unmodified and modified 
asialoEPO were released by PNGaseF incubation and subjected to HPAEC-PAD 
(Figure 11) and MALDI/TOF-MS (Figure 12).  
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Figure 11: HPAEC-PAD analysis of the oligosaccharides released from 
asialoerythropoietin after incubation with FUT9wt. Oligosaccharide elution profiles 
from asialoerythropoietin incubated with extracts Hela cells mock-transfected (A; control) 
and HeLa cells overexpressing FUT9wt (B). Structures (all proximally α6 fucosylated) are 
as follows: a = diantennary; b = 2,4-triantennary; c = 2,6-triantennary; d = tetrantennary;      
e = triantennary + 1 LacNAc-repeat; f = tetrantennary + 1 LacNAc-repeat;                    
g = triantennary + 2 LacNAc-repeats; h = tetrantennary + 2 LacNAc-repeats;                     
i = tetrantennary + 3 LacNAc-repeats and triantennary with three repeats. Fucosylated 
products are indicated by asterisks. Pools indicated by numbered brackets were made 
following on-line desalting and subjected to MALDI/TOF-MS analysis for identification of 
additional fucosylation by FUT9wt. 
 
Using a PA200 column for N-glycan mapping, the resulting HPAEC-PAD 
profile obtained from the glycan mixture of asialoEPO from mock transfected cell 
extracts was identical to the one of the asialoEPO starting material, co-eluted 
with corresponding reference standard oligosaccharides (results not shown), and 
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showed the peaks for di-, tri-, and tetrantennary N-glycans with and without 
LacNAc repeats and proximal Fuc, as described under Materials and Methods 
and in the legend to Figure 11. The profile obtained for the N-glycans from 
asialoEPO incubated in the presence of extracts from FUT9wt cells showed novel 
peaks in the corresponding HPAEC-PAD chromatogram (Figure 11A). Based on 
the peak areas a total of 22% of the HPAEC-PAD signal was attributable to the 
new signals as shown in Figure 11 indicating an efficient modification of 
asialoEPO N-glycans.   
By MALDI/TOF-MS the pool of oligosaccharides modified by FUT9wt, 
showed novel mass signals at m/z 1955.6, 2321.7, 2685.7, 3051.8, 3416.8 and 
3562.9 (Figure 12, indicated with asterisks).  
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Figure 12: MALDI/TOF mass-spectrometric analysis of the oligosaccharides 
obtained from asialoerythropoietin after FUT9wt incubation. Oligosaccharides from 
asialoerythropoietin incubated with extracts of HeLa mock transfected (A) and HeLa 
overexpressing FUT9wt (B). Fucosylated products are indicated by asterisks. 
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From their masses and isotopic composition, these structures probably 
corresponded to monofucosylated species of diantennary, triantennary, 
triantennary with one LacNAc repeat or tetrantennary, triantennary with two 
LacNAc repeats or tetrantennary with one LacNAc repeat, and tetrantennary 
oligosaccharides with two LacNAc repeats, all with proximal Fuc. The novel peak 
at 3562.9 probably corresponded to difucosylated tetrantennary N-glycans with 
two LacNAc repeats with proximal Fuc (Table 2). 
To elucidate the structures of the novel peaks detected by HPAEC-PAD, 
fractions indicated in Figure 11 were desalted on-line by using a carbohydrate 
membrane desalter device (CMD-I; Dionex) and further analyzed by  
MALDI/TOF-MS (results not shown). Pool 1 yielded a molecular ion signal, which 
is in agreement with a diantennary glycan plus an additional deoxyhexose (dHex) 
[M+Na]+ at m/z 1955.7. Pool 2 contained molecular ion signals at m/z 2321.0 
compatible with a triantennary glycan with an additional Fuc, and a low intensity 
signal at m/z 3197 indicating a tetrantennary structure with one repeating unit 
with two additional Fuc residues. In pool 4, a signal at m/z 1809.7 corresponding 
to the unmodified diantennary glycan was detected and a second signal at m/z, 
2685.6, which is compatible with a tetrantennary structure with one additional 
Fuc. Pool 6 contained a signal m/z 2686.9, which we interpreted as a triantennary 
glycan with one additional Fuc as is suggested from its retention time in    
HPAEC-PAD. Pool 7 contained m/z 3051.2, which corresponds to a tetrantennary 
glycan with one repeat and one additional Fuc, and m/z 2174.7 representing the 
unmodified triantennary N-glycan. Pool 8 contained as a major signal m/z 2539.9 
(unmodified tetrantennary) and a weak signal at m/z 2174.8 (corresponding to an 
unmodified triantennary N-glycan) as well as low intensity signals at m/z 3051.2 
and 3416.2, which can be interpreted as a triantennary glycan with two repeats 
plus an additional Fuc and a tetrantennary structure with 2 repeats and with one 
additional Fuc. Pools 9-12 contained the unmodified N-glycans identical to pools 
e-h in Figure 11A. Pools 3 and 5 did not yield any MALDI/TOF-MS signal. 
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Therefore, FUT9wt efficiently fucosylated di-, tri- and tetrantennary 
glycans with or without repeats, yielding significant amounts of the corresponding 
monofucosylated species. On the other hand, difucosylated species were only 
detected in low amounts for the tetrantennary glycans with two LacNAc repeats 
(MS analysis) or for the tetrantennary structures with one LacNAc repeat 
(HPAEC-PAD followed by MS analysis). These results suggested that Fuc was 
preferentially transferred to N-acetylglucosamine from the outer LacNAc motif, 
thus synthesizing the Lex determinant. 
 
 
2.4.5. TGN localization of FUT9 is determined by the cytosolic tail 
 
The biosynthesis of Lex in vivo will depend not only on the activity and 
specificity of FUT9 characterized in vitro, but also on the correct localization of 
the enzyme in the Golgi apparatus. A body of evidence has shown that 
information for correct localization of GTs lies within their TMs and the 
corresponding flanking regions (Grabenhorst and Conradt, 1999; Sousa et al., 
2003; Sousa et al., 2004; Czlapinski and Bertozzi, 2006). Previous evidence from 
our laboratory showed that for FUT3 amino acids from the TM specify location in 
the Golgi apparatus (Sousa et al., 2003), whereas the cytosolic tail is important 
for intra-Golgi sub-compartment localization (Sousa et al., 2004). Others have 
shown the importance of Ser and Thr from the cytosolic tails for GTs localization 
(Milland et al., 2002; Hathaway et al., 2003). The cytosolic tail of FUT9 contains a 
cluster of Ser and Thr residues (Figure 8A).  
In order to evaluate the importance of the cytosolic tail of FUT9 for the 
subcellular localization and in vivo activity, and more specifically the role of the 
Thr and Ser residues, several mutant forms were constructed (Figure 8A): 
FUT9dcyt, where amino acids Thr-2 to Leu-9 where deleted; FUT9d6, without the 
Thr and Ser residues; FUT9S/A, where Ser-3 and Ser-5 were substituted by Ala 
residues. The mutants contained the V5 epitope for detection purposes. 
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Deglycosylation analysis of HeLa cells transiently expressing FUT9dcyt, 
FUT9d10 and FUT9S/A revealed profiles similar to the one observed for the   wild 
type protein (Figure 8B). On the other hand, all mutants were active in vitro (not 
shown). These results indicated that the mutants were correctly folded and 
transported to the Golgi where processing of complex type-glycans occurred.  
The subcellular localization of FUT9wt and mutants, overexpressed in 
HeLa cells was determined by colocalization analysis with markers of the 
secretory pathway in cells incubated with cycloheximide to inhibit protein 
synthesis and allow proteins to reach their steady-state localizations           
(Figure 13A). FUT9wt and the mutants presented the perinuclear staining pattern 
characteristic of Golgi distribution with partial localization with GM130 (cis-Golgi 
marker), GalT (trans-Golgi and TGN) and TGN-46 (TGN). The percentage of 
FUT9 colocalizing with each marker was estimated by the quantification of signal 
intensity corresponding to FUT9 that was present in shared pixels with the 
marker. FUT9wt showed higher colocalization with GalT (60% of signal overlap) 
and TGN-46 (70%), and lower colocalization with GM130 (45%) (Figure 13B). On 
the other hand, FUT9dcyt and FUT9d6 showed higher colocalization with GM130 
than FUT9wt (Figure 13A). Nearly 70% of FUT9dcyt and FUT9d6 colocalized 
with GM130, whereas only 50% of each mutant colocalized with TGN-46. 
FUT9dcyt also showed lower levels of colocalization with GalT with 
approximately 40% of overlap (Figure 13A, B). FUT9S/A presented a localization 
pattern similar to FUT9wt (results not shown). 
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Figure 13: Subcellular localization analysis of FUT9wt and mutants. HeLa cells 
transiently overexpressing FUT9wt, FUT9dcyt and FUT9d6 were treated with 25 μg/ml 
cycloheximide for 3 hours, at 37°C, fixed with 4% paraformaldehyde and permeabilized 
with 0.1% Triton X-100 and processed for confocal microscopy. Cells were              
double-labeled with anti-V5 (secondary antibody AlexaFluor594-conjugated, shown in 
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red) and anti-GM130, anti-galactosyltransferase (GalT) or anti-TGN-46 (secondary 
antibodies AlexaFluor488-conjugated, shown in green). (A) Overlays of single optical 
sections are shown. Insets show 6-fold magnification of indicated areas. Scale bar: 10 
μm. (B) Quantitative analysis of the distribution of FUT9 constructs relative to Golgi and 
TGN markers. The percentage of colocalization of FUT9 constructs with the indicated 
proteins was determined as described in Materials and Methods and took into account 
the fluorescence from 20 confocal plans along the z-axis of eight labeled cells. Error bars 
correspond to the SD of the mean value obtained from eight to twelve cells from at least 
two independent experiments. Asterisks indicate significant difference (p<0.001) from 
control mean by a one-way ANOVA analysis with a Tukey's post-hoc multiple comparison 
test. 
 
Partial colocalization of FUT9wt and mutants was observed with the 
markers: ERGIC-53, a lectin that recycles between the ER and the Golgi 
(Schweizer et al., 1993); GRASP55, a medial-Golgi matrix protein (Shorter et al., 
1999); adaptor protein complex–1 (AP-1) of the clathrin coat (Seaman et al., 
1996) in TGN exiting sites localized in the justanuclear area (results not shown).  
Biotinylation of plasma membrane proteins (Sousa et al., 2003) followed 
by Western blot analysis of FUT9wt and mutants showed that they were not 
localized on the plasma membrane (results not shown).  
These results together suggested that FUT9wt predominantly localized in 
the trans-Golgi and TGN of HeLa cells. Deletion of the complete cytosolic tail or 
the cluster of Thr/ Ser caused a shift from the TGN to the cis-Golgi. 
To confirm the shift of FUT9 mutants to earlier Golgi compartments cells 
were incubated with brefeldin A (BFA), and analyzed by immunofluorescence 
microscopy (Figure 14, shown in red). BFA inhibits the GDP/GTP exchange on 
ADP-ribosylation-factor-1 (ARF-1) impairing the assembly of coatomer protein 
complex I (COPI) and adaptor protein-1 (AP-1) onto target membranes (Elazar et 
al., 1994). This leads to Golgi tubulation with fusion of cis, medial and trans-Golgi 
in the ER (Lippincott-Schwartz et al., 1989) and redistribution of TGN in late 
endosomal elements near the microtubule organizing center (MTOC) (Reaves 
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and Banting, 1992).  After 45 minutes of BFA treatment, most FUT9wt was 
visualized in the vicinity of the MTOC, which was stained with an anti-γ-tubulin 
antibody (Figure 14). On the other hand, FUT9dcyt and FUT9d6 mutants were 
found to redistribute into ER elements that appeared with a reticulate pattern 
through the cytoplasm. These results indicated that FUT9wt was predominantly 
found in the TGN, whereas the cytosolic tail mutants were found from cis- to 
trans-Golgi, thus corroborating the results presented above, where a shift to    
cis-Golgi was found. 
 
 
 
Figure 14: Effect of Brefeldin A on the localization of FUT9wt and cytosolic tail 
mutants. HeLa cells transiently expressing FUT9wt, FUT9dcyt and FUT9d6 were treated 
with 25 μg/ml cycloheximide (CHX), for 3 hours, at 37°C, or CHX followed by 5 μg/ml 
brefeldin A (BFA), for 45 minutes, at 37°C. Cells were fixed with 4% paraformaldehyde, 
permeabilized with 0.1% Triton X-100 and processed for confocal microscopy. Cells were 
double-labeled with anti-V5 antibody (secondary antibody AlexaFluor594-conjugated, 
shown in red) and anti-γ-tubulin antibody (secondary antibody AlexaFluor488-conjugated, 
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shown in green). Single optical sections are shown representative of the results obtained 
in three independent experiments. Scale bar: 10 μm. 
 
In spite of the alterations in localization, confocal immunofluorescence 
microscopy analysis of HeLa cells overexpressing the mutants showed that they 
were all active in vivo, being able to synthesize Lex. Therefore, the displacement 
of part of FUT9 to earlier Golgi compartments did not have a dramatic effect on 
its in vivo activity. Considering the overlapping of the different cisternae it is 
probable that the amount of mutant protein remaining in the trans-Golgi and TGN 
was sufficient for Lex biosynthesis. 
 
 
2.5. Discussion 
 
In this work, human FUT9, cloned from NT2N neurons and overexpressed 
in HeLa cells, has been shown to efficiently fucosylate type II acceptors with the 
synthesis of Lex and Ley from small oligosaccharides linked to a hydrophobic 
moiety, but could not use the corresponding sialylated substrates, similarly to 
results described by other authors (Cailleau-Thomas et al., 2000; Toivonen et al., 
2002). Furthermore, FUT9 was found to efficiently fucosylate non-sialylated 
glycoproteins. The corresponding di-, tri-, or tetrantennary N-glycans were 
fucosylated with similar efficiencies and the predominant products were found to 
be monofucosylated. Considering an average of ten available LacNAc units for 
asialoEPO (3 N-glycosylation sites occupied by tetra-, tri- and diantennary 
oligosaccharides with peripheral LacNAc in an 8:3:1 ratio) the concentrations of 
available LacNAc in the reaction mixtures would be of approximately 170 μM for 
asialoEPO. Thus, taking into account that LacNAc-R was used at 350 µM, and 
that FUT9 activity was approximately two-fold higher for asialoEPO, we 
concluded that FUT9 fucosylated asialoEPO more efficiently than the small 
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synthetic oligosaccharides linked to a hydrophobic moiety. The other glycoprotein 
tested, AF, was also a good substrate for FUT9. 
FUT9wt was not capable of transferring Fuc to native sialylated EPO, 
which is in agreement with the results obtained with the low molecular mass 
acceptors. In contrast, other authors (Toivonen et al., 2002) have found FUT9 
activity towards LacNAc inner repeats of linear polylactosamine synthetic 
acceptors substituted with sialic acid. This difference could be due to the limited 
access of the enzyme to inner LacNAc repeats from the N-glycans with higher 
antennarity.  
Our results clearly demonstrated the high specificity of FUT9 for the 
synthesis of the Lex determinant in glycans N-linked to glycoproteins. The activity 
of FUT9 towards low molecular mass oligosaccharides (Nishihara et al., 1999; 
Cailleau-Thomas et al., 2000; Ikeda et al., 2001; Toivonen et al., 2002) and 
glycolipid acceptors (Baboval et al., 2000; Nishihara et al., 2003) in vitro has 
been shown in the literature. However, its capability of fucosylating glycoproteins 
was suggested in vivo for the rodent brain (Kudo et al., 2007) and for human 
neurons (Brito et al., 2007). Thus, our results in vitro strongly support FUT9 as 
the most likely candidate to play the key role in the CNS, regulating Lex-mediated 
cellular events, by regulating the levels of expression of the determinant in the 
glycoprotein carriers.   
Contrary to a previous report (Nishihara et al., 1999) FUT9 was found to 
be activated by the divalent cation Mn2+. This allowed the finding of low α4-FUT 
of FUT9wt towards the type I Galβ3GlcNAc-R acceptor, with synthesis of Lea. 
FUT9 activation by metal ions is consistent with the presence of the DxD 
sequence in the conserved α3-Motif I (D161SD), also found in the other α3-FUTs 
(Breton et al., 1998; Palma et al., 2004), and shown to be important for FUT 
activity (Pang et al., 1998). The acidic motif DxD is present in many GTs and is 
known to be involved in the interaction with the nucleotide sugar donor, via       
co-ordination of a divalent cation in an octahedral geometry (reviewed by Breton 
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et al., 2006). The presence of the DxD motif usually indicates that a metal ion is 
needed as a cofactor (reviewed by Breton et al., 2006) but for other members of 
the α3-FUT family, e.g., FUT3, the activation by metal ions without their absolute 
requirement has also been described (Murray et al., 1996; Palma et al., 2004). 
The inhibitory effect at higher concentrations of Mn2+ was probably caused by the 
hydrolysis of the GDP-Fuc substrate by Mn2+ (Murray et al., 1996) 
FUT9 overexpressed in HeLa cells was found in the Golgi and TGN, 
where it was active synthesizing the Lex determinant in vivo. Since FUT9 uses as 
substrates peripheral LacNAc structures that require β4-GalT for Gal transfer, 
and considering that β4-GalT is localized in the trans-Golgi and TGN (Nilsson    
et al., 1993), it would be expectable that both enzymes are in the same sub-Golgi 
compartments.  
Human brain-type N-glycans have as characteristic features peripheral 
α3-fucosylation (Lex), low terminal α2,3-sialylation, bisecting GlcNAc, core       
α6-Fuc, and many of the structures are incompletely processed (asialo- or  
asialo-agalactostructures) (Hoffmann et al., 1994; Hoffmann et al., 1995; Albach 
et al., 2001). Since FUT9 is not capable of fucosylating sialylated type II 
acceptors and α2,3-sialyltransferase (α2,3-SialylT)  does not sialylate fucosylated 
acceptors (Wlasichuk et al., 1993), and considering that α2,3- SialylT is also 
localized in the trans-Golgi/TGN since it acts after β4-GalT, competition between 
FUT9 and α2,3- SialylT must occur in the late compartments of the Golgi. The 
high amount of Lex in human as well as in mouse brain (Albach et al., 2001; Ishii 
et al., 2007), contrary to sLex, which is low in human brain N-glycans (Hoffmann 
et al., 1994; Hoffmann et al., 1995; Albach et al., 2001) and non-detectable in 
mouse brain (Ishii et al., 2007), suggests competition between the two enzymes 
favorable to FUT9. Other possibilities such as low expression levels of          
α2,3- SialylT in the brain could also be admitted and need to be further explored.  
Deletion of the cytosolic tail and the cluster of Ser/Thr residues from FUT9 
led to a localization shift to early Golgi sub-compartments, which is in agreement 
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with previous observations from our group for FUT3 (Sousa et al., 2003). 
Furthermore, recent work by Uliana et al., 2006a showed by domain swapping 
experiments with glycolipid GTs fluorescent chimeras that the cytosolic tails of 
SialylTII and N-acetylgalactosaminyltransferase contained information for 
proximal or distal Golgi concentration, respectively. The underlying mechanisms 
may involve retention by direct interaction of the cytosolic tail with other Golgi 
resident proteins of the same sub-compartment, including other GTs, and/or 
retrieval via interaction of the unique cytosolic tail sequences with specific 
components of the intra-Golgi transport machinery. Contrary to that found for 
FUT3, deletion of the cytosolic tail did not cause any detectable effect on the 
biosynthesis of Lex. GTs are distributed through various sub-compartments of the 
GA with a peak of localization into a certain compartment. Even if FUT9dcyt was 
shifted to the cis-Golgi there was still a considerable amount in the late Golgi that 
could synthesize the Lex. 
In summary, evidence proving the efficient synthesis of the Lex 
determinant from N-linked glycoproteins catalyzed by FUT9 has been shown      
in vitro. These findings indicate a similar biological function for FUT9 in the CNS, 
thus underlying neuronal adhesion and differentiation processes mediated by the 
Lex determinant in this tissue. 
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3. Stable expression of an active soluble recombinant form of human 
fucosyltransferase IX in Spodoptera frugiperda Sf9 cells 
 
 
3.1. Summary 
 
A secretory form of human α3-fucosyltransferase IX (sFUT9) was 
overexpressed in Spodoptera frugiperda (Sf9) insect cells, using the stable 
expression vector pIB/V5-His-TOPO, and the signal sequence of human 
interleukin 2 for efficient secretion. sFUT9 was active and its three                 
potential N-glycosylation sites were occupied. sFUT9 efficiently             
fucosylated the type II acceptors Galβ4GlcNAc-R and            
Fucα2Galβ4GlcNAc-R (R = O-(CH2)3NHCO(CH2)5-NH-biotin) but not the 
corresponding sialylated acceptor, and only very poorly the type I  
(Galβ3GlcNAc-R) related acceptors. sFUT9 showed a clear preference for 
glycoproteins containing type II acceptors, with values of 121, 113 and             
110 μU/million cell for asialofetuin, erythropoietin and asialoerythropoietin, 
respectively, values approximately 11-fold higher than those obtained for the 
small acceptors. 
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3.2. Introduction 
 
The fucosylated carbohydrate Lewisx (Lex) determinant (Galβ4(Fucα3) 
GlcNAc) is expressed in several human tissues including the brain, where it has 
been shown Lex on one harm is one of the most common features of neutral 
complex-type N-glycans (Albach et al., 2001). Furthermore, we have recently 
shown that an anti-Lex antibody impaired cell adhesion and neurite formation of 
human NT2N neurons (Brito et al., 2007).  
Human α3-fucosyltransferases (FUTs) transfer fucose (Fuc) residues to 
type II-based oligosaccharide chains, determining the expression of the Lex 
determinant and related carbohydrate structures of cells. FUT9 synthesizes Lex in 
the mouse brain and its knockout caused increased anxiety-like behaviors 
concomitantly to the disappearance of Lex (Kudo et al., 2007). In human neurons 
in culture, FUT9 has also been shown to be the α3-FUT responsible for the 
synthesis of Lex (Brito et al., 2007). 
The evidence supporting an essential role for FUT9 in normal human 
brain development bring forward the importance of unraveling its specificity and 
catalytic properties. Moreover, the high specificity of FUT9 for the synthesis of 
terminal Lex determinant makes it a good candidate enzyme for synthetic 
purposes.  
Endogenous FUT9 from mammalian tissues is expressed in very low 
levels, thus it is necessary to express this enzyme in heterologous systems with 
high production yields. Post-translation modifications, namely N-linked 
oligosaccharides, have been shown to be essential for efficient folding and 
enzymatic activity of FUTs (Morais et al., 2003). The Spodoptera frugiperda Sf9 
insect cell line, capable of  producing large amounts of recombinant proteins 
(McCarroll and King, 1997) and performing rudimentary N-glycosylation required 
for correct folding (reviewed by Altmann et al., 1999), presents a potential host 
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system for the expression of human FUT9 that presents three potential              
N-glycosylation sites in its sequence.  
In this study, we have expressed an active soluble recombinant form of 
human FUT9 in transformed Sf9 insect cells, using the stable pIB/V5-His-TOPO 
vector and the signal sequence of human interleukin-2 (IL-2). The enzyme was 
active, fully glycosylated and efficiently secreted with a production of 14.7 mU/l in 
the second day of culture. Finally, it was found that sFUT9 presented activity 
towards glycoproteins. 
 
 
3.3. Materials and methods 
 
3.3.1. Plasmid construction 
 
The stable expression vector pIB-FUT9wt encoding the full-length 
membrane bound form of human FUT9 (Figure 15) was produced using the 
PCRScriptCam-FUT9 vector, which contained the complete coding sequence of 
FUT9, as template and the primers: 5’-ATGACATCAACATCCAAAGGAATTC-3’ 
(FUT9-fwd) and 5’-TTAATTCCAAAACCATTTCTCTA-3’ (FUT9-rev). PCR was 
carried out under the following conditions: initial denaturation at 94ºC for              
5 minutes, 25 cycles denaturation at 94ºC for 45 seconds, annealing at 55ºC for 
30 s, elongation at 68ºC for 1 minute, and a final elongation step at 68ºC for        
7 minutes. The 25 μl reaction mixtures contained 0.2 mM deoxynucleotides,     
0.3 μM primers, 1μg template DNA/ml and a mixture of 2.5 U of Taq DNA 
polymerase (Invitrogen) and 0.6 U of Pfu Turbo DNA polymerase (Stratagene). 
The resulting fragment (1080 bp) was cloned into the pIB/V5-His-TOPO vector 
(Invitrogen), at room temperature, for 30 minutes.   
The pIB-sFUT9 vector encoded a soluble form of human FUT9 where 
amino acids Ala-1 to Ser-39 were replaced by the 20-amino acid long signal 
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peptide of human IL-2 plus an Ala, the first amino acid of the mature IL-2 protein 
(Figure 15). sFUT9 was constructed in a two-step PCR procedure. The first PCR 
was performed using the pCRS2FT3T2 vector (Costa et al., 1997) as template 
and the primers 5’-ATGTACAGGATGCAAC-3’ (IL2-fwd) and                            
5’-GGCTGATTCCATTGGAGCACTGTTTGTGACAAG-3’ (IL2FUT9d40-rev), at 
the concentrations described above. The PCR conditions were: initial 
denaturation at 95ºC for 5 minutes, 25 cycles: denaturation at 95ºC for 30 
seconds, annealing at 60ºC for 10 s, and a final elongation step at 68ºC for 7 
minutes.  
One-tenth (5 μl) of the first reaction mixture was used as forward primer in 
a second PCR with the PCRScriptCam-FUT9 vector as template and FUT9-rev 
as reverse primer. The PCR conditions were the same as for FUT9wt and the 
amplified fragment was also cloned into the pIB/V5-Hi-TOPO vector.  
All sequences were confirmed by DNA sequencing. Clone analysis and 
maintenance were performed by standard molecular biology techniques. 
 
 
3.3.2. Cell culture   
 
Sf9 cells were grown in suspension at 27ºC and 90 rpm in 250 ml shake 
flasks containing 25 ml serum-free Sf900II medium (Gibco). Cells were 
subcultured at 4x105 cell/ml when a cell density of 3-4x106 cell/ml was reached. 
Cell density was determined by hemacytometer counts (Brand) and cell viability 
was evaluated by trypan blue exclusion dye at 0.1% (w/v) in phosphate buffer 
saline (PBS). Three independent growth curves were performed over a time 
period of 7 days and cell density determination was done in triplicate. Sf9-mock 
transfected cell line expressed a truncated soluble form of human L1 cell 
adhesion glycoprotein (L1-Ig5/6) (Gouveia et al., 2007). 
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3.3.3. Stable expression of human FUT9 in Sf9 cells 
 
Adherent Sf9 cells monolayers in six-well plates (5x105 cell/cm2) were 
transfected with 5 μg of pIB-FUT9wt or pIB-sFUT9 using the Cellfectin 
(Invitrogen) transfection reagent, according to the manufacturer’s protocol. In 
brief, 5 μg of DNA diluted in 250 μl of SF900II medium were added to 10 μl of 
Cellfectin diluted in 250 μl of medium. The solution was incubated for 15 minutes 
at room temperature, added to the cell monolayers. After 4 hours at room 
temperature with agitation, the transfection mixture was supplemented with 2 ml 
of Sf900II medium. The medium was changed 24 hours later and after another 24 
hours, transfectants were selected with 50 μg/ml blasticidin-HCl (Gibco). After 
five weeks selection and stepwise amplifications into larger monolayer cultures, 
Sf9-FUT9wt and Sf9-sFUT9 blasticidin-resistant cells were cultured in 
suspension flasks and maintained in 10 μg/ml blasticidin-HCl supplemented 
medium. Expression of FUT9 was monitored by fucosyltransferase activity assay 
two and five weeks after transfection. 
 
 
3.3.4. Fucosyltransferase activity 
 
The FUT9 activity along the culture was monitored in the supernatants 
and corresponding cell extracts solubilized in 100 mM Mops/NaOH buffer pH 7.0 
with 1% Triton X-100 (TX-100) for 1 hour. 
 Enzymatic activity was determined from the incorporation of radioactive 
Fuc from the GDP-[14C]-Fuc (GE HealthCare) donor to the Galβ4GlcNAc-R type 
II acceptor (Lectinity Holding), where R = O-(CH2)3NHCO(CH2)5NH-biotin. The 
fucosyltransferase activity was assayed at 37°C for two hours, in 25 μl of the 
following reaction mixture: 100 mM Mops/NaOH buffer, pH 7.0, 100 mM NaCl,  
50 mM MnCl2, 0.15 mM GDP-Fuc (containing GDP-[14C]-Fuc in a 1:60 molar 
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ratio) and 0.35 mM of oligosaccharide acceptor. One unit of enzyme activity was 
defined as the amount of enzyme catalyzing the transfer of 1 μmol Fuc/min to the 
acceptor.  
In specificity studies Sf9-sFUT9 supernatants recovered from the second 
day of culture were monitored in the assay conditions described above using the 
following synthetic acceptor substrates: NeuAcα2,3Galβ4GlcNAc-R, 
Fucα2Galβ4GlcNAc-R, Galβ3GlcNAc-R, NeuAcα2,3Galβ3GlcNAc-R and 
Fucα2Galβ3GlcNAc-R, where R=O-(CH2)3NHCO(CH2)5-NH-biotin (Lectinity 
Holding). The following glycoproteins were also tested: bovine asialofetuin 
(Sigma) (2 mg/ml, which corresponds to 52 μM, assuming fetuin molecular mass 
38.4 kDa, from Swiss-Prot) and native or asialo human erythropoietin (EPO) 
(GlycoThera) (0.5 mg/ml, which corresponds to 17μM assuming EPO molecular 
mass 30 kDa as determined by SDS-PAGE). For type I acceptors the radioactive 
to non-radioactive Fuc molar ratio was 1:30. Activity determinations were done in 
triplicates or duplicates from two independent cultures. 
 
 
3.3.5. Protein analysis 
 
Secreted and intracellular protein corresponding to 30 μl of cell 
suspension was analyzed. Cell supernatants were cleared from cells and cell 
debris by a 500× g centrifugation, for 5 minutes, followed by a 10000× g 
centrifugation, for 10 minutes Cells were solubilized for 1 hour in 100 mM 
Mops/NaOH buffer pH 7.0 with 1% TX-100 and the extracts centrifuged at   
10000× g, for 10 minutes. Supernatants were precipitated in 80% ethanol, at       
–20ºC, for 3 hours. The pellet was collected after a centrifugation at 10000× g, for 
10 minutes, at 4°C.  
Deglycosylations of sFUT9 with endoglycosidase H (EndoH) (New 
England Biolabs) and peptide-N-glycosidase F (PNGaseF) (Roche) were 
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performed according to the supplier’s instructions. In brief, precipitated protein 
was solubilized in the denaturation buffer provided by the EndoH supplier.  After 
10 minutes of denaturation at 100ºC, samples were allowed to cool down and 
100 U of EndoH or 1 U of PNGaseF and the corresponding buffers were added. 
For EndoH, the supplier’s buffer was used and for PNGaseF the buffer was       
10 mM NaH2PO4, 5 mM EDTA, 1% NP-40, pH 7.5. Incubations were done in 30 
μl, at 37ºC for 18 hours and the reaction was stopped by precipitation in 80% 
ethanol at -20ºC.  
Proteins were separated by SDS-PAGE and transferred to polyvinyledene 
difluoride membrane (Millipore). Membranes were blocked in 5% nonfat dry milk 
(Nestle) in PBS with 0.1% Tween-20. The anti-FUT9 polyclonal antibody C-17 
(Santa Cruz Biotechnology) was used at 1:500 dilution in blocking solution.   
HRP-labeled polyclonal secondary antibody anti-goat IgG (Sigma) was diluted 
1:20000 in blocking solution. Chemiluminescent detection was performed by the 
ECL Plus system (GE Healthcare). Protein from three independent growth curves 
was analyzed. 
 
 
3.4. Results and discussion  
 
3.4.1. Expression of soluble human FUT9 (sFUT9) in Sf9 cells 
 
Stable expression in insect cells has been shown to yield higher 
productivities for FUTs than the baculovirus infection system (Morais and Costa, 
2003; Munster et al., 2006). Furthermore, stable expression in Sf9 insect cells 
has been used previously in our laboratory with successful results for a soluble 
form of human FUT3 using the pIB/V5-His-TOPO vector and the signal sequence 
of beta-trace protein (Morais and Costa, 2003), as well as for several truncated 
forms of the human membrane glycoprotein L1 adhesion molecule with the 
expression vector pMIB/V5-His-TOPO that contains the signal sequence of 
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honeybee melittin (Gouveia et al., 2007). Thus, to obtain a stable source of 
human FUT9 that would allow a continuous production of active enzyme we 
chose the Sf9 insect cell line and generated vectors for stable expression of 
recombinant protein in insect cells. We used the signal sequence of human IL-2, 
known to be recognized and correctly cleaved in S. frugiperda lytic expression 
system (Smith et al., 1985). 
We cloned the full-length form of human FUT9 (FUT9wt) and a truncated 
form containing the catalytic domain of the enzyme (sFUT9) into the          
pIB/V5-His-TOPO vector, obtaining the expression vectors pIB-FUT9wt and    
pIB-sFUT9, respectively. sFUT9 was constructed by replacement of the 
cytoplasmic tail, the transmembrane domain and part of the stem region of 
human FUT9 (Ala-1 to Ser-39) by the signal sequence of the secreted human 
protein IL-2 (Figure 15).  
 
 
Figure 15: Schematic representation of human FUT9 constructs. Human FUT9 
(FUT9wt) is composed of a short cytoplasmic tail (cyt), a single transmembrane domain 
(TM) and a C-terminal catalytic domain (cat). The three potential N-glycosylation sites are 
indicated (*). The truncated soluble form (sFUT9) comprises the catalytic domain of the 
enzyme: it contains the sequence of IL2 signal peptide (ssIL2) plus the first amino acid 
residue (Ala) of mature IL2, linked to Pro-40 of the FUT9 sequence. 
 
Adherent insect Sf9 cells were transfected with the described expression 
vectors and selected with 50 µg/ml basticidin-HCl for five weeks. Sf9-FUT9wt and 
Sf9-sFUT9 cells were grown in Sf900II medium at 27ºC, in shake flasks at 90 
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rpm, from an initial concentration of 4x105 cell/ml and reached a maximum cell 
density of approximately 7x106 cell/ml on the fifth day of culture with a cell 
viability of approximately 90% (Figure 16). The growth and viability of Sf9 cells 
were not affected by the expression of recombinant human FUT9, when 
compared to Sf9 cells transfected with a vector encoding a non-related protein 
(Sf9-mock), under the same culture conditions (Figure 16). 
 
 
Figure 16: Production of FUT9wt and sFUT9 from Sf9 cells grown in shake flasks. 
Cell growth curve (closed symbols, continuous line) and viability (open symbols, broken 
line) of Sf9-FUT9wt (?, ?), Sf9-sFUT9 (?, ?) and Sf9-mock cells (?, ?). Twenty five ml 
suspension cultures at initial cell densities of 4x105 cell/ml were grown in Sf900II medium 
for 7 days. Results are presented as means ± S.D. (n=3). 
 
In order to determine the amount of active enzyme produced, α3-FUT 
activity was monitored along the days in culture. The transfer of radiolabelled Fuc 
from GDP-[14C]-Fuc to a type II acceptor coupled to a hydrophobic moiety was 
measured. For the soluble sFUT9 form, we observed that the secreted activity 
increased until the second day, when it reached the value of 14.7 mU/l in the 
supernatant (Figure 17). By the same time, approximately 51% of the activity was 
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retained inside the cells. For FUT9wt, there was also an increase in the activity 
recovered from the cell extracts until the second day of culture (Figure 17), 
although the maximum value obtained (1.8 mU/l cellular suspension) 
corresponded to only 12% of the activity recovered from sFUT9 under identical 
conditions. Subsequent production and characterization was performed with the 
soluble sFUT9, which contained the catalytic domain of human FUT9 and 
presented the α3-FUT activity, indicating that it acquired the correct fold.  
 
 
Figure 17: α3-Fucosyltransferase activity of Sf9-FUT9wt and Sf9-sFUT9 cells.      
α3-Fucosyltransferase activity was monitored in supernatants (closed symbols, 
continuous line) and cell extracts (open symbols, broken line) of Sf9-FUT9wt (?, ?) and 
Sf9-sFUT9 cells(?, ?) corresponding to 30 μl cell suspension. The transfer of 
radiolabelled Fuc from GDP-[14C]-Fuc to a type II acceptor coupled to a hydrophobic 
moiety (Galβ4GlcNAc-O-(CH2)3NHCO(CH2)5-biotin) was measured. One unit of enzyme 
activity was defined as the amount of enzyme catalyzing the transfer of 1 μmol Fuc/min to 
the acceptor. 
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Supernatants and cell lysates of Sf9-sFUT9 along the culture days were 
analyzed by SDS-PAGE and Western Blot with a polyclonal anti-human FUT9 
antibody that recognizes a C-terminal peptide of the protein. In supernatants an 
immunoreactive band was detected with an apparent molecular mass of 
approximately 41.3 kDa, in the range predicted for sFUT9 (Figure 18A, arrow). A 
peak of protein detection at the second day of production was observed. Analysis 
of the corresponding cell extracts revealed that there was also an increase until 
the second day of culture in the sFUT9 detected intracellularly (Figure 18B, 
arrow). After that, the intracellular detection decreased concomitantly with the 
decrease of the amount of protein detected in the supernatant. Thus, we did not 
observe an increased intracellular accumulation of protein, which corroborated 
the conclusion that the active sFUT9 construct was being efficiently secreted. 
These results showed that the human IL-2 signal sequence was adequate for the 
expression in non-lytic insect cell systems.  
 
 
Figure 18: Western blot analysis of secreted (A) and intracellular (B) sFUT9. Protein 
from 15 μl of cell supernatants (A) and corresponding cell extracts (B) was analyzed. As 
primary antibody, the C-17 anti-FUT9 polyclonal antibody at 1:500 dilution was used. 
Chemiluminescent detection was performed by the ECL Plus system. sFUT9 is indicated 
with arrows (?) and a non-specific band (also detected in Sf9-mock cells) with asterisks 
(*). 
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The protein profiles (Figure 18) correlated with the α3-FUT activities 
obtained (Figure 17): after the second day of culture there was an almost total 
loss of the enzymatic activity recovered from the supernatant, concomitantly with 
a decrease in the detection of secreted sFUT9. The action of secreted proteolytic 
enzymes could explain the decrease of both activity and total product yield after 
the second day of culture. The proteolytic action may affect amino acid residues 
essential for enzymatic activity and later degrade the C-terminal portion of FUT9, 
the region recognized by the anti-FUT9 antibody. Sf9 cells express several 
classes of proteases, namely Cys, that are secreted into the extracellular medium 
(Lindskog et al., 2006) and whose activity was shown to increase from the third 
day of culture onwards (Gotoh et al., 2001). The decrease of sFUT9 activity and 
detection in the supernatant was not due to protein denaturation since we did not 
observe protein precipitation in the culture medium. 
In the cell extracts, we detected several bands with lower apparent 
molecular masses after the second day of culture, when using higher exposure 
times (results not shown). These may correspond to proteolytic processing of 
sFUT9 by endogenous intracellular proteases, different from those secreted to 
the medium. Nevertheless, there was a decrease in the total amount of sFUT9 
detected. sFUT9 expression may be regulated not only post-translationally, but 
also at the level of transcription or translation. For example, it has been described 
that expression of FUT9 in LEC29 CHO cells, was under a translational 
regulation mechanism mediated by 5’-untranslated mRNA regions (Patnaik et al., 
2004). Furthermore, we have previously experienced difficulties in creating stable 
cell lines expressing human FUT9wt or a truncated soluble form. We have 
performed transfection assays with the pcDNA3.1/V5-HisTOPO expression 
vector in several mammalian cell lines (BHK-21B hamster cell line, Neuro2A 
murine neuroblastoma cell line, HeLa and HEK293T human cell lines). Although 
significant α3-FUT activity levels and corresponding protein were detected soon 
after the transfection in all cell lines tested, selection of stable transfectants was 
not efficient, even under very stringent antibiotic conditions (Figure 19). A   
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single-clone selection strategy by limiting dilution and antibiotic selection methods 
was assayed in BHK-21B and HeLa cell lines, but the resistant cells presented no 
expression (Figure 19). These high expression levels obtained transiently after 
transfection and subsequent rapid decrease also suggested that human FUT9 is 
under tight regulation control.  
These results together showed the advantage of using Sf9 insect cells to 
produce soluble and active sFUT9.  
 
  
Figure 19: Western blot analysis of FUT9 transfection assays in HeLa cells. Protein 
from approximately 5x105 cells transfected with pcDNA-FUT9wtV5 were analyzed after 
one day (lane 1), after two weeks of selection with 1.5 mg/ml of G418 sulphate (lane 3) or 
after 4 weeks of single-clone selection by limiting dilution and selection with 1.5 mg/ml of 
G418 sulphate (lanes 4, 5 and 6). Non-transfected HeLa cells were used as negative 
control (lane 2). As primary antibody, an anti-V5 monoclonal antibody at 1:5000 dilution 
was used. Chemiluminescent detection was performed by the ECL Plus system. 
FUT9wtV5 is indicated with an arrow (?) and a degradation product also recognized by 
the antibody with an asterisk (*).  
 
 
3.4.2. Characterization of sFUT9 
 
3.4.2.1. N-glycosylation of sFUT9 
 
Human FUT9 has three potential N-glycosylation sites (Asn-62, Asn-101 
and Asn-153), all present in the sFUT9 mutant. The apparent molecular mass of 
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sFUT9 detected in the supernatants (41.3 kDa) (Figure 18) was higher than the 
molecular mass predicted from the amino acid sequence of sFUT9 (37.8 kDa), 
suggesting that N-glycosylation sites of the protein were occupied. To elucidate 
the type of sFUT9 N-glycosylation, protein collected from the supernatant at the 
second day of culture was digested with the glycosidases PNGaseF or EndoH 
and analyzed by Western Blot. PNGaseF treatment yielded two bands that 
presented a shift to lower molecular masses (Figure 20).  
 
 
Figure 20: Deglycosylation and Western blot analysis of secreted sFUT9. Protein 
from 30 μl of cell supernatant was incubated with PNGaseF, EndoH, or buffer alone (Ctl) 
and analyzed by Western Blot. As primary antibody, the C-17 anti-FUT9 polyclonal 
antibody at 1:500 dilution was used. Chemiluminescent detection was performed by the 
ECL Plus system.   
 
The higher band presented an apparent molecular mass of approximately 
37.8 kDa, which corresponds to the predicted molecular mass for the peptide 
sequence of secreted sFUT9. This result suggested that the three potential       
N-glycosylation sites of FUT9 were occupied, as the most common N-linked 
oligosaccharides present in recombinant proteins expressed in Sf9 cells 
(Man3GlcNAc2Fuc), have a molecular mass of 1039 Da (Hollister et al., 2002). 
The lowest band observed presented an apparent molecular mass lower than   
37 kDa, and probably corresponded to a proteolytic product of sFUT9. This may 
have been produced due to higher sensibility to degradation of the 
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deglycosylated form. EndoH had no effect on secreted sFUT9 (Figure 20), 
indicating that the three N-glycans of sFUT9 sensitive to PNGaseF were of the 
paucimannosidic-type oligosaccharides with proximal Fuc. 
 
3.4.2.2. Acceptor specificity of sFUT9 
 
The maintenance of FUT9 specificity of is one of the major issues to 
consider when developing a production strategy of the protein. We detected 
activity of sFUT9 expressed in Sf9 cells towards the type II acceptor (Figure 17), 
which indicated that the soluble form of the enzyme retained the FUT9 biological 
activity, the synthesis of the Lex epitope (Nishihara et al., 2003). In order to 
further characterize sFUT9 specificity, fucosyltransferase activity assays were 
performed with cell supernatants collected in the second day of production, using 
a panel of oligosaccharides coupled to a hydrophobic moiety as acceptor 
substrates.  
We observed that sFUT9 expressed in Sf9 cells had a clear preference for 
type II acceptors. The activity towards Galβ4GlcNAc-R was 10 ± 0.59 μU/million 
cell (Table 3), leading to the production of Lex determinant. A substitution of Gal 
with α2-linked Fuc (Fucα2Galβ4GlcNAc-R) yielded an increase in activity of 1.6 
fold, with the production of Lewis y (Ley) determinant. Nevertheless, a substitution 
of Gal with α2,3-linked N-acetylneuraminic acid (NeuAcα2,3Galβ4GlcNAc-R) 
yielded undetectable radioactivity incorporation. These results are in good 
agreement with the substrate specificity of human FUT9 expressed in Namalwa 
cells (Toivonen et al., 2002) and COS7 cells (Cailleau-Thomas et al., 2000). 
Activity towards type I acceptors was also detected but at lower levels (Table 3). 
Of the type I acceptors tested, Galβ3GlcNAc-R presented the highest activity 
value (0.19 ± 0.01 μU/million cell), although activity was also detected when Gal 
was substituted with α2,3-linked  N-acetylneuraminic acid (Fucα2Galβ4GlcNAc-
R) or α2-linked Fuc (Fucα2Galβ3GlcNAc-R). The detection of FUT9 activity 
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towards type I acceptors has been found for Galβ3GlcNAc (Toivonen et al., 
2002), but not for Galβ3GlcNAcβ-O-(CH2)8COOCH3 (Cailleau-Thomas et al., 
2000) or pyridylaminated lacto-N-tetraose (Galβ3GlcNAcβ3Galβ4Glc-PA) 
(Kaneko et al., 1999b; Baboval et al., 2000). In this work, we have shown that 
sFUT9 also synthesizes the Lea determinant when the disaccharide acceptor is 
linked to a hydrophobic moiety.  
 
Table 3: Substrate specificity of sFUT9 from Sf9 cells.  
Substrate Activity 
(μU/106cell) 
Relative Activity 
Type II acceptors (a)   
     Galβ4GlcNAc-R 10.00 ± 0.59 1.00 
     NeuAcα2,3Galβ4GlcNAc-R N.D. N.D. 
     Fucα2Galβ4GlcNAc-R 16.02 ±1.24 1.60 
Type I acceptors (b)   
     Galβ3GlcNAc-R 0.19 ± 0.01 0.02 
     NeuAcα2,3Galβ3GlcNAc-R 0.13 ± 0.05 0.01 
     Fucα2Galβ3GlcNAc-R 0.07 ± 0.01 0.01 
One unit of enzyme activity defined as the amount of enzyme catalyzing the transfer of 1 
μmol Fuc/min to the acceptor. Activity relative to Galβ4GlcNAc-R at 0.35 mM in the 
presence of 0.15 mM GDP-Fuc, containing GDP-[14C]-Fuc in a 1:60 (a) or 1:30 (b) molar 
ratio, and 5 mM MnCl2; R= O-(CH2)3NHCO(CH2)5-NH-biotin. N.D.: not detected. 
 
FUT9 activity towards glycolipid acceptors in vitro has been described by 
others (Nishihara et al., 2003). During this Thesis work, we found that full-length 
FUT9 expressed in HeLa cells efficiently transferred Fuc to N-linked 
oligosaccharides of glycoproteins (Chapter 2).  
In order to determine if sFUT9 was also able to transfer Fuc to 
glycoproteins, activity towards bovine asialofetuin (AF) and recombinant human 
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erythropoietin (EPO) expressed in CHO cells was also tested (Table 4). We 
detected efficient transfer of Fuc to all three glycoproteins tested, with activities of 
120.6±0.7, 113.0±10.3 and 110.2±3.9 μU/million cell towards AF, EPO and 
asialoEPO, respectively (Table 4). Probably, sFUT9 added Fuc to the peripheral 
type II determinants present in AF and in asialoEPO, forming terminal Lex 
determinants, as FUT9 has been described to fucosylate preferentially outermost 
type II structures (Toivonen et al., 2002).   
 
Table 4: Activity of sFUT9 from Sf9 cells towards glycoproteins 
Glycoprotein Activity 
(μU/106cell) 
Relative Activity 
     Asialofetuin 120.6 ± 0. 7 12.1 
     Erythropoietin 113.0 ± 10.3 11.3 
     Asialoerythropoietin 110.2 ± 3.9 11.0 
One unit of enzyme activity defined as the amount of enzyme catalyzing the transfer of 1 
μmol Fuc/min to the acceptor. Activity relative to Galβ4GlcNAc-R at 0.35 mM in the 
presence of 0.15 mM GDP-Fuc and 5 mM MnCl2; R= O-(CH2)3NHCO(CH2)5-NH-biotin. 
 
Assuming that the three potential N-glycosylation sites of AF are 
occupied, and since N-glycans from AF are predominantly of the triantennary 
type with mainly peripheral type II structures (Costa et al., 1997), there would be 
approximately 468 μM of Galβ4GlcNAc-R’ acceptor in the reaction mixture, 
considering 9 terminal branches in average. This is 1.3 fold higher than that used 
for the small acceptor Galβ4GlcNAc-R. On the other hand, recombinant human 
EPO from CHO cells has three occupied N-glycosylation sites and presents 
peripheral type II determinants substituted with sialic acid on tetrantennary, 
triantennary and biantennary oligosaccharides in an 8:3:1 ratio (Chapter 2). 
Therefore, there would be 10 terminal branches Galβ4GlcNAc-R’ in average, with 
the corresponding final concentration of 170μM. This value is 2.3 times lower 
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than that used for the small acceptor Galβ4GlcNAc-R. These results revealed a 
higher efficiency of sFUT9 for fucosylating glycoproteins with terminal type II 
structures relatively to small oligosaccharides linked to a hydrophobic moiety. 
sFUT9 also presented efficient transfer of Fuc to native sialylated EPO 
(Table 4), contrary to that found for the sialylated type II acceptor as presented 
above (Table 3). It has previously been shown by others using linear synthetic 
acceptors with repeats that substitution of terminal Gal with sialic acid caused a 
shift in FUT9 specificity towards Galβ4GlcNAc inner repeats (Toivonen et al., 
2002). We observed that 40 and 26% of the tetrantennary oligosaccharides had 
one or two lactosamine repeats, respectively, and that 35 and 21% of the 
triantennary had one and two repeats, respectively (Chapter 2). Therefore, in the 
case of native EPO, sFUT9 most probably catalyzed the transfer of Fuc to the 
innermost type II structures of the tetrantennary or triantennary oligosaccharides 
with repeats.  
We tested the activity of the FUT9wt membrane form produced in Sf9 
cells (Figure 15) towards EPO and asialoEPO and observed that the transfer was 
1.4 fold more efficient for the asialo form (results not shown), contrary to sFUT9 
that presented similar efficiency for both native and asialoEPO (Table 3). Thus, it 
is probable that the ablation of the N-terminal region of FUT9 contributed to the 
accessibility of the enzyme to the inner repeats. Accordingly, we have previously 
shown that a soluble form of human FUT3 presented augmented activity towards 
glycoprotein acceptor substrates (Sousa et al., 2001).  
Furthermore, the FUT9wt membrane bound form expressed in HeLa cells 
presented only residual transfer to native EPO and good transfer to asialoEPO 
and AF. The activities towards the terminal Galβ4GlcNAc units of the 
glycoproteins were equivalent to those obtained for the oligosaccharide type II 
acceptor linked to a hydrophobic moiety (Chapter 2). Thus, FUT9 presented 
higher efficiency in fucosylating glycoproteins when expressed in Sf9 insect cells 
than in HeLa cells. This may be due to the different N-glycosylation of FUT9 
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itself, as insect cell-type glycosylation present differences from mammalian N-
glycosylation (Hollister et al., 2002). One hypothesis is that the paucimannosidic-
type oligosaccharides that occupy the N-glycosylation sites of sFUT9 (Figure 20) 
allow a better accessibility and/or interaction to the glycoprotein substrates than 
the mammalian hybrid and complex-type oligosaccharides present in FUT9 from 
HeLa cells (Chapter 2).  
In summary, sFUT9 was active and synthesized the Lex and Ley 
determinants in vitro. Furthermore, it efficiently fucosylated sialylated and non-
sialylated glycoproteins.  
 
 
3.5. Conclusions 
 
In the present work, we have produced an active recombinant soluble 
form of human FUT9 from stably transformed Sf9 cells. Therefore, sFUT9 can be 
used for the in vitro synthesis of fucosylated glycoconjugates and is suitable for 
further functional and structural studies of the enzyme. 
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Chapter 4 
 
 
Increased levels of fucosyltransferase IX and carbohydrate 
Lewisx adhesion determinant in human NT2N neurons 
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"Increased levels of fucosyltransferase IX and carbohydrate Lewisx adhesion 
determinant in human NT2N neurons" J. Neurosci. Res. 85, 1260-1270. 
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4. Increased levels of fucosyltransferase IX and carbohydrate Lewisx 
adhesion determinant in human NT2N neurons 
 
 
4.1. Summary 
 
The expression of the fucosylated carbohydrate Lewisx (Lex) determinant 
(Galβ4(Fucα3)GlcNAc-R) has been found in glycoproteins, proteoglycans, and 
glycolipids from the nervous system. Evidence suggests its association with   
cell-cell recognition, neurite outgrowth, and neuronal migration during central 
nervous system development. In the present work, we detected increased levels 
of Lex in differentiated human NT2N neurons cultured in vitro. To identify which 
fucosyltransferase (FUT) synthesized the Lex in NT2N neurons, RT-PCR, FUT 
substrate specificity and Western blot analysis were carried out. Strong activity 
toward acceptors Galβ4GlcNAc-R and Fucα2Galβ4GlcNAc-R                  
(R = O-(CH2)3NHCO(CH2)5NH-biotin), together with strong FUT9 detection by 
Western blot and presence of transcripts showed that FUT9 was the enzyme 
associated with Lex biosynthesis in NT2N neurons. Lex was detected at the 
plasma membrane of NT2N neurons, in lysosomes marked with            
lysosomal-associated membrane protein 1 (LAMP-1), and it was found for the 
first time to colocalize with the tetanus neurotoxin-insensitive vesicle-associated 
membrane protein (TI-VAMP) that defines the TI-VAMP exocytic compartment 
which is involved in neurite outgrowth. Furthermore, incubation with anti-Lex 
monoclonal antibody L5 led to impaired adhesion of NT2N neurons to the surface 
matrix and inhibited neurite initiation. In conclusion, FUT9 and its product Lex are 
detected specifically in human NT2N neurons and our results indicate that they 
underlie cell differentiation, cell adhesion, and initiation of neurite outgrowth in 
those neurons. 
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4.2. Introduction 
 
Glycoconjugates containing fucose (Fuc) have been shown to play 
important roles in cell adhesion and cell-cell interactions. The fucosylated 
carbohydrate Lewisx (Lex) determinant (Galβ4(Fucα3)GlcNAc) from glycolipids, 
glycoproteins, or proteoglycans is expressed in several human tissues, including 
the brain. It is the most probable candidate to play an important role in normal 
brain development because its expression was found temporally and spatially 
regulated in the developing central nervous system (CNS) of diverse species, 
including human, rat, mouse, chicken, and Xenopus (Dasgupta et al., 1996; Gotz 
et al., 1996; Mai et al., 1999; Yoshida-Noro et al., 1999). Furthermore, complex-
type N-glycans with terminal Lex on one arm are among the most abundant 
neutral carbohydrates detected in human brain (Albach et al., 2001). At the 
cellular level, it has been detected in mouse neurons at the surfaces of cell 
bodies, processes, and growth cones (Nishihara et al., 2003). Furthermore, Lex 
seems to have a role in neurite outgrowth or adhesion because anti-Lex 
antibodies inhibit neurite outgrowth in explant brain cultures from Xenopus 
embryos (Yoshida-Noro et al., 1999). A specific association between Lex and 
mouse brain cells was also suggested by its role as a neural stem cell marker 
(Capela and Temple, 2002). 
The final step in the biosynthesis of Lex is catalyzed by                          
α3-fucosyltransferases (α3-FUTs), which add a Fuc residue to type II-based 
oligosaccharide chains. To date, six α3-FUTs have been cloned and 
characterized (FUT3, FUT4, FUT5, FUT6, FUT7, and FUT9). FUT10 and FUT11 
have been identified as fucosyltransferases due to their degree of homology with 
other fucosyltransferases (Roos et al., 2002), however, their activity has not been 
validated (Baboval et al., 2000). The enzymes show different specificity patterns: 
they can all synthesize the Lex determinant, with the exception of FUT7 (Becker 
and Lowe, 2003). FUT4 and FUT9 are the main enzymes responsible for the 
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synthesis of Lex (Grabenhorst et al., 1998; Baboval et al., 2000). FUT3 has only 
residual α3-FUT activity and exhibits predominant α4-FUT activity (Costa et al., 
1997). Their specificity differences together with their different tissue distributions 
underlie distinct biological roles. FUT9 is expressed mainly in the CNS, in both 
the developing and mature brain of human, rat, and mouse (Kaneko et al., 1999b; 
Baboval et al., 2000; Cailleau-Thomas et al., 2000). α3-FUT has been shown to 
be responsible for the synthesis of Lex in the mouse brain (Nishihara et al., 2003), 
where it is controlled by Pax6, a transcription factor involved in brain patterning 
and neurogenesis (Shimoda et al., 2002). Recently, the importance of FUT9 for 
the synthesis and role of Lex in mouse brain was shown unequivocally with the 
study of FUT9-/- mouse (Kudo et al., 2007). This animal showed disappearance of 
Lex in the brain concomitantly to increased anxiety-like behaviors. 
We have used NTERA-2/cl.D1 (NT2) cells as a model of the human CNS 
in this study. The NT2 cell line is derived from a human embryonic carcinoma 
(EC), and is characterized by undifferentiated neuronally committed progenitor 
cells (NT2-) that after exposure to retinoic acid (RA), differentiate into post-mitotic 
neurons (NT2N) (Pleasure et al., 1992). Differentiation of NT2N neurons in 
culture follows a pattern of differential gene expression similar to that of the 
neuronal precursors during neurogenesis (Przyborski et al., 2000). NT2N 
neurons have been shown by several laboratories to have characteristics of 
primary human neurons (Sandhu et al., 2003). 
We have shown that differentiated NT2N neurons expressed Lex, which 
was synthesized by FUT9. The Lex was detected on the cell surface of both 
dendrites and axons and, intracellularly, was detected in lysosomes and found to 
colocalize with the exocytic TI-VAMP compartment that is associated with neurite 
outgrowth. Incubation with anti-Lex antibody caused a decrease in the initiation of 
neurite outgrowth and cell adhesion. 
CHAPTER 4 
104 
4.3. Materials and methods 
 
4.3.1. Neuronal culture 
 
NTERA-2/cl.D1 cells were cultured and differentiated into neurons 
essentially as described previously (Pleasure et al., 1992). Briefly, 
undifferentiated NT2- cells were grown in Opti-MEM I (Gibco) with 5% fetal 
bovine serum (FBS) (HyClone), 100 U/ml penicillin (P) and 100 μg/ml 
streptomycin (S) (Gibco). For differentiation, cells were cultured in Dulbecco's 
modified Eagle's medium (DMEM)-High Glucose (HG) (Gibco) with 10% FBS, P, 
S, and 10 μM RA (Sigma, St. Louis, MO) for 5 weeks. For neuron enrichment, 
cell culture was in DMEM-HG with 5% FBS, P, S, supplemented with the mitosis 
inhibitors 1 μM cytosine arabinoside (Sigma), 10 μM fluorodeoxyuridine (Sigma), 
and 10 μM uridine (Sigma) for further 10 days. NT2N neurons were recovered 
after selective hydrolysis with trypsin (Gibco) and plated on 10 μg/ml              
poly-D-lysine (Sigma) and 0.26 mg/ml Matrigel (BD Biosciences)-coated 
surfaces. 
 
 
4.3.2. Fucosyltransferase assays 
 
For FUT assays, cells were solubilized with 50 mM MOPS-NaOH buffer 
pH 7.5, containing 1% Triton X-100 (TX-100), 4°C, for 1 hour. The FUT activity in 
cell extracts was determined by the incorporation of radioactive Fuc from the 
GDP-[14C]-Fuc donor onto several acceptors as described previously (Sousa et 
al., 2001). One unit of enzyme activity was defined as the amount of enzyme 
catalyzing the transfer of 1 μmol Fuc/minute to the acceptor. The synthetic 
acceptors used were the type I: Galβ3GlcNAc-R, NeuAcα2,3Galβ3GlcNAc-R, 
and Fucα2Galβ3GlcNAc-R (H type I); and the type II: Galβ4GlcNAc-R (LacNAc), 
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NeuAcα2,3Galβ4GlcNAc-R (sLacNAc), and Fucα2Galβ4GlcNAc-R (H type II) 
(Lectinity Holding), where R = O-(CH2)3NHCO(CH2)5NH-biotin. 
 
 
4.3.3. SDS-PAGE and Western blot analysis 
 
Total cell protein was solubilized with 50 mM Tris-HCl buffer pH 7.4, 
containing 5 mM EDTA, 1% TX-100, and protease inhibitors (Complete Cocktail; 
Roche). Proteins were separated by SDS-PAGE and transferred to 
polyvinylidene difluoride membrane. Membranes were blocked in 5% non-fat dry 
milk (Nestle) in PBS with 0.1% Tween-20. Primary antibodies were: L5 anti-Lex 
monoclonal antibody (Streit et al., 1990; Streit et al., 1996), C-20 anti-FUT4 and 
C-17 anti-FUT9 polyclonal antibodies (Santa Cruz Biotechnology) at 1:500 
dilutions, L1-11A anti- L1 monoclonal antibody 1:4 (Stoeck et al., 2006), H4A3 
anti-human LAMP-1 monoclonal antibody (BD Biosciences) at 1:200, VC1.1 anti-
HNK-1 monoclonal antibody (Sigma) at  1:10000 dilution and anti-calnexin (Chen 
et al., 1995) at 1:15000 dilution. All dilutions were in blocking solution.           
HRP-labeled polyclonal secondary antibodies anti-mouse IgM, anti-goat IgG 
(Sigma), anti-mouse IgG and anti-rabbit IgG (Amersham Biosciences) were 
diluted in blocking solution. Chemiluminescent detection was by the ECL Plus 
system (Amersham Biosciences). 
Mucin extract from a gastric mucosa adjacent to a gastric carcinoma was 
used as a control in anti-Lex Western blot. The sample was obtained from a 
surgical specimen of a patient undergoing surgical resection in the Hospital S. 
João, Porto, Portugal. Sample was collected after informed consent. Mucin 
extraction was carried out as described previously (Reis et al., 1997). 
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4.3.4. Glycosidase hydrolysis  
 
Total cell protein from 5x105 NT2N neurons after 8 days in plates coated 
with poly-D-lysine and Matrigel was solubilized with 50 mM Tris-HCl buffer pH 
7.4, containing 5 mM EDTA, 1% TX-100, and protease inhibitors (Complete 
Cocktail; Roche), at 4ºC for 1 hour. After centrifugation at 10000× g, for 10 
minutes, the cell extract was precipitated in 80% ethanol, at –20ºC, for 3 hours. 
The pellet was collected after a centrifugation 10000× g, 10 minutes, at 4ºC. 
Deglycosylations with peptide-N-glycosidase F (PNGase F) (Roche), 
neuraminidase (Roche) and chondroitinase ABC (ChABC) (Sigma) were 
performed according to the supplier’s instructions. Twenty μg serum ferritin 
(Sigma) and 30 μg decorin (Sigma) were used as positive control for 
neuraminidase and ChABC activity, respectively. In brief, precipitated protein was 
solubilized in denaturation buffer (0.5% SDS and 1% β-mercaptoethanol) for 10 
minutes at 100ºC, samples were allowed to cool down and 5 U of PNGase F, 50 
μU neuraminidase or 25 mU of ChABC and the corresponding buffers were 
added. The buffers were: 10 mM NaH2PO4, 5 mM EDTA, 1% Nonidet P-40    
(NP-40), pH 7.5 for PNGaseF; 50 mM NaCH3CO2, 5 mM CaCl2 pH 5.5 for 
neuraminidase; 50 mM Tris, 60 mM NaCH3CO2 and 0.02 % (w/v) BSA pH 8 for 
ChABC. Incubations were done in 25 μl reaction mixtures, at 37ºC, for 18 hours 
(PNGaseF and neuraminidase) or 6 hours (ChABC) and the reactions were 
stopped by precipitation in 80% ethanol at -20ºC. Proteins were separated by 
SDS-PAGE in precasted NuPAGE Novex Tris-Acetate gels 3-8% (Invitrogen) and 
analyzed by Western blot with the L5 anti-Lex monoclonal antibody, as described 
above. 
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4.3.5. Cell-surface biotinylation  
 
Cell surface proteins were biotinylated as described before (Sousa et al., 
2003). NT2N neurons after 8 days in 6-well plates coated with poly-D-lysin and 
Matrigel, were cooled to 4ºC, three-fold washed with PBS and incubated with   
0.5 mg/ml sulfo-NHS-SS-biotin (Pierce) in PBS containing 1 mM CaCl2 and 1 mM 
MgCl2 (PBSCM) for 30 minutes. After a two-fold wash with PBSCM containing  
50 mM NH4Cl followed by DMEM with 10% FCS, proteins were extracted with 
PBS containing 1% TX-100, 0.5% sodium deoxycholate, 0.1% SDS, 5 mM EDTA 
and a complete cocktail of protease inhibitors (Roche) and incubated with 50 μl 
streptavidin-agarose suspension (Sigma) for 2 hours. The agarose beads were 
five-fold washed with 10 mM Tris-HCl buffer pH 8.0, containing 0.5 M NaCl,         
1 mM EDTA, 1% NP-40. All steps were performed at 4°C. The biotinylated 
proteins were eluted by boiling in SDS sample buffer, separated by SDS-PAGE in 
a precasted Tris-Acetate Criterion gel 3-8% (BioRad) and analyzed by Western 
blot with the L5 anti-Lex monoclonal antibody and the rabbit polyclonal anti-
calnexin antibody, as described above.  
 
 
4.3.6. RNA extraction and reverse transcription 
 
Total RNA was extracted from NT2- cells and NT2N neurons. The RNeasy 
extraction kit (Qiagen) was used according to the manufacturer’s protocol. In 
brief, 5x106 cells were lysed, homogenized and applied to an Rneasy minispin 
column of a silica-based membrane that selectively binds to RNA. Total RNA was 
eluted with 30 μl of RNase-free water. 
Two μg of total RNA was subjected to reverse transcription primed with 
random primers (Invitrogen). The mixture was incubated at 65ºC for 5 minutes 
and chilled on ice. One unit of Moloney Murine Leukemia Virus Reverse 
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Transcriptase (Invitrogen) was added and the mixture was incubated at 37ºC for 
50 minutes. The reaction was terminated by incubating the reaction mixture at 
70ºC, for 15 minutes. One μl of the resulting cDNA was amplified in a final 
volume of 25 μl of polymerase chain reaction (PCR) reaction mixture containing 
1.5 mM MgCl2, 0.2 mM dNTPs, 0.4 μM of each primer, 5% DMSO (for FUT4) and 
2.5 U Taq DNA Polymerase (Invitrogen). The primers for FUT4 were FUT4-fwd: 
5’-GAGAGGCTCAGGCCGTGCTTTT-3’ and FUT4-rev:                            
5’-GCAGGAGCCCAATTTCGGGCAC-3’, described by Numahata et al., 2002. 
The primers for β-actin have been described by Kudo and Narimatsu,             
1995 - β-actin-fwd: 5’-GATATCGCCGCGCTCGTCGTCGAC-3’ and β-actin-rev:           
5’-CAGGAAGGAAGGCTGGAAGAGTGC-3’. The primers specific for FUT9 were 
deduced from cDNA sequences (Kaneko et al., 1999b) - FUT9-fwd:                     
5’-GGGCAGACCTTTGACCTTACAT-3’ and FUT9-rev:                            
5’-CTTTTCACATGATCGCAAGC-3’. PCR was carried out in a                       
2720 Thermalcycler (Applied Biosystems) under the following conditions: 94ºC 
for 5 minutes; 30 cycles of 94ºC for 45 seconds, 55-64ºC (depending on primers 
used) for 1 minute and 72ºC for 2 minutes; 72ºC for 7 minutes. The PCR 
products were analyzed by electrophoresis in 1.5 % agarose gel with 0.5 μg/ml 
ethidium bromide and their size estimated relatively to a gene ruler consisting of 
1 kb and 100 bp DNA ladders.  
 
 
4.3.7. Immunofluorescence microscopy 
 
NT2- cells, grown on coverslips to half confluency, and NT2N neurons, 
after 8 days in 24-well plates with coverslips coated with poly-D-lysine and 
Matrigel, were washed with PBS containing 0.5 mM MgCl2, fixed with 4% (w/v) 
paraformaldehyde (PF) and 4% sucrose (suc) in PBS for 20 minutes and, when 
described, permeabilized with 0.1 or 0.3% (w/v) TX-100 in PBS (NT2- cells and 
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NT2N neurons, respectively) for 20 minutes. Blocking was done with 1% bovine 
serum albumin (BSA) and 0.1% TX-100 in PBS for 1 hour and primary and 
secondary antibodies were incubated at room temperature for 2 and 1 hour, 
respectively. Antibody solutions were prepared in blocking solution and washes 
were carried out with PBS. Coverslips were mounted in Airvol. Primary antibodies 
were: rat IgM anti-Lex L5 (1:200); mouse IgG anti-Lex SH1 used at  10-fold 
concentrate containing BSA 1% (Singhal et al., 1990); mouse IgM                  
anti-SSEA-1 MC-480 (1:1) (DSHB); mouse IgM anti-Lewisy (Ley) AH6 (1:1) (Abe 
et al., 1983); rabbit IgG anti-NF-L (1:2,000) (Trojanowski et al., 1989); mouse IgG 
anti-hypophosphorylated NF-M RMdO.20 (1:1) (Pleasure et al., 1992); rat IgG 
anti-highly phosphorylated NF-M H014 (1:1) (Pleasure et al., 1992); mouse IgG 
anti-TI-VAMP clone 158.2 (1:200) (Alberts et al., 2003); mouse IgG anti-EEA-1 
(1:200) (BD Biosciences); mouse IgG anti-LAMP1 H4A3 (1:50); mouse IgG anti-
GM130 (1:200) (BD Biosciences); and sheep IgG anti-TGN46 (1:200) (Serotec). 
Secondary antibodies were: goat anti-mouse IgG TRITC-conjugate (1:64) 
(Sigma); goat anti-rat IgM TRITC-conjugated (1:50) (Jackson ImmunoResearch); 
goat anti-mouse IgM TRITC-conjugated (1:50) (Jackson ImmunoResearch); goat 
anti-mouse IgG AlexaFluor488 (1:500) (Molecular Probes); donkey anti-mouse 
IgG AlexaFluor488 (1:500) (Molecular Probes); and donkey anti-sheep IgG 
AlexaFluor488 (1:500) (Molecular Probes). For double labeling with anti-LAMP-1 
and anti-TI-VAMP mouse IgGs, neurons were permeabilized with 0.1% TX-100 
for 10 minutes, and incubated sequentially with the two antibodies. After 
incubation with anti-LAMP-1 followed by goat anti-mouse IgG-AlexaFluor594 
conjugated, non-labeled goat anti-mouse IgG Fab fragment (Sigma) at the 
saturating concentration of 0.2 mg/ml was used. Incubations with anti-TI-VAMP 
followed by goat anti-mouse IgG-AlexaFluor488 were carried out. As control, the 
experiment was carried out without anti-LAMP-1 or anti-TI-VAMP, and resulted in 
staining patterns similar to those obtained for each primary antibody 
independently. 
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Confocal images were acquired in a confocal microscope SP2+AOBS 
(Leica) equipped with a 63× objective using zoom 2. Each fluorophore used was 
excited and detected separately to avoid channel bleed-through. For each 
channel, photomultiplier gains and offsets were adjusted to use full image 
dynamic range. Each picture consisted of a z-series of 20 images of 1024 × 1024 
pixel resolution with a pinhole of 1.0 Airy unit and typically, 0.6 μm focus 
intervals. Merge between channels and maximum z-projections were created 
using the open source ImageJ software version 1.35         
(http://www.rsb.info.nih. gov/ij/). Image editing software (Adobe Photoshop, 
Adobe Systems) was used to create montages. The only modifications made 
during image editing were linear brightness and contrast adjustments. 
 
 
4.3.8. Recycling assay 
 
Live NT2N neurons, after 8 days in 24-well plates with coverslips coated 
with poly-D-lysine and Matrigel, were cooled and incubated with L5 anti-Lex 
monoclonal antibody at 1:150 dilution at 4ºC for 1 hour. After washing with 
medium, neurons were incubated at 37ºC for 1, 2 or 3 hours, to allow endocytosis 
and recycling to occur, or at 4ºC for 1 hour. Cells were then washed, fixed with 
4% PF containing 4% suc for 20 minutes and PM Lex was detected with a goat 
anti-rat IgM-AlexaFluor488 (Invitrogen). NT2N neurons were then permeabilized 
and probed for NF-L as described above. Secondary antibody was a goat anti-
rabbit IgG-AlexaFluor594 conjugated. 
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4.3.9. Anti-Lex incubation assays  
 
NT2N neurons were plated on 24-well plates (5 x 104 cells/cm2) coated 
with poly-D-lysine and Matrigel. The assays were carried out in conditioned 
medium with mitosis inhibitors. 
Anti-Lex antibody (L5) was added to NT2N neurons at the time of plating 
or to neurons already in culture for 4 days. Equivalent volumes of PBS (the 
solvent of the stock solution of anti-Lex) and equivalent concentrations of the  
non-related IgM MOPC-104E (Sigma) that recognizes α3-glucan (Klimpel and 
Goldman, 1988) were used as control. Cells were observed by bright-field 
microscopy using a Leica DM IRB inverted microscope attached to an Olympus 
DP11 digital camera. Neurite length was measured using the NeuronJ 1.1.0 
plugin (Meijering et al., 2004) of the open source ImageJ software version 1.35. A 
neurite was defined as a process with a length greater than one cell body 
diameter (approximately 15 μm). At least 60 neurites were measured. 
Experiments were carried out at least twice. Statistical analysis was carried out 
using the GraphPad Prism 4 software. 
 
 
4.4. Results  
 
4.4.1. Level of the Lex determinant is increased during NT2N neurons 
differentiation 
 
To monitor Lex during differentiation of the teratocarcinoma NT2- cells into 
NT2N neurons on RA induction, we have analyzed the two cell types by 
immunofluorescence microscopy with several monoclonal anti-Lex antibodies: L5 
(Streit et al., 1990; Streit et al., 1996), SH1 (Singhal et al., 1990), and             
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anti-SSEA-1 (Solter and Knowles, 1978). We found that both L5 and SH1 
antibodies stained NT2N neurons but not NT2- cells (Figure 21A).  
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Figure 21: Immunodetection of Lewis determinants in NT2- cells and NT2N neurons 
by immunofluorescence confocal microscopy. (A) Permeabilized NT2- cells and 
NT2N neurons were probed with the monoclonal antibodies anti-Lex L5, SH1 and SSEA-
1; anti-sLex FH6; anti-Ley AH6; anti-Lea PR5C5; anti-sLea CA19-9; anti-Leb BG6 (shown 
in red) and a polyclonal antibody anti-NF-L (shown in green). Secondary antibodies were: 
goat anti rat IgM-TRITC, goat anti-mouse IgG-AlexaFluor594, goat anti-mouse            
IgM-TRITC, and goat anti-rabbit IgG-AlexaFluor488. The experiment was done at least 
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three independent times. (B) Permeabilized NT2N neurons cultured on poly-D-lysine 
coated surfaces with serum-depleted medium were probed with the monoclonal antibody 
anti-Lex L5. Secondary antibody was goat anti rat IgM-TRITC. Maximum intensity z-
projections of 20 optical sections are shown. Scale bars = 10 μm. 
 
The staining appeared in vesicles, which were concentrated in the cell 
body, with a perinuclear pattern, and extended into neurites. The anti-SSEA-1 
antibody presented no reactivity in neither NT2- nor NT2N neurons (Figure 21A), 
as described by other authors (Fenderson et al., 1987).  
The labeling in NT2N neurons did not consist of material internalized from 
FBS nor Matrigel because it was detected by immunofluorescence microscopy in 
NT2N neurons cultured in serum-depleted medium and on poly-D-lysine coated 
surfaces (Figure 21B). As a control for neuronal differentiation, a polyclonal 
antibody against low molecular weight neurofilament protein (NF-L) was used as 
neuronal marker, which stained NT2N neurons (Figure 21A) but not NT2- cells 
(results not shown). Other Lewis determinants derived from type II 
oligosaccharides were also monitored. Ley was detected with the AH6 antibody in 
NT2- cells but not in NT2N neurons (Figure 21A). This decrease was probably 
due to a downregulation of α2-FUT during differentiation. Alternatively, 
reorganization of glycosyltransferases in the Golgi during differentiation could 
occur in a way that α2-FUT would not have access to the type II precursor. The 
sLex epitope was not detected in NT2- cells nor in NT2N neurons (Figure 21A). 
Lewis determinants derived from type I precursors, Lea, Leb, and sLea, were not 
expressed at detectable levels in any of the cell lines (Figure 21A). 
 
 
4.4.2. Lex from NT2N neurons is synthesized by FUT9 
 
To determine the expression pattern of FUTs during NT2N differentiation 
RT-PCR analysis was carried out (Figure 22).  
Increased level of FUT9 in NT2N neurons 
115 
 
 
Figure 22: RT-PCR analysis of fucosyltransferases along NT2N neurons 
differentiation induced by retinoic acid. cDNA was obtained from undifferentiated NT2- 
cells (1), cells in retinoic acid for 3 (2), 10 (3), 17 (4), 24 (5), and 31 (6) days, cells in 
mitosis inhibitors for 10 days (7) and mature NT2N neurons plated on poly-D-lysine and 
Matrigel for 8 days (8). The PCR products were electrophoretically resolved on 1.5% 
agarose gel in the presence of 0.5 μg/ml ethidium bromide. The sizes of the amplified 
fragments are indicated on the left in base pairs (bp). The gels presented correspond to 
one representative experiment of the four experiments carried out from three independent 
RNA extractions. 
 
The RT-PCR products of FUT4 (516 bp), FUT5 (555 bp), FUT6 (534 bp) 
and FUT9 (809 bp) were present in NT2- cells, during RA-induced differentiation, 
and in NT2N neurons. FUT10 gene transcripts (681 bp) were detected in all 
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stages of differentiation except in NT2N neurons. FUT3 (521 bp) and FUT7 (497 
bp) were only detected, with weak signals, in late differentiating stages, starting 
after 24 days in the presence of RA, and in NT2N neurons. FUT11 transcripts 
(650 bp) were not detected in any of the stages analyzed. These results showed 
that there were transcripts of FUT4, FUT5, FUT6, FUT9, and to a minor extent 
FUT3 and FUT7, in NT2N neurons. 
To elucidate the activity profiles of FUTs during the differentiation of NT2N 
cells, we studied the acceptor specificities of cell homogenates during the 
differentiation process toward a panel of small oligosaccharides of the type I and 
II acceptor substrates coupled to a hydrophobic moiety (Figure 23).  
 
 
 
Figure 23: Fucosyltransferase activity - acceptor specificity profile along NT2N 
neurons differentiation induced by retinoic acid. Fucosyltransferase activity was 
determined using 1 × 106 cells of each differentiation step (1 - 8 as indicated in Figure 22 
legend) per assay with the synthetic acceptors: Galβ4GlcNAc-R (LacNAc), 
NeuAcα2,3Galβ4GlcNAc-R (sLacNAc), Fucα2Galβ4GlcNAc-R (H type II),   
Galβ3GlcNAc-R, NeuAcα2,3Galβ3GlcNAc-R and Fucα2Galβ3GlcNAc-R (H type I).         
R = O-(CH2)3NHCO(CH2)5NH-biotin. 
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Activity assays showed that Galβ4GlcNAc-R (LacNAc-R) was a good 
substrate, leading to the production of Lex determinant in every cell homogenate 
from each differentiation step analyzed. A substitution of Gal with α2-linked Fuc 
(H type II-R) yielded an increase in activity. Nevertheless, a substitution of the 
Gal with α2,3-linked N-acetylneuraminic acid (sLacNAc-R) yielded very low 
radioactivity incorporation. These results suggested that FUT4 or FUT9 would be 
the enzymes associated with the synthesis of Lex in differentiating NT2N 
neurons, because FUT5 and FUT6 are capable of fucosylating sialylated type II 
acceptors (Weston et al., 1992a; Weston et al., 1992b), the activity of which was 
not observed for the cell extracts tested in this study (Figure 23).  
Activity toward type I acceptors, Galβ3GlcNAc-R, 
NeuAcα2,3Galβ3GlcNAc-R, and H type I-R, to generate the Lea, sLea, and Leb 
epitopes, respectively, was very poor, from NT2- cells to NT2N neurons, 
representing residual or not detectable values (Figure 23). These results agreed 
with the absence or extremely low amounts of FUT3 transcripts detected     
(Figure 22). 
To distinguish between FUT4 and FUT9 as the enzymes synthesizing Lex 
during NT2N neuron differentiation, we have carried out Western blot analysis 
with polyclonal antibodies against carboxy-terminal peptides of FUT4 and FUT9. 
FUT4 and FUT9 proteins were detected in NT2- cells (Figure 24). FUT4 had an 
apparent molecular mass of 63 kDa, which probably corresponded to the long 
form of the enzyme, ELFT-L (Goelz et al., 1990). The polypeptide chain has a 
predicted molecular mass of 59 kDa with two potential N-glycosylation sites 
(Goelz et al., 1990). Therefore, the difference between the observed molecular 
mass and the theoretical prediction indicated that the glycosylation sites were 
occupied. FUT9 showed an apparent molecular mass of 44 kDa. The polypeptide 
chain has a predicted molecular mass of 42 kDa with three potential                  
N-glycosylation sites (Kaneko et al., 1999b). The 2 kDa molecular mass observed 
was probably due to N-glycosylation. Human FUT9 expressed transiently in HeLa 
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cells was used as a positive control for FUT9 detection (results not shown). After 
differentiation to NT2N neurons, the levels of FUT9 were increased markedly 
whereas FUT4 was no longer detected even after long exposure times (Figure 
24). These results showed clearly that FUT9 was the α3-FUT that catalyzed the 
synthesis of Lex in human NT2N neurons. Additionally, we also found transient 
higher levels of FUT9 in cells treated with RA for 10 and 17 days.  
 
 
Figure 24: Immunodetection by Western blot of FUT4 and FUT9 along NT2N 
neurons differentiation induced by retinoic acid. Total protein from 1 × 106 cells of 
each differentiation step was applied per lane (1 - 8 as indicated in Figure 22 legend). 
Detection was carried out using anti-human FUT4 and FUT9 polyclonal antibodies C-17 
and C-20, respectively. As secondary antibody a polyclonal antibody anti-goat IgG    
HRP-conjugated was used. Detection was carried out by the ECL+ method. Experiments 
were carried out twice from two independent protein extractions of each differentiation 
step. For each experiment, one blot per FUT was done and then reprobed for the other 
FUT to confirm that differences did not arise from different protein loads. 
 
In conclusion, the α3-FUT activity observed in NT2- cells was the result of 
combined activities of FUT4 and FUT9 whereas in NT2N cells only FUT9 
participated in the Lex biosynthesis. The observation that NT2N cells contained 
FUT4 transcripts (Figure 22) but not the corresponding protein (Figure 24) 
suggested that FUT4 was post-transcriptionally downregulated in neurons. 
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4.4.3. Identification of a Lex-carrier glycoprotein associated specifically with NT2N 
neurons 
 
The L5 antibody has been described to react with Lex present on neural 
cell adhesion molecule L1, neural chondroitin sulfate proteoglycans, and other 
neuronal glycosylated proteins. Furthermore, it was shown to bind a mouse 
astrocyte proteoglycan of approximately 500 kDa (Streit et al., 1990). Therefore, 
to identify a possible Lex-carrier glycoprotein from NT2N neurons, cellular 
extracts were analyzed by Western blot using the monoclonal anti-Lex antibody 
L5 during differentiation. Most striking was the finding of a Lex-containing 
glycoprotein at a molecular mass higher than 206 kDa, present in NT2N neurons 
but absent from NT2- cells (Figure 25, lanes 8 and 1, respectively). This protein of 
approximately 460 kDa was associated endogenously with NT2N neurons and 
was not internalized from the FBS because it was still detected by Western blot in 
neurons cultured in serum-depleted medium (Figure 26A, lane 1). Furthermore, it 
was not internalized from the Matrigel used to coat the plates because the carrier 
was already detected in extracts of cells differentiated with RA and in MI for 10 
days (Figure 25, lane 7). Finally, it was absent from Western blot analysis of 
Matrigel extracts (Figure 26A, lane 5). A less abundant glycoprotein was also 
detected in NT2N neurons but not in NT2- cells that had an apparent molecular 
mass of approximately 175 kDa (Figure 25, lanes 8 and 1, respectively). Other 
Lex-containing glycoproteins were detected transiently at intermediary 
differentiation stages at 10-17 days after RA addition (Figure 25, lanes 3 and 4). 
At these stages, higher levels of FUT9 were also observed, as shown above 
(Figure 24). It is probable that the higher FUT9 levels would underlie the higher 
Lex-carrier glycoprotein detection observed by Western blot. Lex-containing 
mucins extracted from a gastric mucosa adjacent to a gastric carcinoma were 
used as positive control (Figure 25, lane C).  
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Figure 25: Immunodetection by Western blot of Lex-carrier proteins along NT2N 
neurons differentiation induced by retinoic acid and of LAMP-1 in NT2N neurons. 
Total protein from 1 × 106 cells of each differentiation step was applied by lane (1 - 8 as 
indicated in Figure 22 legend). Detection was carried out using the anti-Lex monoclonal 
antibody L5. Mucins containing Lex extracted from a gastric mucosa adjacent to a gastric 
carcinoma were used as positive control (lane C). Total protein from 1 × 105 NT2N 
neurons was applied for detection with the anti-LAMP-1 monoclonal antibody H4A3   
(lane L). As secondary antibodies polyclonal anti-mouse IgM and goat anti-mouse IgG 
HRP-conjugated were used. Detection was carried out by the ECL+ method. Experiments 
were carried out three times from at least two independent protein extractions of each 
differentiation step. 
 
As referred above, L5 has been shown to bind astrochondrin, a 
chondroitin sulfate proteoglycan of approximately 500 kDa present in mouse 
astrocytes (Streit et al., 1990; Streit et al., 1993). L5 binding to astrochondrin, to 
other Lex–carriers present in the mouse brain (Streit et al., 1990) and also to a 
500 kDa carrier present in the neural tissue of the chick embryo (Roberts et al., 
1991), showed sensitivity to PNGaseF digestion. According to the 
characterization of the L5 antibody reactivity (Streit et al., 1990; Streit et al., 
1996), it recognizes preferentially the Lex epitope in N-linked glycans from 
glycoproteins.  
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Aiming to characterize the high molecular mass Lex-carrier glycoprotein 
identified in NT2N neurons, we performed digestions with PNGaseF, 
neuraminidase and chondroitinase ABC (ChABC) before Lex detection with the 
L5 antibody (Figure 26A, lanes 2, 3 and 4, respectively). After incubation of NT2N 
neurons extracts with each of the enzymes, we did not observe changes in the 
detection pattern, neither disappearance of the detected band nor a shift in its 
apparent molecular mass. Use of increased amount of enzyme or extended 
incubation time did not increase the digestion efficiencies (results not shown). 
 Decorin, a chondroitin sulfate proteoglycan from bovine articular cartilage 
was used as a positive control for chondroitinase activity (Figure 26B). Decorin 
was detected in SDS-PAGE as a diffuse band above 100 kDa (Figure 26B, 
arrowhead) and after ChABC digestion there was a shift to approximately 40 kDa 
(Figure 26B, arrow), the molecular mass deduced from the polypeptide chain. 
The maintenance of the L5 binding after PNGase F digestion (Figure 26A, lane 2) 
suggested that the Lex determinant was present in oligosaccharides attached to 
the polypeptide chain via a linkage other than N-glycosidic. Nevertheless, we 
cannot rule out that the enzyme was not able to exert its catalytic activity due to 
spatial restrictions caused, for example, by glycosaminoglycan chains.  
Resistance to ChABC digestion suggested that the nature of the          
Lex-carrier identified in human NT2N neurons was distinct from those previously 
identified in mouse astrocytes (Streit et al., 1990) and embryonic rat brain 
(Shimoda et al., 2002). It may correspond to a heparan sufate proteoglycan, a 
class of proteoglycans involved in several roles in the developing nervous 
system, such as connectivity between neurons and target cells (reviewed by Van 
Vactor et al., 2006).  
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Figure 26: Characterization of Lex-carrier protein of NT2N neurons. (A) Western blot 
of Lex-carrier proteins of extracts of NT2N neurons: cultured in serum depleted medium 
(lane 1); after digestion with PNGaseF (lane 2), neuraminidase (lane 3) and 
chondroitinase ABC (lane 4). Matrigel extract (lane 5) was also probed. Detection was 
carried out using the anti-Lex monoclonal antibody L5. (B) SDS-PAGE analysis of decorin 
(arrowhead) digestion (arrow) with chondroitinase ABC (ChABC). BSA from the ChABC 
incubation buffer is also detected (asterisk). (C) Western blot analysis of Lex and       
HNK-1-carrier proteins of NT2N neuron extracts (lane 1 and 2, respectively) and of HNK-
1-carrier proteins of rat brain extract (lane 3). Detection was carried out using the anti-Lex 
monoclonal antibody L5 and the anti-HNK-1 monoclonal antibody clone VC1.1. Detection 
was performed by the ECL+ method. 
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The HNK-1 (human natural killer-1) epitope is a common carbohydrate 
antigen in the CNS, present in neuronal glycoproteins, glycolipids, and 
proteoglycans, including astrochondrin (Streit et al., 1990), proposed to play 
important functional roles in neural development (reviewed by Yanagisawa and 
Yu, 2007). We probed the NT2N neurons extract with L5 and an anti-HNK-1 
antibody and observed that, in addition to Lex (Figure 26B, lane 1), the HNK-1 
epitope was also present in the 460 kDa carrier (Figure 26B, lane 2). The       
anti-HNK-1 antibody also recognized a 170 kDa band that could correspond to 
neuronal cell adhesion molecule (N-CAM). In rat brain extract, used as a positive 
control for anti-HNK-1 binding, we detected a group of bands between 117 and 
238 kDa that probably included the membrane bound forms 145 and 170 forms of 
N-CAM and the myelin associated membrane protein (Naegele and Barnstable, 
1991). Another band between 268 and 460 kDa was also detected which could 
correspond to chondroitin or keratan sulfate proteoglycans carrying HNK-1 
described in other species (Zaremba et al., 1990). A possibility is that the HNK-1 
and Lex epitopes are present in O-mannosyl oligosaccharides, as this type of    
O-glycosidic linkage has been described in rat brain proteoglycans (Krusius et al., 
1987) which carry HNK-1 (Yuen et al., 1997) and Lex (Kogelberg et al., 2001).  
Additional studies will be required to clarify the nature of the Lex-carrier 
glycoprotein identified. 
 
 
4.4.4. Lex determinant is localized at the plasma membrane and in the TI-VAMP 
compartment of NT2N neurons 
 
We further analyzed Lex subcellular localization in NT2N neurons by 
immunofluorescence microscopy using the L5 antibody. Lex was found to be 
present at the PM of non-permeabilized NT2N neurons at the cell bodies as well 
as at the neurites (Figure 27A).  
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Figure 27: Localization of Lex in NT2N neurons by immunofluorescence confocal 
microscopy. (A) NT2N neurons without permeabilization were probed with the antibody 
anti-Lex L5. As secondary antibody, a goat anti-rat IgM-TRITC was used. (B). 
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Colocalization analysis of Lex with markers of the endocytic and exocytic pathways and of 
LAMP-1 with TI-VAMP. (C) Colocalization analysis of Lex with axon and dendrite markers. 
B, C: Permeabilized NT2N neurons were probed with the following antibodies: 
monoclonal anti-Lex L5 and monoclonal anti-GM130, polyclonal anti-TGN-46, 
monoclonals anti-EEA-1, anti-LAMP-1, anti-TI-VAMP, anti-hypophosphorylated medium 
molecular weight neurofilament protein (NF-M P-), or anti-hyperphosphorylated medium 
molecular weight neurofilament protein (NF-M P+). Secondary antibodies were: goat  
anti-mouse IgG-AlexaFluor594, goat anti-mouse IgG-AlexaFluor488, goat anti-rat       
IgG-AlexaFluor488, goat anti-rat IgM-TRITC, and goat anti-sheep IgG-AlexaFluor488. 
Maximum intensity z-projections of 20 optical sections are shown in (A) and (C) and 
single optical sections in (B). The experiments were carried out at least three times and in 
each at least five neurons per marker were analyzed by confocal microscopy.           
Scale bar = 10 μm. 
 
The epitope presented a discrete distribution, being accumulated in 
clusters at the membrane. These did not correspond to labeled intracellular 
vesicles because in vivo incubation of NT2N neurons with L5 antibody at 4°C for 
1 hour yielded the same labeling pattern (Figure 29A).  
To identify the intracellular vesicles containing Lex identified above (Figure 
21), we carried out colocalization analysis with markers of the exocytic and 
endocytic pathways by confocal immunofluorescence microscopy (Figure 27B). 
Most striking was the finding that Lex colocalized with the v-SNARE tetanus 
neurotoxin insensitive vesicle-associated membrane protein (TI-VAMP) or 
VAMP7. TI-VAMP is a v-SNARE with a broad neuronal expression, proposed to 
mediate a specific exocytic pathway (Proux-Gillardeaux et al., 2005). In neuronal 
cells, the TI-VAMP defines an exocytic pathway involved in neurite outgrowth via 
late endosome/lysosome compartment labeled by CD63, but not via early 
recycling endosomes containing the transferrin receptor or EEA-1 (Coco et al., 
1999). It has been shown recently that there was an extensive colocalization 
between TI-VAMP and lysosomal-associated membrane protein-1             
(LAMP-1)-positive late endosomes/lysosomes in developing primary mouse 
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neurons from sympathetic cervical ganglia (SCGs) (Arantes and Andrews, 2006). 
We observed that in human NT2N neurons there was also colocalization between 
TI-VAMP and LAMP-1, both in cell bodies and in neurites (Figure 27B), although 
there was not a complete overlap, contrary to that found in SCG neurons 
(Arantes and Andrews, 2006). This may arise from differences between species, 
type of neurons, or differences in the development stage analyzed. Lex 
colocalized extensively with LAMP-1, but not with the early endosomal marker 
early endosomal antigen-1 (EEA-1) (Figure 27B). LAMP-1 is a lysosomal highly 
glycosylated protein (Carlsson et al., 1988), therefore, we investigated if it would 
be the carrier of the Lex epitope in NT2N neurons. This was not the case, 
however, because LAMP-1 had an apparent molecular weight of approximately 
114 kDa as detected in duplicate by SDS-PAGE and Western blot analysis 
(Figure 25, lane 8), which is lower than the masses of the two bands detected 
with the L5 antibody. Furthermore, immunoprecipitated LAMP-1 was not 
recognized by the L5 antibody, corroborating that in NT2N human neurons 
LAMP-1 was not a Lex-carrier (results not shown). The staining observed in the 
lysosomes was not due to protein uptake from the serum or from the Matrigel 
coat because the staining with L5 was also observed in NT2N neurons cultured in 
serum-depleted medium for 24 hours and in poly-D-lysine coated plates. 
Lex showed only minor colocalization with the Golgi protein GM130 and 
the trans-Golgi network (TGN) marker TGN-46 (Figure 27B). 
NT2N neurons possess identifiable dendrites and axons (Pleasure et al., 
1992). Using monoclonal antibodies that recognize specifically the 
hypophosphorylated (RMdO.20) and highly phosphorylated (HO14.4) forms of 
medium molecular weight neurofilament protein (NF-M), exclusively found on 
somatodendritic and axonal domains respectively, it is possible to distinguish 
between dendrites and axons. Lex was found on neurites marked with both 
antibodies (Figure 27C). These results suggested that the Lex participated in cell 
events common to dendrites and axons (e.g., neurite initiation and elongation of 
outgrowth). 
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To investigate if the Lex-containing glycoproteins found in NT2N neurons 
(Figures 25 and 26) were also present at the PM we have isolated biotinylated 
PM proteins following a procedure described before (Sousa et al., 2003), and 
have analyzed them by Western blot using the L5 antibody. We observed that the 
heavier glycoprotein was partially found at the PM (Figure 28, arrow) whereas the 
lighter less abundant one was predominantly found at the PM (Figure 28, 
arrowhead).  
 
 
Figure 28: Western blot analysis of biotinylated plasma membrane proteins 
containing the Lex determinant. PM proteins were biotinylated with sulfo-NHS-SS-biotin 
and isolated by affinity with streptavidin-agarose beads. The primary antibody used was 
L5. As secondary antibody, a polyclonal antibody anti-mouse IgM HRP-conjugated was 
used. An arrow and an arrowhead identify the two detected carriers. As positive control 
L1 detection was performed using the primary monoclonal antibody L1-11A, and 
secondary anti-mouse IgG HRP-conjugated. As negative control calnexin (cnx) detection 
was performed using a polyclonal antibody anti-cnx, and secondary anti-rabbit IgG    
HRP-conjugated. Detection was carried out by the ECL+ method. 
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As positive control, we used the L1 cell adhesion molecule, that recycles 
between the PM and endocytic organelles of neurons (Kamiguchi and Lemmon, 
2000), and we observed that a fraction of total L1 was indeed found in the PM 
fraction (Figure 28). As negative control, we have analyzed the intracellular 
protein calnexin, an endoplasmic reticulum resident chaperone (Hammond et al., 
1994), and we observed that the level of calnexin found in the PM fraction was 
almost undetectable (Figure 28). This small fraction was probably from a low 
number of lysed cells. Thus, although Lex was detected on the PM, an 
intracellular pool was also observed. This may corresponded to the TI-VAMP and 
LAMP-1-positive vesicles detected (Figure 27B). 
 
 
4.4.5. Lex is recycled to the plasma membrane of NT2N neurons 
 
To investigate the trafficking of the Lex-carriers detected by 
immunofluorescence microscopy  (Figure 27B) we have labeled living NT2N 
neurons with the L5 antibody at 4ºC for 1 hour, followed by incubations of 1, 2 
and 3 hours at 37ºC to allow adsorption, endocytosis and recycling to occur. 
Subsequent fixation and incubation with a fluorescently labeled secondary 
antibody allowed the visualization of the Lex fraction that was present at the PM. 
After the initial incubation at 4°C, Lex–labeling was accumulated in discrete 
clusters in cell bodies and neurites (Figure 29A), a distribution similar to that 
found by immunofluorescence microscopy of non-permeabilized cells (Figure 
27A). Subsequent incubation at 37ºC for 1 and 2 hours caused a decrease in the 
Lex detected at the PM to almost undetectable levels(Figure 29B, C), suggesting 
that the Lex-carrier - L5 antibody complexes had been internalized. After 3-hour 
incubation, Lex reappeared at the PM (Figure 29D).  
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Figure 29: Plasma membrane distribution of recycled Lex in NT2N neurons by 
immunofluorescence confocal microscopy. Live NT2N neurons were incubated with 
L5 anti-Lex antibody at 4ºC for 1 hour (A) and allowed to internalize and recycle the       
L5–Lex-carrier complex at 37ºC for 1 (B) 2 (C) or 3 (D) hours. Cells were fixed and       
L5–Lex-carrier complex present at the PM detected by a goat anti-rat IgM-AlexaFluor488 
antibody. After permeabilization, NT2N neurons were also probed with an anti-NF-L 
polyclonal antibody followed by a goat anti-rabbit IgG-AlexaFluor594. Maximum intensity 
z-projections of 20 optical sections are shown. The experiments were carried out at least 
two times and in each at least five neurons per marker were analyzed by confocal 
microscopy. Scale bar = 10 μm. 
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These results suggested that Lex-carriers present at the PM of NT2N 
neurons were endocytosed and recycled back to the cell surface. This may occur 
via the membrane compartment defined by TI-VAMP which has been implicated 
in the trafficking of molecules that recycle between the PM and endocytic 
organelles of neurons, like the L1 cell adhesion molecule (Alberts et al., 2003).  
 
 
4.4.6. Anti-Lex antibody impairs initiation of neurite outgrowth and adhesion of 
NT2N neurons 
 
To investigate the biologic role of Lex in NT2N neurons, we have studied 
the effect of anti-Lex monoclonal antibody L5 on the neurons. We have used a 
non-related IgM (ctl IgM) to rule out unspecific effects caused by the IgM size. In 
cultures that were allowed to adhere and form neurites before the incubation with 
anti-Lex antibody, we observed that attachment of neurons and their neurites to 
the surface was significantly impaired with 30 nM of antibody, when compared to 
incubation with 30 nM of control IgM (Figure 30A, arrows). At 15 nM L5, the effect 
was already visible but was less evident (results not shown). Furthermore, it 
seemed that traces of neurite remaining after detachment or retraction were 
observed (Figure 30A, arrowheads). When incubations were prolonged for        
48 hours, neurons were detached from the surface at 10 nM L5 (results not 
shown). These results indicated that the L5 antibody inhibited NT2N cell 
adhesion to the plates.  
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Figure 30: Effect of anti-Lex antibody L5 on the adhesion and initiation of neurite 
outgrowth from NT2N neurons. (A) NT2N neurons in culture for 4 days were incubated 
with 30 nM anti-Lex antibody L5; 30 nM of a non-related IgM (ctl IgM) was used as 
control. The same areas of the cultures were monitored at the time of the antibody 
addition (0 hr) and 24 hours later (24 hr). The assay was carried out in one (ctl IgM) or 
three independent experiments in duplicate. Scale bar = 50 μm. (B) Quantification of 
NT2N neurons with neurites in the presence of increasing L5 concentrations. L5 was 
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added to the cultures at the time of plating and PBS was used as control. The percentage 
of neurons with neurites was quantified 24 hours later. Data are mean ± SD of at least 
150 neurons counted in 10 equivalent optical fields from one (30 nM ctl IgM), two (10 and 
30 nM L5), and three (ctl and 15 nM L5) independent experiments in duplicate. *Indicates 
significant difference (P < 0.001) from 30 nM ctl IgM mean by a one-way ANOVA analysis 
with a Tukey's post-hoc multiple comparison test. 
 
To investigate the effect of L5 on neurite outgrowth incubation in the 
presence of the antibody at the time of plating was carried out. Twenty-four hours 
later we observed that a lower number of NT2N neurons developed neurites on 
L5 addition. The effect was dose-dependent because increasing L5 concentration 
from 0 to 30 nM caused a decrease of the percentage of cells with neurites, from 
79 ± 6% to 43 ± 8% (Figure 30B). There were no statistically significant 
differences between control without antibody and incubation with 30 nM of control 
IgM (Figure 30B). Furthermore, differences between incubations with 30 nM of 
control IgM and with 15 or 30 nM L5 were statistically different (P < 0.001) as 
evaluated by a one-way ANOVA analysis with a Tukey's post-hoc multiple 
comparison test. In the presence of L5 the cell bodies presented a round 
morphology. We have also measured neurite length in both experiments. In 
average, 24 hours after plating, neurites were 51 μm long in the presence        
(51 ± 36 μm) or absence of L5 (51 ± 35 μm). These results showed that L5 
prevented the initiation of neurite outgrowth in NT2N cells but not its elongation. 
 
 
4.5. Discussion 
 
We have shown that during neuronal differentiation of human NT2N 
neurons from teratocarcinoma NT2- cells there was an increase in the levels of 
the cell adhesion carbohydrate Lex determinant, concomitantly to FUT9 detection. 
The results obtained from RT-PCR analysis, FUT activities toward several 
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acceptor substrates, and Western blot analysis indicated clearly that FUT9 was 
the FUT responsible for the synthesis of Lex in NT2N neurons. FUT9 has also 
been shown to be required for the synthesis of Lex in mouse brain (Nishihara et 
al., 2003; Kudo et al., 2007) and to be increasingly expressed during neuronal RA 
induced differentiation of PC19 murine EC cells (Osanai et al., 2001). In addition, 
FUT9 is regulated by the transcription factor Pax6 in murine brain (Shimoda et 
al., 2002). Because Pax6 was increased during RA-induced differentiation of 
NT2N neurons (Przyborski et al., 2000), it could be assumed that it also 
upregulates FUT9 in NT2N neurons, thus supporting our conclusion. 
We found high levels of FUT9 in cells treated with RA for 10 and 17 days. 
Accordingly, at this stage higher levels of Lex-containing glycoproteins were also 
detected (Figure 23, lanes 3, 4). These results suggested that the expression of 
FUT9 was induced transiently during RA-induced differentiation and that it 
catalyzed the synthesis of Lex in vivo, the glycoproteins detected constituting the 
endogenous acceptor substrates. Because, at that stage, NT2 cells are in a 
phase of differentiation where committed precursor cells began to leave the cell 
cycle and follow a program of neuronal cell differentiation, as monitored by the 
transcription of neuroD1 gene (Przyborski et al., 2000), it is conceivable that the 
expression of FUT9 and Lex in the same phase would have a correlation with 
such initial events from neuronal differentiation. 
The FUT9 sequence is highly conserved between species (Kaneko et al., 
1999b; Baboval et al., 2000), indicating that it has been under strong selective 
pressure during evolution. Even if the FUT9-/- mouse develops well and is fertile 
(Kudo et al., 2004), recent evidence has shown the disappearance of Lex from its 
brain concomitant to increased anxiety-like behaviors. FUT9 seems to play a role 
in the functional regulation of interneurons from basolateral amygdala as 
detected by a decreased number of calbindin-positive neurons in this region of 
the brain (Kudo et al., 2007). 
Regarding cellular localization, we have shown that Lex was 
predominantly localized on the PM, and intracellularly, in the TI-VAMP 
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compartment and in lysosomes, both LAMP-1-containing intracellular 
compartments (Figures 27 and 28). The TI-VAMP compartment has been 
proposed to define an exocytic pathway involved in neurite outgrowth, based on 
the observations that expression of TI-VAMP mutants (Martinez-Arca et al., 2001) 
and TI-VAMP silencing in neuronal cells (Alberts et al., 2003) impaired neurite 
outgrowth. The exact nature and molecular composition of this pathway is not yet 
clarified. In mouse sympathetic neurons it has been shown that it occurs via late 
endosomes/lysosomes immunoreactive for both TI-VAMP and LAMP-1 (Arantes 
and Andrews, 2006). We have detected in human NT2N neurons a subset of 
vesicular structures labeled with TI-VAMP and LAMP-1, that possibly correspond 
to this pathway. Until now, two proteins are known to be associated with the TI-
VAMP pathway in neurons: L1, a cell-cell adhesion molecule involved in axonal 
growth, whose surface expression and recycling was shown to be TI-VAMP 
mediated (Alberts et al., 2003); and synaptotagmin VII, a Ca2+-sensing 
synaptotagmin (Arantes and Andrews, 2006). A possible candidate of another 
cargo molecule for this pathway could be the high molecular mass                   
Lex- and HNK-1-carrier glycoprotein that we have identified (Figures 25 and 26), 
which was distinct from L1 because it was not detected by Western blot with the 
monoclonal antibody L1-11A (results not shown), that recognizes the membrane 
bound form of L1 with 220 kDa (Stoeck et al., 2006), and also distinct from 
synaptotagmin VII, which has a molecular mass of 45.6 kDa. The Lex-carrier may 
correspond to a neuronal proteoglycan, other than a chondroitin sulfate, as it was 
not sensitive to ChABC (Figure 26). One possibility is a heparan sulfate, a class 
of proteoglycans found at cell surfaces and extracellular matrixes and known to 
be involved in neuronal connectivity (reviewed by Bishop et al., 2007; Van Vactor 
et al., 2006). We cannot, however, exclude the possibility that by 
immunofluorescence microscopy, the L5 antibody detected molecules distinct 
from the Lex-carrier glycoprotein, such as glycolipids. 
With respect to the possible biological role of Lex, we have found that the 
anti-Lex L5 antibody decreased the adhesion of neurons and neurites already 
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formed to the surface (Figure 30A), and also caused a decrease in the initiation 
of outgrowing neurites (Figure 30B) in human NT2N neurons. It did not, however, 
inhibit neurite elongation of outgrowth contrary to that reported by others for 
explant Xenopus brain cultures (Yoshida-Noro et al., 1999). It is possible that 
incubation with the anti-Lex antibody would block interactions between the 
neurons and matrix components essential for adhesion and neurite outgrowth. 
Alternatively, it could be internalized (Figure 29) via the TI-VAMP pathway, 
negatively affecting the intracellular interactions that regulate neurite outgrowth. 
Others also observed that anti-Lex antibody L5 inhibited process formation of 
astrocytes and granule cell migration in mouse cerebellar explant cultures (Streit 
et al., 1993). Further studies are required to clarify the function at the molecular 
level of Lex in human NT2N neurons. 
In summary, we found that the adhesion carbohydrate Lex determinant 
was upregulated during differentiation from human NT2- cells to NT2N neurons, 
where it was synthesized by FUT9. Lex was localized on the PM and in the 
exocytic TI-VAMP compartment and it played an important role in neuronal cell 
adhesion and neurite initiation of outgrowth. 
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5. Levels of Lewisx during differentiation of rat primary hippocampal 
cultures 
 
 
5.1. Summary 
 
The Lewisx (Lex) epitope has been associated with central nervous 
system development of diverse species including human and rodents.  
In this work, we observed that Lex expression was regulated during 
development of rat hippocampus neurons in culture. We found increased levels 
of Lex in a subset of neurons, which were identified as GABAergic interneurons. 
Lex from the cell bodies and neuritic processes was localized in the cell periphery 
and also intracellularly, where it colocalized with the v-SNARE tetanus neurotoxin 
insensitive vesicle-associated membrane protein (TI-VAMP) that defines the     
TI-VAMP exocytic compartment, involved in neurite outgrowth. These results 
were in good agreement to our previous observations of Lex localized at the 
plasma membrane and in the TI-VAMP compartment of human NT2N neurons. 
In conclusion, we showed that rat hippocampal neuronal cultures, which 
have the advantage of presenting optimized experimental tools, are a valid model 
to study the cross talk between Lex-carriers and the TI-VAMP compartment.  
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5.2. Introduction 
 
The Lewisx (Lex) determinant is temporally and spatially regulated in the 
developing central nervous system (CNS) of diverse species, including human, 
rat, mouse, chicken, and Xenopus (Dasgupta et al., 1996; Gotz et al., 1996; Mai 
et al., 1999; Yoshida-Noro et al., 1999). 
As described in Chapter 4, we observed that Lex expression was induced 
during human neuronal differentiation, being detected in NT2N neurons but not in 
undifferentiated NT2 cells (Brito et al., 2007). In NT2N neurons Lex was restricted 
to the membrane-trafficking pathway mediated by the v-SNARE                         
TI-VAMP/VAMP7 (Brito et al., 2007). In neurons, this exocytic pathway via late 
endosomes / lysosomes has been implicated in neurite outgrowth (reviewed by 
Proux-Gillardeaux et al., 2005) and, until now, only two proteins are known to be 
associated with it. L1, a cell-cell adhesion molecule involved in axonal growth, 
whose surface expression and recycling was shown to be TI-VAMP mediated 
(Alberts et al., 2003), and synaptotagmin VII (SYT7), a Ca2+-sensing SYT 
(Arantes and Andrews, 2006). Another possible cargo molecule for the TI-VAMP 
pathway is the high molecular mass glycoprotein identified by us in human NT2N 
neurons which was a carrier of the Lex and HNK-1 (human natural killer-1) 
epitopes (Chapter 4).  
The overlapping localization of Lex and TI-VAMP in NT2N neurons, 
together with the evidence suggesting the involvement of Lex in neuronal 
development (Gotz et al., 1996; Yoshida-Noro et al., 1999; Brito et al., 2007), 
unraveled the possibility that the Lex-carriers may be cargo of the TI-VAMP 
compartment and play a role in the cell-cell or cell-matrix interactions responsible 
for neurite outgrowth.  
The descriptions of Lex expression in rat brain during development and in 
adult are numerous (reviewed by Gocht et al., 1996). Lex-carrier glycoproteins 
and glycolipids developmentally regulated were identified in rat embryonic, 
postnatal and adult brain (Chou et al., 1996; Allendoerfer et al., 1999). Aiming to 
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develop an experimental system that would allow us to study the correlation 
between neuronal Lex-carriers and the membrane-trafficking pathway mediated 
by TI-VAMP, in the present work, we characterized Lex expression during 
development of neurons from rat hippocampal cultures.  
We showed that Lex expression was regulated during development of rat 
hippocampal cultures. A subset of GABAergic interneurons was found to express 
Lex-carriers, localized in the cell bodies and neuritic processes. The Lex epitope 
was detected in lysosomal associated membrane protein-1 (LAMP-1)-positive 
lysosomes and found to colocalize with the exocytic TI-VAMP compartment that 
is associated with neurite outgrowth.  
 
 
5.3. Materials and methods 
 
5.3.1. Neuronal culture 
 
Hippocampal cultures were prepared as described previously (Danglot et 
al., 2003). Briefly, hippocampi were dissected from embryonic E18         
Sprague–Dawley rats in Hank’s balanced salt solution (HBSS) (Sigma) 1-fold 
concentrated and 20 mM HEPES (Gibco) (HBSS-HEPES). Cells were dissociated 
by treatment with 0.25% trypsin (Gibco) for 15 min at 37°C, and triturated through 
a fire-constricted Pasteur pipette in HBSS-HEPES with                  
0.1 mg/ml DNase (Sigma), at 37°C. Cells were plated at 1.65x104 or 3.3x104 
cells/cm2, onto 40 μg/ml poly-DL-ornithine (PO) (Sigma)-coated glass coverslips, 
and at 2.1x104 cells/cm2, onto 35-mm dishes. Plating was done in minimum 
essential medium (MEM) (Gibco) supplemented with 10% horse serum, 0.6% 
glucose (Sigma), 0.2% NaHCO3 (Gibco), 2 mM glutamine (Gibco), and 10 U/ml 
penicillin–streptomycin (P/S) (Gibco) (complete MEM). After attachment of cells, 
neurons were maintained in NB-B27 conditioned media (see below), up to           
4 weeks with replacement of 1/3 of the media weekly.  
CHAPTER 5 
142 
Glial cultures were also prepared from hippocampi dissected by the same 
procedure. Cells were plated in T75 culture flasks, at a density of 1x105 cells/cm2 
in complete MEM. Medium was changed every 3 days until confluency. NB-B27 
conditioned medium was prepared by incubating serum-free neurobasal medium 
(Gibco) supplemented with B27 (Gibco), 2 mM glutamine (Gibco) and 5 U/ml P/S 
(Gibco) with the glial monolayers for one week.  
All cultures were maintained at 37°C in a 5% CO2 humidified incubator.  
 
 
5.3.2. Immunofluorescence microscopy 
 
Hippocampal neurons cultured on PO-coated glass coverslips were 
analyzed after 4 and 18 hours; 1, 2, 3, 7 and 14 days in vitro (DIV). Neurons were 
washed with phosphate buffer saline (PBS), fixed with 4% (w/v) 
paraformaldehyde (PF) and 4% sucrose (suc) in PBS for 20 minutes, quenched 
with 50 mM NH4Cl in PBS for 20 minutes, permeabilized with 0.1% (w/v) Triton X-
100 (TX-100) for 4 minutes and then blocked in 0.25% (w/v) cold water fish 
gelatin in PBS for 30 minutes. Primary and secondary antibodies were incubated 
at room temperature for 1 hour and 45 minutes, respectively. Antibody solutions 
were prepared in 0.1% (w/v) gelatin in PBS and washes were carried out with 
PBS. Coverslips were mounted in Mowiol (Calbiochem). 
Primary antibodies were: rat IgM anti-Lex L5 (1:200) (Streit et al., 1990; 
Streit et al., 1996); rabbit IgG anti-microtubule-associated proteins (MAPs) 
(1:200) (Sigma); mouse IgG anti-TI-VAMP clone 158.2 (1:200) (Muzerelle et al., 
2003); mouse IgG anti-rat LAMP-1 LYC6 (1:5) (DSHB); rabbit IgG                   
anti-synaptophysin MC1 (1:1000) (Chilcote et al., 1995); rabbit IgG                 
anti-glutamate decarboxylase  (GAD) 65/67 (1:500) (Chemicon). Secondary 
antibodies were: goat anti-rat IgM AlexaFluor594 (1:400) (Molecular Probes); 
cross adsorbed goat anti-mouse IgG AlexaFluor488 (1:400) (Molecular Probes); 
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cross adsorbed goat anti-rabbit IgG AlexaFluor488 (1:400) (Molecular Probes); 
cross adsorbed goat anti-rabbit IgG Cy5 (1:200) (Jackson ImmunoResearch).  
Fluorescence images were acquired on a Leica DMRD microscope using 
FITC, Cy3, Cy5 and DAPI-specific sets of filters and a high-resolution camera 
driven by the Metamorph Image Analysis System. Confocal images were 
acquired in a confocal microscope SP2+AOBS (Leica) equipped with a            
63× objective. Each fluorophore used was excited and detected separately to 
avoid channel bleed-through. For each channel, photomultiplier gains and offsets 
were adjusted to use full image dynamic range. Typically, stacks of 10 to              
15 sections of 1024 × 1024 pixel resolution, with a pinhole of 1.0 Airy unit and a 
0.5 μm focus interval, were scanned 4 times, to optimize the signal/noise ratio.  
Merge between channels and maximum z-projections were created using 
the open source ImageJ software version 1.35 (http://www.rsb.info.nih. gov/ij/). 
The only modifications made during image editing were linear brightness and 
contrast adjustments, using the Adobe Photoshop software (Adobe Systems). 
 
 
5.3.3. SDS-PAGE and Western blot analysis 
 
Hippocampal neurons cultured on PO-coated 35-mm dishes, in the 
presence of 1 μM of the mitosis inhibitor cytosine arabinoside (ara-C) (Sigma) 
when stated, were analyzed after 8 hours in vitro, 1, 2, 3, 7, 14 and 21 DIV.  
Total protein was solubilized with 50 mM Tris-HCl buffer pH 8, containing 
150 mM NaCl, 1 mM EDTA, 1% TX-100, and protease inhibitors (Complete 
Cocktail; Roche), at 4ºC for 30 minutes. After 20 minutes centrifugation at 
16,000× g, at 4ºC, the protein was precipitated in 80% ethanol, at –20ºC, for        
3 hours and then solubilized in sample buffer provided by the SDS-PAGE gel 
supplier (Invitrogen).  
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Proteins were separated by SDS-PAGE in precasted NuPAGE Novex 
Tris-Acetate gels 3-8% (Invitrogen) and transferred to polyvinylidene difluoride 
membranes. Blocking was with 5% non-fat dry milk (Nestle) and 0.1% Tween-20 
in PBS. Primary antibodies were: L5 anti-Lex monoclonal antibody 1:500, anti-L1 
polyclonal antibody 1:2000 and anti-β-tubulin monoclonal antibody 1:50000 
(DSHB). HRP-labeled polyclonal secondary antibodies anti-mouse IgM, (Sigma), 
anti-rabbit IgG (Jackson ImmunoResearch) and anti-mouse IgG (Jackson 
ImmunoResearch) were used. All dilutions were in blocking solution. 
Chemiluminescent detection was by the ECL system (GE Healthcare). 
 
 
5.4. Results  
 
5.4.1. Lex expression is induced during development of rat hippocampal cultures  
 
In order to characterize Lex expression during development of rat 
hippocampus neurons at a cellular level, we monitored Lex by 
immunofluorescence microscopy during rat hippocampal cultures. We used the 
L5 monoclonal antibody, specific for the Lex epitope, and a polyclonal antibody 
anti-microtubule-associated proteins (MAPs), to distinguish neurons from glia 
cells, also present in the hippocampal cultures. To screen the cultures after 4 and 
18 hours in vitro, 1, 2, 3, 7, and 14 DIV.  
In the first hours after plating many of the adherent cells, neurons and 
glia, were labeled with L5 at the surface (Figure 31a). As differentiation 
proceeded, from 18 hours in vitro to 3 DIV, the Lex staining was restricted to cells 
that were not labeled by anti- MAPs, used as a neuronal marker (Figure 31b). At 
7 DIV, Lex was detected in a minoritary population of neurons that presented 
highly branched neurites as common feature. The immunoreactivity was 
observed on neuronal cell bodies and neurites in discrete puncta (Figure 31c). 
From 7 to 14 DIV cultures Lex staining remained confined to a neuronal 
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subpopulation, generally with high degree of neuritic arborisation (Figure 31d). 
Moreover, many of the cells labeled with L5 were MAP-negative (Figure 31d). 
 
  
Figure 31: Detection of the Lex determinant along rat hippocampal cultures 
development by immunofluorescence confocal microscopy. Primary cultures from 
rat hippocampus plated on poly-DL-ornithine coated coverslips were fixed at different 
times: 4 hours (a); 3 DIV (b); 7 DIV (c); 14 DIV. Permeabilized cells were probed with the 
anti-Lex L5 antibody (shown in red) and an anti-MAPs antibody (shown in blue) to 
distinguish neurons (n) from glia cells (g). Secondary antibodies were: goat anti-rat     
IgM-AlexaFluor594 and goat anti-rabbit IgG-Cy5. Maximum intensity z-projections of 10 
to 15 optical sections of 0.5 μm are shown. Scale bars = 10 μm. The experiment was 
performed with at least two independent cultures.                            . 
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5.4.2. GABAergic neurons from rat hippocampus express Lex-carriers 
 
The observation that only a small population of highly branched 
hippocampal neurons expressed the Lex epitope (Figure 31) led us to 
hypothesize that those could correspond to a subtype of hippocampal 
interneurons. Interneurons in the CNS are usually inhibitory neurons and            
γ-aminobutyric acid (GABA) is the principal inhibitory neurotransmitter in the brain 
(Maccaferri and Lacaille, 2003). Thus, aiming to identify the population of 
neurons that expressed the Lex determinant, we probed 14 DIV hippocampal 
cultures with L5 and an antibody for glutamate decarboxylase (GAD), the enzyme 
that catalyzes the conversion of L-glutamate to GABA (reviewed by Varju et al., 
2001). All neurons positive for GAD detected in the cultures also presented Lex 
labeling (Figure 32a, b), indicating that at 14 DIV hippocampal interneurons 
express Lex-carriers.  
Lex staining at 14 DIV presented a punctate pattern in the cell bodies and 
in neuritic processes (Figures 31d and 32). As shown at higher magnification 
(Figure 32c), the two stainings were interspersed and did not overlap. Lex puncta 
accumulated in spine-like protrusions or phillopodia (arrows in Figure 32e and 
32f, the higher magnifications insets of 32d). Nevertheless, Lex-containing 
glycoconjugates were not exclusive of interneurons as some MAP-positive cells 
not labeled by GAD also presented Lex staining (Figure 32a), suggesting that 
distinct Lex-carriers may be present in a different subpopulation of neurons, in 
addition to glial cells (Figure 31). 
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Figure 32: Detection of the Lex determinant in 14 DIV rat hippocampus neurons by 
immunofluorescence microscopy. Primary cultures from rat hippocampus plated on 
poly-DL-ornithine coated coverslips were fixed at 14 DIV. Permeabilized cells were 
probed with the following antibodies: anti-Lex L5 (shown in red) and anti-GAD (shown in 
green) (a, b, c) or anti-Lex L5 (shown in red) and anti-MAPs (shown in blue) (d, e, f). 
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Secondary antibodies were: goat anti-rat IgM-AlexaFluor594, goat anti-rabbit IgG-A488 
and goat anti-rabbit IgG-Cy5. The insets indicated in (b) and (d) are presented at higher 
magnification in (c), (e) and (f), respectively. Arrows indicate Lex labeling in spine-like 
protrusions or phillopodia. Scale bars = 10 μm. The experiment was performed with two 
independent cultures.  
 
 
5.4.3. The Lex determinant is localized at the plasma membrane and in the       
TI-VAMP compartment of rat hippocampus neurons 
 
To check if the Lex-carriers detected by the L5 antibody in rat 
hippocampal neurons were contained in the TI-VAMP compartment, as in human 
NT2N neurons (Chapter 4), we performed colocalization analysis with TI-VAMP 
and LAMP-1 by confocal immunofluorescence microscopy in 7 DIV cultures. 
Neurons were identified by staining with polyclonal anti-MAPs antibody. 
In neurons, Lex colocalized with TI-VAMP in the cell body and most 
extensively in the puncta stained along the neurites (Figure 33a, inset magnified 
in 33b). Lex and TI-VAMP positive puncta were also detected in growth cones, 
presenting a lower level of colocalization (Figure 33c, inset magnified in 33d). In 
MAP-negative cells labeled with Lex there was also TI-VAMP staining, although 
no colocalization was observed (results not shown). These results indicate that 
Lex-carriers may be cargo of the TI-VAMP compartment in GABAergic neurons 
but not in glia cells.  
Lex and LAMP-1-positive puncta were observed mainly in the cell body, 
where LAMP-1 labeling was more intense and colocalization was almost total 
(Figure 33e, inset magnified in 33f). There was also some colocalization in the 
neuritic processes (Figure 33e, inset magnified in 33f). 
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Figure 33: Colocalization analysis of Lex in hippocampus neurons by 
immunofluorescence confocal microscopy.  Primary cultures from rat hippocampus 
plated on poly-DL-ornithine coated coverslips were fixed at 7 DIV. Permeabilized cells 
were probed with the following antibodies: anti-Lex L5 (shown in red), anti-TI-VAMP 
(shown in green) and anti-MAPs (shown in blue) (a, b, c, d) or anti-Lex L5 (shown in red) 
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and anti-LAMP-1 (shown in green) (e, f). Secondary antibodies were: goat anti-rat IgM-
AlexaFluor594, goat anti-mouse IgG-AlexaFluor488 and goat anti-rabbit IgG-Cy5. Single 
optical sections of 500 nm are shown. Scale bars = 10 μm. The insets indicated in (a), (c) 
and (e) are presented at higher magnification in (b), (d) and (f), respectively. The 
experiments were carried out with at least two independent cultures and for each 
condition at least five neurons per marker were analyzed by confocal microscopy. 
 
The possibility of LAMP-1, a lysosomal highly glycosylated protein 
(Carlsson et al., 1988), being a carrier of the Lex epitope in rat hippocampal 
primary cultures, was ruled out by SDS-PAGE and Western Blot analysis (see 
below, Figure 34). LAMP-1 has an apparent molecular mass of approximately 
120 kDa (Carlsson et al., 1988) and no Lex-reactive bands were detected in 
hippocampus primary cultures homogenates in that molecular mass range 
(Figure 34a). Thus, the Lex-carriers detected in GABAergic neurons are localized 
in the lysosomal or TI-VAMP compartments, different from LAMP-1, and probably 
neuron-specific proteins.  
 
 
5.4.4. Lex-carrier glycoproteins are expressed by neurons in rat hippocampal 
cultures 
 
Lex-carriers have been described in glycoproteins and glycolipids of the 
developing rat brain (Allendoerfer et al., 1999). Aiming to identify Lex-carrier 
glycoproteins from rat hippocampal neurons, cellular extracts from primary 
cultures were analyzed along differentiation in vitro, in the presence of the mitosis 
inhibitor ara-C in order to obtain a culture enriched in post-mitotic neurons. 
Extracts from cells for 8 hours in vitro; 1, 2, 3, 7, 14 and 21 DIV were screened by 
Western blot with the monoclonal anti-Lex antibody L5 (Figure 34).  
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Figure 34: Immunodetection by Western blot of Lex-carrier proteins from 
hippocampal cultures. SDS-PAGE and Western Blot analysis of  cultures with 8 hours, 
1, 2, 3, 7, 14, and 21 days in vitro (DIV), in the presence of cytosine arabinoside (ara-C), 
when stated. Equivalent amounts of protein were applied by lane. (A) Anti-Lex L5 
antibody detected a Lex-carrier at 8 hours of culture (arrowhead) and three Lex-carriers at 
7 DIV (arrows 1, 2 and 3). The heavy chains of rat IgMs present in the cell extracts were 
detected by the secondary anti-rat IgM antibody (asterisk). (B) Reprobe with an anti-L1 
antibody detected the full-length form of L1 (arrowhead) and several proteolytic products. 
(C) Reprobe with an anti-β-tubulin (β-tub) antibody was used as a loading control 
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(arrowhead). Secondary antibodies were HRP-conjugated anti-mouse IgM, anti-rabbit IgG 
and anti-mouse IgG. Detection was carried out by the ECL method. 
 
Eight hours after plating, a single band was detected that migrated near 
the 71 kDa marker (Figure 34A, arrowhead). This band did not correspond to a 
cleaved form of L1, a cargo molecule of the TI-VAMP compartment (Alberts et al., 
2003), as confirmed by re-probing of the membrane with an anti-L1 antibody 
(Figure 34B), nor to LAMP-1 as the latest migrates at approximately 120 kDa 
(Carlsson et al., 1988). No L5 immunoreactive bands were observed from           
1 to 3 DIV (Figure 34a). At 7 DIV three Lex-carriers were detected: one that 
migrated above the 460 kDa marker (Figure 34A, arrow 1), a second that         
co-migrated with the 460 kDa marker (Figure 34A, arrow 2) and a third carrier of 
lower apparent molecular mass between the 71 and the 117 kDa markers (Figure 
34A, arrow 3). In 7 DIV cultures that were not incubated with ara-C, presenting 
mainly glial cells, the three carriers were not detected (Figure 34A). Thus, the 
glycoproteins detected with the L5 antibody in rat hippocampal primary cultures 
were most probably expressed by neurons. The three bands peaked at 7 DIV and 
from that day on, along the maturation of the culture, the detection levels of the 
carriers decreased markedly (Figure 34A).  
The variations observed during the in vitro culture were not due to 
differences in total protein content, as shown by the detection of equivalent levels 
of β-tubulin (Figure 34C, arrowhead). From 1 to 21 DIV a band was observed 
between the 71 and 55 kDa markers (Figure 34A, asterisk), also detected only 
with secondary anti-rat IgM antibody (results not shown), that most probably 
corresponded to the heavy chain of rat IgM. 
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5.5. Discussion 
 
In this study, we detected the cell adhesion carbohydrate Lex determinant 
in different phases of differentiation of rat hippocampal primary cultures and in 
distinct cell types (Figure 31). Our results suggested that during the culture time 
the Lex epitope was present in different carriers, expressed by distinct cell types, 
in a developmentally regulated manner. In agreement, data obtained from 
immunolabeling experiments in rat brain indicated that the Lex epitope was 
carried by distinct glycoproteins and glycolipids during embryonic and post-natal 
development (Allendoerfer et al., 1999). Furthermore, Lex was also detected in 
rat telencephalic regions during development, presenting a correlation with 
selective adhesion of cell subpopulations (Gotz et al., 1996).  
We detected Lex soon after plating (Figure 31a), consistent with the 
presence of Lex in rat neural stem cells (Ko et al., 2005). Furthermore, Lex has 
also been described as a marker of murine neuronal progenitor cells, particularly 
strong in regions with prolonged neurogenesis, such as the hippocampus 
(Capela and Temple, 2006).  
During the first days of differentiation of the in vitro culture (18 hours to 3 
DIV), the Lex-positive cells detected were essentially MAP-negative non-neuronal 
cells (Figure 31b). Although we did not investigate further the lineage of MAP-
negative cells, morphologically they resembled the GFAP and vimentin-positive 
population of immature astrocytes, also labeled by anti-Lex in primary cultures of 
brain from mouse (Streit et al., 1990) and rat embryos (Sajdel-Sulkowska, 1998).  
At 7 DIV there was the increase in the detection of Lex in a subset of 
neurons (Figure 31c). The Lex-positive neurons were mostly highly branched 
GABAergic interneurons, as shown by labeling with both L5 and an anti-GAD 
antibody in 14 DIV hippocampal cultures (Figure 32). 
The Lex epitope was detected in the hippocampal neurons in punctate 
structures localized in the cell bodies and in the neuritic processes (Figure 31, 32 
and 33). These puncta did not colocalize with GAD, that labels inhibitory synaptic 
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regions (Figure 32c). In the neurites, Lex-positive structures were detected in 
spine-like protrusions or phillopodia (arrows in figure 32e and 32f, the higher 
magnifications insets of 32d). These are highly dynamic post-synaptic structures 
characteristic of sites of excitatory synaptic contact on dendrites (Dailey and 
Smith, 1996). Furthermore, preliminary results indicated that Lex-labeling was in 
apposition with structures labeled with an anti-synaptophysin antibody (results 
not shown), a presynaptic protein that, as synaptogenesis occurs, forms high 
density of puncta in the cell bodies and in the neurites         (de Lima et al., 1997). 
Moreover, Lex staining was often peripherally localized or even detected in 
extracellular locations, adjacent to MAP labeling. These results suggested that 
the Lex-carriers of GABAergic interneurons were probably on the plasma 
membrane and on the extracellular matrix, in post-synaptic domains closely 
related to the sites of establishment of synapses.  
Also regarding cellular localization, we showed that intracellularly Lex was 
localized in the TI-VAMP compartment and in LAMP-1-containing endosomal 
compartments (Figure 33). Previously, we have shown that the Lex epitope was 
present on the plasma membrane and in the TI-VAMP compartment of human 
NT2N neurons, playing a role in neuronal adhesion and neurite regeneration 
(Chapter 4). Furthermore, many of the TI-VAMP-labeled vesicles detected in the 
cell bodies and neurites of NT2N neurons were LAMP-1-positive late 
endosomes/lysosomes (Brito et al., 2007). Moreover, in developing primary 
mouse sympathetic neurons, the TI-VAMP exocytic pathway has been shown to 
occur via late endosomes/lysosomes immunoreactive for both TI-VAMP and 
LAMP-1 (Arantes and Andrews, 2006). Although there was some discrepancy in 
the degree of overlapping between TI-VAMP and LAMP-1, which may reflect 
differences in the types of neurons or in the development stage analyzed, our 
results strengthened the hypothesis that the neuronal TI-VAMP exocytic pathway 
share common cross-species features.  
Concerning the identification of Lex-carriers, we have detected three 
proteins by Western Blot at 7 DIV (Figure 34A), a stage coincident with the 
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detection of Lex-carriers in the TI-VAMP compartment (Figure 33). One of the 
detected high molecular mass carriers observed (Figure 34A) may correspond to 
a form of phosphocan. This high molecular mass chondroitin sulfate proteoglycan 
(CSPG) contains Lex in mannose-linked O-oligosaccharides when expressed in 
the early postnatal rat brain (Krusius et al., 1986; Allendoerfer et al., 1995). 
Furthermore, phosphocan is a soluble alternative splicing product of a 
transmembrane receptor-type protein-tyrosine phosphatase (RPTPβ) which binds 
neural cell adhesion molecules (Maurel et al., 1994). Mannose-linked                 
O-oligosaccharides have been described in rat brain proteoglycans that carry Lex 
and HNK-1 epitopes (Krusius et al., 1987; Yuen et al., 1997; Kogelberg et al., 
2001). In addition, in human NT2N neurons we also detected a Lex and        
HNK-1-carrier of 460 kDa that, although not being a CSPG, presented Lex 
labeling insensitive to PNGaseF digestion (Chapter 4), suggesting that it could be 
attached to mannose-linked O-oligosaccharides. Recently, Cat-315, an              
O-mannose linked epitope of the HNK-1 family was also found in proteoglycans 
related to neuritogenesis and synaptogenesis (Dino et al., 2006).  
Astrochondrin is another Lex-bearing CSPG identified in rodent brain, with 
a molecular mass of 500 kDa, proposed to be involved in the outgrowth of 
astrocytes processes on the extracellular matrix (Streit et al., 1990; Streit et al., 
1993). Despite the similar apparent molecular masses of the carriers 1 and 2 
identified by us (Figure 34A), these could not correspond to astrochondrin as this 
proteoglycan is produced by astrocytes (Streit et al., 1990; Streit et al., 1993) and 
not by neurons. Lex has also been described on mouse neural cell adhesion 
molecule L1 (Streit et al., 1990), a known cargo molecule of the TI-VAMP 
pathway (Alberts et al., 2003), nevertheless in rat hippocampal neurons we did 
not detect the epitope on this protein (Figure 34).  
In summary, we found that the adhesion carbohydrate Lex determinant 
was upregulated in a subset of GABAergic neurons during differentiation of rat 
hippocampal neurons. Lex was localized in extra-synaptic sites and in the 
exocytic TI-VAMP compartment. The characterization performed in this work 
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opens the door for further studies to better understand connections between 
neuronal Lex-carriers, the TI-VAMP exocytic mediated pathway and neurite 
outgrowth. This includes, for example, the evaluation of the effect of impaired TI-
VAMP-mediated membrane trafficking, and consequent inhibition of neurite 
outgrowth, on Lex distribution, using the siRNA methodology that was optimized 
for rat hippocampus primary cultures (Alberts et al., 2003). 
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6. General discussion and conclusions 
 
 
6.1. General discussion and perspectives 
 
The Lex determinant is expressed in glycolipids and glycoproteins of the 
brain of several species (Roberts et al., 1991; Dasgupta et al., 1996; Allendoerfer 
et al., 1999; Mai et al., 1999; Shimoda et al., 2002), being one of the most 
abundant carbohydrate structures detected in neutral complex-type N-glycans in 
the human brain (Albach et al., 2001). Furthermore, Lex has been implicated in 
cell-cell recognition, neurite outgrowth and neuronal migration in the CNS of 
Xenopus (Yoshida-Noro et al., 1999), rodents and chicken (Streit et al., 1993; 
Gotz et al., 1996) and loss of Lex expression in the murine CNS led to anxiety-like 
behaviors (Kudo et al., 2007) .  
Specificity studies of FUT activity from human brain homogenates 
(Mollicone et al., 1990; Mollicone et al., 1992) and human neuroblastoma cells 
(Foster et al., 1991) showed the synthesis of Lex and Ley but not of sLex or Lea. 
These characteristics corresponded to the FUT9 and FUT4 profiles but not to the 
ones of any other member of the family (reviewed by Becker and Lowe, 2003). 
Moreover, FUT4 and FUT9 were found to be significantly expressed in the 
human embryonic brain (Cailleau-Thomas et al., 2000) and in rodent embryonic 
and adult brain (Kaneko et al., 1999b; Baboval et al., 2000). Further evidence 
suggested that FUT9 catalyzed Lex synthesis in the mouse brain (Shimoda et al., 
2002; Nishihara et al., 2003). Demonstration by cDNA macroarray of a 
developmentally regulated expression pattern of FUT9 in embryonic and adult 
mouse cerebral cortex, correlating with Lex detection on complex N-glycans    
(Ishii et al., 2007), and observation of disappearance of the Lex epitope from the 
FUT9-/- mouse brain (Kudo et al., 2007), confirmed that FUT9 is the enzyme that 
synthesizes Lex in the brain. Despite the evidence accumulated until present 
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supporting the importance of FUT9 and its biosynthetic product Lex in the CNS, 
several issues were poorly addressed or remain to be elucidated. 
The glycosylation profile of a newly synthesized glycoconjugate depends 
on several factors (reviewed by Czlapinski and Bertozzi, 2006). These include the 
levels of expression and the specificity of glycan modifying enzymes, the 
availability of donor substrates for GTs and the sequential action of glycosidases 
and GTs, organized throughout the Golgi in an ordered, although overlapping, 
way. As FUT9 is the last GT involved in the biosynthesis of the Lex epitope, it 
plays a key role in the regulation of Lex expression. In this context, we studied 
human FUT9 specificity towards biologically relevant acceptors, such as GP, and 
the localization of the enzyme in the secretory pathway. Concerning Lex function, 
we focused on its in vivo expression in the CNS and on the assignment of the 
Lex-carriers and their biological role during neuronal differentiation.  
 
 
6.1.1. Characterization of recombinant full-length and soluble forms of human 
FUT9   
 
The role of human FUT9 in the CNS was not known at the beginning of 
this thesis work. A detailed characterization of FUT9 catalytic properties has been 
performed, in particular its specificity towards acceptor substrates of biological 
relevance, in order to assess the enzyme function in vivo.  
As endogenous FUT9 from neuronal sources is expressed in low levels, it 
was necessary to use heterologous systems in order to obtain higher amounts of 
the enzyme. The FUT9 sequence was cloned from human NT2N neurons and 
transiently transfected into the HeLa human cell line (Chapter 2). In vitro 
specificity studies, using a panel of small oligosaccharides coupled to a 
hydrophobic moiety as acceptor substrates, confirmed that the recombinant     
full-length FUT9 (FUT9wt) expressed in HeLa cells was essentially an α3-FUT, 
as it showed a clear preference for type II acceptor structures (Chapter 2). 
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Substitution of the hydroxyl group at the C-2 of Gal from LacNAc with Fuc 
resulted in enhanced transfer rates, whereas substitution at C-3 with NeuAc 
reduced the transfer to undetectable levels, in agreement with the specificity 
described for human FUT9 (Cailleau-Thomas et al., 2000; Toivonen et al., 2002).  
Most interestingly, we showed that human FUT9 presented activity 
towards GP acceptor substrates with high specificity for the synthesis of the Lex 
determinant in N-linked glycans. The detailed analysis of the resulting N-linked 
oligosaccharide chains revealed that human FUT9 was an N-glycan fucosylating 
enzyme with the ability of transferring Fuc residues to asialo N-glycans, 
irrespective of the number of branches or of LacNAc repeats in each branch. The 
results suggested that FUT9 could fucosylate GPs with the synthesis of the cell 
adhesion Lex determinant in vivo, including in human neurons. This was the first 
study of FUT9 activity towards GPs in vitro. In vivo, several studies have 
indicated that FUT9 would use N-glycans on GPs as acceptor substrates. 
Examples include: the adhesion molecule CEACAM-1, co-expressed with human 
FUT9 in HEK cells (Bogoevska et al., 2006); GPs from CHO Lec8 cells             
co-transfected with human FUT9 and β4-GalNAcT (Kawar et al., 2005); a CSPG 
from rat embryonic brain (Shimoda et al., 2002); GPs from mouse brain (Ishii     
et al., 2007; Kudo et al., 2007). On the other hand, FUT9 has also been shown to 
fucosylate synthetic analogues of N- and O-glycans in vitro (Toivonen et al., 
2002). 
Stable transfection of FUT9 was achieved using the Sf9 insect cell line 
(Chapter 3), characterized by high producing levels of recombinant proteins that 
acquire post-translational modifications required for correct folding (reviewed by  
Altmann et al., 1999). Two cell lines were constructed expressing the  
membrane-bound form, FUT9wt, and a soluble form, sFUT9, of the enzyme. 
FUT9wt produced in Sf9 insect cell line maintained the in vitro specificity profile 
towards small oligosaccharide acceptors already observed (Chapter 2). Most 
striking, the enzyme was able to catalyze the transfer of Fuc to the native 
sialylated form of EPO, although less efficiently than to the asialo form of the GP. 
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This result differed from the one obtained for FUT9wt expressed in HeLa cells but 
correlated with the specificity profile of human FUT9 detected by other authors 
towards polylactosamine chains. It has been reported that the transfer of Fuc was 
shifted to the internal LacNAc units when terminal Gal was substituted with 
neuraminic acid, in levels lower than the observed for terminal LacNAc units of 
asialo polylactosamine chains (Nakayama et al., 2001; Toivonen et al., 2002). 
Thus, FUT9wt expressed in Sf9 cells most probably transferred Fuc to the inner 
LacNAc units of the terminally sialylated, triantennary and tetrantennary 
structures with LacNAc repeats present on native EPO.  
Analysis of the specificity of the efficiently secreted sFUT9 form revealed 
that removal of the cytoplasmic tail, transmembrane domain and stem region of 
the enzyme did not alter the in vitro specificity profile towards small 
oligosaccharide acceptors (Chapter 3). However, when activity towards GPs was 
assayed, differences were observed when compared to FUT9wt: 1) sFUT9 
transferred Fuc to LacNAc units from GP with higher efficiency than from 
oligosaccharide acceptors; 2) sFUT9 did not distinguish between sialylated and 
asialo N-glycans of EPO, being able to fucosylate both types of structures with 
equivalent efficiency. Those data suggested that, although the N-terminal regions 
of FUT9 were not essential for enzyme activity, they might play an important role 
in enzyme specificity, in particular in the recognition of the protein environment of 
the acceptor substrate. Previous results obtained by us for human FUT3 also 
support this hypothesis - we have shown that truncation of the N-terminal region 
of FUT3 produced a soluble form of the enzyme, which presented activity 
towards GP, contrary to the full-length enzyme (Sousa et al., 2001).  
During the optimization of the FUT9 activity assay, we found an 
approximately 2-fold activating effect of Mn2+, in the 2.5-10 mM concentration 
range, despite not being essential for the α3-activity (Chapter 2). The 
dependence of divalent cations by GTs has been associated with the motif     
Asp-X-Asp (DxD), Glu-X-Asp (ExD), or equivalent, known to be involved in the 
co-ordination of the nucleotide sugar donor. The DxD/ExD motif is present in the 
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catalytic domain of enzymes of the GT-A structural superfamily that require a 
divalent cation as cofactor, but typically absent from members of the GT-B that 
may be activated by divalent cations although not strictly needing them for activity 
(reviewed by Qasba et al., 2005). Human α3-FUTs have been proposed to 
belong to the GT-B superfamily of GTs (Breton et al., 1996; Breton et al., 2006), 
however, they have the DxD motif (Breton et al., 1998; Palma et al., 2004). In 
these enzymes Mn2+ acts as an activator, probably through the coordination of 
the phosphate groups of GDP-Fuc (Palma et al., 2004) and binding to the DxD 
motif (D161SD for FUT9). In the absence of Mn2+ they are active, possibly due to 
the interaction of conserved amino acid residues with the donor substrate, via 
hydrogen bounds, similarly to that found from the X-ray structure of an H. Pylori 
α3-FUT (Sun et al., 2007a) that possesses the DxE motif (Ma et al., 2003). 
The presence of Mn2+ allowed the detection of low levels of α4-FUT 
activity towards the Galβ4GlcNAc-R acceptor (where                   
R = O-(CH2)3NHCO(CH2)5NH-biotin) for both FUT9wt and sFUT9 (Chapters 2 
and 3). The absence in the FUT9 sequence of the Trp residue of the acceptor 
binding motif, shown to be responsible for the recognition of type I acceptors in 
human FUT3 and FUT5 (Dupuy et al., 1999; Sherwood et al., 2002; Dupuy et al., 
2004) and H. Pylori α3/4-FUT (Ma et al., 2005), could justify the low α4-activity of 
FUT9.  
The full understanding of the catalytic properties and mechanism of FUT9 
will necessarily require the determination of the three-dimensional structure of the 
protein. Additionally, co-crystallization with Mn2+ and GDP-Fuc will allow the clear 
assignment of the role of the divalent cation in the catalytic activity of the enzyme. 
The sFUT9 form produced by us in the Sf9 insect cell line may be utilized as a 
source of enzyme for this purpose. 
In summary, we found that FUT9 presented high α3-activity towards 
asialoGPs, irrespective of the degree of branching or LacNAc repeats of the      
N-glycans, synthesizing the Lex epitope with great specificity. Moreover, we were 
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able to produce a secreted recombinant form of FUT9 in Sf9 insect cells (sFUT9) 
with enhanced ability to fucosylate sialylated GPs with LacNAc repeated units in 
their N-glycans. The described characteristics make sFUT9 a good candidate 
enzyme for in vitro synthesis of glycoconjugates containing fucosylated 
determinants, specially the Lex epitope. 
 
 
6.1.2. Localization of human FUT9 
 
Besides the in vitro specificity of each particular GT, other factors 
contribute to the regulation of glycosylation in vivo including the sequential action 
of glycosidases and GTs, organized throughout the Golgi in an ordered way 
(Rabouille et al., 1995). The full-length FUT9wt was found to localize in the  
trans-Golgi and the TGN of transfected HeLa cells (Chapter 2). The late 
localization of FUT9wt in the glycan biosynthetic pathway is in accordance with 
the functional role of the enzyme, which is involved in the last step of the 
biosynthesis of the terminal glycan epitope Lex. Thus, FUT9wt acted after the 
production of LacNAc catalyzed by β4-GalT, an enzyme assigned to the       
trans-Golgi/TGN of HeLa cells (Nilsson et al., 1993).  
Deletion of the cytosolic tail of FUT9 (FUT9dcyt) caused a redistribution of 
the protein in the GA, as revealed by colocalization analysis with markers of the 
secretory pathway and BFA treatment (Chapter 2). FUT9dcyt localization was 
shifted to earlier Golgi sub-compartments, when compared to FUT9wt, and there 
was no accumulation in later compartments of the secretory pathway, namely the 
plasma membrane. As addressed in Chapter 1, the localization of GTs in the 
Golgi has been the subject of numerous studies in the last decades and the       
N-terminal portions (cytosolic tail, transmembrane domain and stem region) of 
several Golgi-resident GTs have been implicated (reviewed by Kartberg et al., 
2005). Our data pointed to the importance of the cytosolic tail of FUT9 in the 
regulation of its sub-compartment localization, in accordance to our previous 
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observations for another late-Golgi localized GT, human FUT3 (Sousa et al., 
2003). Studies from different laboratories with other GTs (Milland et al., 2002; 
Fenteany and Colley, 2005; Uliana et al., 2006a) also substantiate the hypothesis 
that the cytosolic tails of GTs play an essential role in the fine-tuning of Golgi 
localization. In this work, detailed analysis of the cytosolic tail of FUT9, by 
deletions and point mutations, suggested that amino acid residues containing 
hydroxyl groups could be important for the sub-compartment localization of the 
enzyme (Chapter 2). Accordingly, others have shown that a hydroxylated amino 
acid residue of the cytosolic tail of α2-FUT mediated its intra-Golgi localization 
(Milland et al., 2002).  
According to the cisternal maturation model, which is widely accepted to 
explain the steady-state maintenance of the GA contents, sorting into retrograde 
COPI transporters would be responsible for the correct localization of the     
Golgi-resident proteins. Therefore, FUT9 should be incorporated into COPI 
vesicles in order to be maintained in the correct Golgi cisternae. The 11 amino 
acid residues of the cytosolic tail of human FUT9 do not encode any known 
sorting motif and, most probably, this domain is too short to interact directly with 
COPI coat components. Nevertheless, the cytoplasmic tail could mediate 
interactions with other GTs in the formation of multienzyme complexes, as 
observed for GTs involved in the synthesis of gangliosides (Giraudo et al., 2001; 
Giraudo and Maccioni, 2003) and yeast GTs (reviewed by de Graffenried and 
Bertozzi, 2004; Young, 2004). Considering the importance of the Ser and Thr 
residues of the cytosolic tail of FUT9 for the sub-compartment localization of the 
enzyme, the referred interactions could occur via hydrogen bonds. The 
incorporation of FUT9 in multienzyme complexes has never been addressed, 
thus further studies are required to explore this hypothesis.  
The unique sequences of the cytoplasmic tails of GTs may also be 
involved in interactions with other types of Golgi-resident proteins, such as 
members of the intra-Golgi transport machinery. Tethering factors have been 
shown to interact with components of the COPI coat, other tethering factors and 
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SNARE proteins (reviewed by Ungar et al., 2006), defining subpopulations of 
COPI vesicles enriched in distinct cargo molecules (Malsam et al., 2005). In this 
context hypothetical interaction partners of FUT9 would be, for example, subunits 
of the COG tethering complex, essential for GT recycling and normal protein 
glycosylation, as shown by accumulation of intra-Golgi COG complex-dependent 
(CCD) vesicles in knock-down cells for the Cog3 and Cog7 subunits (Zolov and 
Lupashin, 2005). These vesicles were enriched in the medial-Golgi enzymes 
GlcNAcTI and mannosidase II and in the trans-Golgi enzyme GalT (Shestakova 
et al., 2006) thus, it is feasible that FUT9 may also be accumulated in those 
vesicles.  
Additional levels of complexity in the regulation of sorting of Golgi-resident 
proteins seem to be played by lipid environment (Bretscher and Munro, 1993; 
Mitra et al., 2004) and the pH gradient present in the GA. It has been shown that 
the pH influenced oligomerization and stable retention of the late-Golgi enzyme 
α2,6-SialylT (Chen et al., 2000; Fenteany and Colley, 2005) and that the 
neutralization of the pH gradient of the GA caused alterations in the localization 
of GlcNAcTI, GlcNAcTII and GalT (Axelsson et al., 2001). Lumenal pH may 
induce protein-protein interactions or structural/conformational changes in    
Golgi-resident proteins (Weiss and Nilsson, 2000) that could expose the 
cytoplasmic tails and make them available to specific sorting interactions. Only 
the identification of the molecular partners of the cytoplasmic tails of GTs, in 
particular of FUT9, and the determination of the nature of the interaction will allow 
the clarification of the role of this domain in the trans-Golgi/TGN localization of 
the enzyme. 
 
In vivo, the LacNAc acceptor substrate can originate several glycan 
structures besides Lex, some of which were found in the brain. Generally,     
brain-type glycosylation is characterized by predominance of neutral N-glycans 
and low levels of peripheral sialylation (reviewed by Albach et al., 2001). 
However, NeuAc is known to play important functions in the CNS, and the    
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α2,3-linked NeuAc acid in the reducing end of LacNAc of N-glycans can be the 
starting point for the formation of polysialic acid (Finne, 1982; Muhlenhoff et al., 
1996; Nakayama and Fukuda, 1996). As endogenous FUT9 is not capable of 
fucosylating sialylated type II acceptors (Chapters 2 and 4) and α2,3-SialylT is 
not capable of sialylating fucosylated acceptors (Wlasichuk et al., 1993), the 
enzymes catalyze mutually exclusive reactions. Another possible product formed 
from LacNAc in the brain is the HNK-1 epitope (SO3--GlcAβ3Galβ4GlcNAc) 
(Schachner and Martini, 1995). In several regions of the murine brain it was 
observed that HNK-1 and Lex presented complementary locations (Mai et al., 
1995). Moreover, both epitopes can decorate the same glycoconjugate in a 
developmentally-regulated manner, like it has been observed for the CSPG 
phosphocan (Maeda et al., 1994; Allendoerfer et al., 1995). Thus, the synthesis 
of Lex, polysialic acid or HNK-1 will be determined by the competition between 
FUT9, α2,3-SialylT and β3-glucoronyltransferase. The predominance of one 
structure over the others may depend on the affinities of the different GTs for the 
terminal LacNAc acceptor substrate, the levels of expression of each GT and the 
relative localization of the competing enzymes in the GA.  Recently, it was shown 
that the sub-Golgi localization of glycolipid GTs integrated in multienzyme 
complexes was influenced by the relative contribution of each element of the 
complex (Uliana et al., 2006b). This study suggested that sub-compartment 
localization of GTs may change according to the levels of expression, reinforcing 
the concept that interference in the correct localization of FUT9 may have a great 
impact on the definition of the predominant biosynthetic route and, consequently, 
on the biological events to which these carbohydrate epitopes are associated, 
such as neural cell-adhesion, cell migration and neurite outgrowth (Fujimoto       
et al., 2001; Chou et al., 2004; Johnson et al., 2005).  
167 
CHAPTER 6 
6.1.3. Expression of FUT9 and Lex during neuronal development 
 
In this thesis work, FUT9 was identified as the enzyme responsible for Lex 
biosynthesis in NT2N neurons, a model of human CNS neurons (Pleasure et al., 
1992). This conclusion was based on the detection of both FUT9 transcripts and 
protein, which correlated with Lex expression levels, and on the presence of an 
α3-FUT activity with an acceptor specificity profile typical of FUT9 (Chapter 4). As 
referred above, FUT9 had already been assigned as the α3-FUT that catalyzes 
the synthesis of Lex in the rodent brain. Our data associating FUT9 and Lex in 
human CNS generalize the definition of FUT9 as the brain-type FUT            
cross-species.  
An important role for FUT9 has been hypothesized since its first cloning 
from a cDNA library of human gastric mucosa (Kaneko et al., 1999b). The 
divergence of the FUT9 from the other α3-FUT family members and the high 
conservation of the FUT9 gene between species (Kudo et al., 1998;           
Kaneko et al., 1999b; Baboval et al., 2000; Patnaik et al., 2000) at the level of 
genes such as histone and α-actin (Kaneko et al., 1999b), suggested a strong 
selective pressure during evolution.  
The biosynthetic product of FUT9, the Lex epitope, was upregulated 
during human NT2N neurons differentiation in vitro, being detected in the majority 
of the NT2N neurons (Chapter 4). Moreover, analysis of the levels of the Lex 
epitope in rat hippocampal cultures showed detection of Lex confined to a small 
sub-population of neurons (Chapter 5). The Lex could play a similar functional 
role in the CNS of the two species. 
We have identified a subset of rat hippocampus neurons that expressed 
the Lex determinant as GABAergic interneurons (Chapter 5). In the brain of the 
FUT9-/- mouse, concomitantly to Lex disappearance, a reduction in the number of 
amygdalar calbindin (CB)-positive GABAergic neurons was observed           
(Kudo et al., 2007). The NT2 cell line is a model system of human neuronal 
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differentiation and NT2N neurons present features of CNS human immature 
neurons (Pleasure et al., 1992; Przyborski et al., 2000), such as the ability to 
express several neurotransmitter phenotypes, including GABA (Yoshioka et al., 
1997; Guillemain et al., 2000). Thus, it is feasible to hypothesize that the NT2 cell 
line, under the used culture conditions, differentiated preferentially into 
GABAergic neurons, the neuronal subtype that presented high detection of the 
Lex epitope in rat hippocampus. Favoring this hypothesis, results obtained using 
differentiation conditions similar to ours, indicated that 62 to 66% of the total 
NT2N neurons in culture were GABAergic (Guillemain et al., 2000). Co-detection 
of Lex and a marker of GABAergic neurons, such as GABA or GAD, in NT2N 
neurons will be needed to clarify this issue.  
 
Concerning the cellular localization of Lex, both in human NT2N neurons 
and rat hippocampus GABAergic neurons, the epitope was present in the cell 
bodies and in the neuritic processes, localized at the plasma membrane and in 
TI-VAMP and LAMP-1 positive intracellular structures (Chapters 4 and 5). These 
most probably corresponded to the TI-VAMP exocytic compartment, which is 
associated with LAMP-1 positive late endosomes/lysosomes (Arantes and 
Andrews, 2006), and known to be involved in neurite outgrowth in rodent 
(reviewed by Proux-Gillardeaux et al., 2005). Our results suggested that the 
neuronal TI-VAMP exocytic pathway might share common cross-species 
features, including Lex-carriers as cargo, and, consequently, common functions.  
Several Lex-carrier proteins of high apparent molecular masses (above 
400 kDa) were identified in human NT2N neurons and rat hippocampus neurons 
and might correspond to the cargo of the TI-VAMP pathway detected by 
immunofluorescence microscopy (Chapters 4 and 5). So far, besides the already 
mentioned LAMP-1, only the L1 adhesion molecule (Alberts et al., 2003) and the 
SYT7 Ca2+-sensor (Arantes and Andrews, 2006) have been identified as 
components of the TI-VAMP neuronal pathway. In spite of being glycosylated 
(Carlsson et al., 1988; Streit et al., 1990) none of these proteins where identified 
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by us as Lex-carriers. The 460 kDa carrier detected in NT2N neurons was also 
decorated with the HNK-1 epitope in addition to Lex. Both epitopes were 
insensitive to PNGaseF digestion and the apparent molecular mass of the carrier 
remained unaltered after chondroitinase ABC incubation, suggesting that the Lex 
and HNK-1 epitopes could be attached to O-mannosyl oligosaccharides on a 
neuronal PG, which was not of the chondroitin sulfate type (Chapter 4). 
Supporting this hypothesis, there were previous reports of mannose-linked        
O-oligosaccharides in rat brain proteoglycans that carried Lex and HNK-1 
epitopes (Krusius et al., 1987; Yuen et al., 1997; Kogelberg et al., 2001). 
Furthermore, Cat-315, a neuron specific epitope of the HNK-1 family, probably  
O-mannose linked, was recently detected in proteoglycans and related to 
neuritogenesis and synaptogenesis (Dino et al., 2006). Changes in the 
carbohydrate epitopes presented by the same glycoconjugate have been 
reported (Rauch et al., 1991; Maeda et al., 1994; Allendoerfer et al., 1995) and 
are thought to regulate its function. Additional studies will be required to clarify 
the nature of the Lex-carriers identified in human and rat neurons and to 
understand if the expression of the determinant occurs in the same 
glycoconjugates. 
An important role for Lex in neuronal adhesion and neurite initiation of 
outgrowth was revealed by anti-Lex antibody incubation assays. In human NT2N 
neurons, an anti-Lex antibody impaired adhesion of neurons and neurites already 
formed to the surface and caused a decrease in the initiation of outgrowing 
neurites (Chapter 5). The antibody could block interactions between the neurons 
and matrix components or it could be internalized via the TI-VAMP pathway, 
affecting intracellular interactions important for the above-mentioned functions. 
On the other hand, a role for the Lex-carriers in synaptogenesis was suggested 
by analysis of mature rat hippocampal co-cultures, 3 weeks after plating. It was 
observed that at the plasma membrane of GABAergic neurons, the Lex-carriers 
were in post-synaptic domains, including spine-like protrusions or phillopodia. 
The labelling was closely related to the sites of establishment of synapses, as 
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determined by the detection of Lex epitope in punctate structures that were not in 
colocalization with GAD and were in apposition with synaptophysin labeling 
(Chapter 5).  
In order to relate the results obtained in both cell systems it will be useful 
to perform additional studies. NT2N neurons become mature and functional, 
forming excitatory and inhibitory synapses, when in co-culture with astrocytes 
(Hartley et al., 1999). The detection of Lex, neuronal subtype markers and 
synaptic markers in these cultures would help not only to relate the pattern of 
expression of Lex-carriers with the neurotransmitter phenotype but also to 
investigate if, accordingly to our hypothesis, in human NT2N neurons there is 
also an association of Lex with synaptogenesis. Furthermore, studies performed 
in human and rat cultures that would allow the evaluation of the effect of impaired 
TI-VAMP mediated membrane trafficking, and consequent inhibition of neurite 
outgrowth on Lex distribution, would be of great importance for the enlightenment 
of the relation between Lex-carriers and the TI-VAMP exocytic mediated pathway 
in neurite outgrowth and synaptogenesis. Finally, the identification of the         
Lex-carriers would allow the undoubtedly assignment of the conserved function of 
the Lex epitope in the CNS. 
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6.2. General conclusions 
 
The work described in this thesis allowed a better understanding of the 
properties and functions of FUT9 and its biosynthetic product, Lex, in the CNS. 
In vitro, human FUT9 was shown to efficiently catalyze the synthesis of 
the Lex determinant in N-glycans from glycoproteins. In human NT2N neurons, 
Lex synthesis was assigned to FUT9, defining the enzyme as the brain-type     
α3-FUT.  
Lex was shown to be upregulated during neuronal differentiation both on 
human NT2N neurons and on a subpopulation of GABAergic rat hippocampus 
interneurons. In both cellular systems, Lex was localized on the PM and in the 
exocytic TI-VAMP compartment, suggesting a common function for the TI-VAMP 
pathway in human and rat CNS.  
Lex played an important role in neuronal cell adhesion and neurite 
initiation of outgrowth from human NT2N neurons. Furthermore, it was present in 
synaptic adjacent regions from rat hippocampus GABAergic interneurons. 
In summary, this work indicates that FUT9 synthesizes the Lex epitope in 
the human CNS, specifically on N-linked oligosaccharides of glycoproteins, 
underlying the biological functions of Lex in neuronal adhesion and differentiation 
processes, such as initiation of neurite outgrowth and possibly synaptogenesis. 
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